Clinical Trials - AZN

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07201558Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsNOT_YET_RECRUITINGPHASE12025-11-282028-06-272028-06-27
NCT07073950A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD)NOT_YET_RECRUITINGPHASE42025-11-142027-03-312027-03-31
NCT07088926A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa ColonizationNOT_YET_RECRUITINGPHASE22025-11-122028-06-142027-12-09
NCT07155226Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionNOT_YET_RECRUITINGPHASE1, PHASE22025-11-032029-06-182029-06-18
NCT07109219Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic LeukemiaNOT_YET_RECRUITINGPHASE1, PHASE22025-10-312028-07-032028-04-28
NCT06594068Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab UsersRECRUITINGPHASE42025-10-312027-08-312027-08-31
NCT07123454A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaNOT_YET_RECRUITINGPHASE1, PHASE22025-10-312028-03-012028-03-01
NCT06531798Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary DiseaseNOT_YET_RECRUITINGPHASE42025-10-302027-12-302026-10-30
NCT07161414A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyNOT_YET_RECRUITINGPHASE12025-10-212028-03-282026-08-27
NCT06996782A Platform Study in Non-Small Cell Lung Cancer (NSCLC)NOT_YET_RECRUITINGPHASE1, PHASE22025-10-132028-10-132028-10-13
NCT07192614A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerRECRUITINGPHASE1, PHASE22025-09-302029-04-022029-04-02
NCT07205822A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerNOT_YET_RECRUITINGPHASE32025-09-302028-02-022028-02-02
NCT06909773The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular DiseasesNOT_YET_RECRUITINGNA2025-09-302026-06-302026-03-31
NCT07024706Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± ObinutuzumabNOT_YET_RECRUITINGPHASE22025-09-302032-11-302032-11-30
NCT07181161Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerNOT_YET_RECRUITINGPHASE1, PHASE22025-09-222029-01-092029-01-09
NCT06992609Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.RECRUITINGPHASE32025-09-152029-06-302029-06-30
NCT07029737A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in SpainRECRUITINGPHASE22025-09-052028-12-152027-06-15
NCT07128615A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)RECRUITINGPHASE1, PHASE22025-09-042027-01-072026-01-29
NCT07060365A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian CancerRECRUITINGPHASE1, PHASE22025-09-022029-05-292029-05-29
NCT06851806Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) DiseaseNOT_YET_RECRUITINGNA2025-08-302026-06-302026-06-30
NCT07143604A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2RECRUITINGPHASE22025-08-292027-09-282026-09-28
NCT07154901A Phase I Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)RECRUITINGPHASE12025-08-182025-12-312025-12-31
NCT07098338A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)RECRUITINGPHASE22025-08-072029-04-062027-03-21
NCT07007793A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary AldosteronismRECRUITINGPHASE32025-08-072028-02-182028-02-18
NCT06952803A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationRECRUITINGPHASE32025-08-062036-05-222033-04-22
NCT07081633Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular CarcinomaRECRUITINGPHASE22025-08-052028-12-312026-11-30
NCT07044336Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)RECRUITINGPHASE32025-08-012028-04-032027-11-02
NCT07073547A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple MyelomaRECRUITINGPHASE12025-07-312028-06-192028-06-19
NCT07115043A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRECRUITINGPHASE1, PHASE22025-07-292029-04-092029-04-09
NCT07000149A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCCRECRUITINGPHASE32025-07-282032-07-292030-02-21
NCT07088913A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy ParticipantsRECRUITINGPHASE12025-07-282025-09-292025-09-29
NCT07069712A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRECRUITINGPHASE22025-07-172028-09-202026-12-23
NCT07064122A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)NOT_YET_RECRUITINGPHASE1, PHASE22025-07-042028-10-052028-10-05
NCT06839872A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWITHDRAWNPHASE22025-06-302030-07-292028-07-28
NCT07082738A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseRECRUITINGPHASE22025-06-272027-11-052027-11-05
NCT06951880A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersNOT_YET_RECRUITINGPHASE12025-06-272026-09-242026-09-24
NCT06884267Hyperkalemia Quality Improvement Program (HK-QIP) StudyRECRUITINGNA2025-06-252027-12-112027-12-11
NCT07065331A Study of Inhaled AZD8630 in Adolescents With AsthmaRECRUITINGPHASE12025-06-112026-02-132026-02-13
NCT07000136A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFHRECRUITINGPHASE32025-06-102027-04-062027-04-06
NCT07024823A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortRECRUITINGPHASE12025-06-092026-04-302026-04-30
NCT06995820A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.RECRUITINGPHASE12025-06-062026-10-122026-10-12
NCT07000357A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventRECRUITINGPHASE32025-06-042029-10-262029-10-26
NCT07013643A Study to Investigate the Effect of AZD6234 and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or ObesityRECRUITINGPHASE12025-06-042026-01-072026-01-07
NCT06942936A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female ParticipantsRECRUITINGPHASE12025-05-282026-03-252026-03-25
NCT07000123A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD EventRECRUITINGPHASE32025-05-282027-03-242027-03-24
NCT06980428A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) LevelsRECRUITINGPHASE12025-05-272026-12-042026-12-04
NCT07069725The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.RECRUITINGPHASE12025-05-262026-02-192026-02-19
NCT06996886A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral FormulationsCOMPLETEDPHASE12025-05-222025-07-252025-07-15
NCT06929260A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug ZRECRUITINGPHASE12025-05-212026-03-022025-11-12
NCT07017179This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/OverweightRECRUITINGPHASE22025-05-202026-08-062026-08-06
NCT06979388A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.COMPLETEDPHASE12025-05-202025-07-122025-07-12
NCT06989983A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462COMPLETEDPHASE12025-05-202025-06-252025-06-25
NCT06960577Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)RECRUITINGPHASE32025-05-152028-10-312028-10-31
NCT06974565A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With QuinidineCOMPLETEDPHASE12025-05-122025-07-182025-07-18
NCT06973005A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy ParticipantsCOMPLETEDPHASE12025-05-082025-07-182025-07-18
NCT06942910A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High ProteinuriaRECRUITINGPHASE22025-05-072026-07-312026-07-31
NCT06921785Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaRECRUITINGPHASE32025-05-062030-03-142029-03-16
NCT06948747A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-05-062025-09-252025-09-25
NCT06916806A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies.RECRUITINGPHASE12025-05-012027-06-222027-02-09
NCT06921928Study for AZD4360 in Participants With Advanced Solid TumoursRECRUITINGPHASE1, PHASE22025-04-292027-12-162027-03-31
NCT06948006A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy ParticipantsCOMPLETEDPHASE12025-04-232025-06-272025-06-27
NCT06942923A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With ObesityCOMPLETEDPHASE12025-04-222025-09-292025-09-29
NCT06897930A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLERECRUITINGPHASE1, PHASE22025-04-212029-05-012029-05-01
NCT06512883A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesRECRUITINGPHASE32025-04-172027-12-292026-10-06
NCT06925854A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy ParticipantsCOMPLETEDPHASE12025-04-172025-06-122025-06-12
NCT06897748A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated EosinophilsRECRUITINGPHASE22025-04-122026-04-302026-04-30
NCT06868277A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerRECRUITINGPHASE32025-04-102030-12-022030-01-17
NCT06908577An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of TozorakimabACTIVE_NOT_RECRUITINGPHASE12025-04-072025-11-252025-11-25
NCT06713369AZD5305 hADME in Patients With Advanced Solid MalignanciesRECRUITINGPHASE12025-04-022026-10-022026-10-02
NCT06943833A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)RECRUITINGPHASE22025-03-312029-03-302028-03-31
NCT06750289Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentRECRUITINGPHASE32025-03-282027-11-022027-11-02
NCT06989112DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerRECRUITINGPHASE32025-03-272031-02-192029-01-19
NCT06795022First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursRECRUITINGPHASE1, PHASE22025-03-272028-07-252028-02-25
NCT06932263Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsRECRUITINGPHASE22025-03-262028-03-162027-06-24
NCT06899061Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of SaruparibRECRUITINGPHASE12025-03-252026-11-192026-07-21
NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)RECRUITINGPHASE32025-03-252029-06-052029-03-13
NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPDRECRUITINGPHASE32025-03-182029-06-052029-03-13
NCT06677060Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinRECRUITINGPHASE32025-03-142029-12-172029-12-17
NCT06792695A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerRECRUITINGPHASE22025-03-122028-06-072027-05-31
NCT06851858Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistRECRUITINGPHASE22025-03-122026-07-082026-07-08
NCT06879041A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerRECRUITINGPHASE12025-03-102029-04-162029-04-16
NCT06857695A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004COMPLETEDPHASE12025-03-062025-05-052025-05-05
NCT06824987Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney DiseaseRECRUITINGPHASE22025-03-052027-08-302027-08-30
NCT06742723A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRECRUITINGPHASE32025-03-032030-04-182030-04-18
NCT06764875A Phase â…˘ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerRECRUITINGPHASE32025-03-012030-12-092029-04-27
NCT06732882Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.COMPLETEDPHASE12025-02-272025-05-292025-05-29
NCT06846528A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy ParticipantsCOMPLETEDPHASE12025-02-262025-04-232025-04-23
NCT06845813Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234RECRUITINGPHASE12025-02-242026-01-082026-01-08
NCT06862791A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs AloneACTIVE_NOT_RECRUITINGPHASE22025-02-182026-06-182026-06-18
NCT06644924A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaCOMPLETEDPHASE22025-02-102025-06-042025-06-04
NCT06812780A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389COMPLETEDPHASE12025-02-042025-09-042025-09-04
NCT06651970Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailureRECRUITINGPHASE42025-02-042030-08-162030-08-16
NCT06564038A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell MalignanciesRECRUITINGPHASE1, PHASE22025-01-302031-04-252031-04-25
NCT06795906A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With AsthmaCOMPLETEDPHASE12025-01-282025-06-272025-06-27
NCT06723756A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy AdultsCOMPLETEDPHASE12025-01-232025-06-012025-06-01
NCT06754761Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of CeralasertibNOT_YET_RECRUITINGPHASE12025-01-172025-08-082025-08-08
NCT06764186A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in SpainRECRUITINGPHASE32025-01-072027-12-312027-12-31
NCT06429761Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian PatientsRECRUITINGPHASE42025-01-022026-10-312026-10-31
NCT06749457A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)RECRUITINGPHASE1, PHASE22024-12-302027-07-062026-10-09
NCT06746116A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in SpainACTIVE_NOT_RECRUITINGPHASE32024-12-302028-11-302028-11-30
NCT06742853A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.ACTIVE_NOT_RECRUITINGPHASE12024-12-202025-10-312025-10-31
NCT06813781Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004RECRUITINGPHASE12024-12-192025-10-062025-10-06
NCT06742762A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004COMPLETEDPHASE12024-12-172025-04-202025-04-20
NCT06681324Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyRECRUITINGPHASE22024-12-112027-06-182026-05-04
NCT06675175A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.RECRUITINGPHASE12024-12-092025-10-272025-10-27
NCT06834932A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With DyslipidaemiaRECRUITINGPHASE2, PHASE32024-12-062027-06-182027-06-18
NCT06750276A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.COMPLETEDPHASE22024-12-062025-07-282025-07-28
NCT06715670A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese ParticipantsCOMPLETEDPHASE12024-12-052025-02-192025-02-19
NCT06706817A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabRECRUITINGPHASE32024-12-032027-01-292027-01-29
NCT06627647A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLCRECRUITINGPHASE32024-11-272030-03-252029-05-10
NCT06526793AZD0486 as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRECRUITINGPHASE22024-11-272029-06-142027-03-10
NCT06693765A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy ParticipantsCOMPLETEDPHASE12024-11-182025-04-232025-04-23
NCT06692738A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)RECRUITINGPHASE32024-11-182029-10-082029-02-05
NCT06661733A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants With Renal ImpairmentCOMPLETEDPHASE12024-11-182024-12-232024-12-23
NCT06703658A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12024-11-022025-03-132025-03-13
NCT06657105A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing PotentialCOMPLETEDPHASE12024-11-012025-02-032025-02-03
NCT06639997Safety and Tolerability of AZD5148 in Japanese ParticipantsACTIVE_NOT_RECRUITINGPHASE12024-10-312026-01-192026-01-19
NCT06692764A Study to Assess the Effect of AZD0780 on Ambulatory Blood PressureCOMPLETEDPHASE22024-10-302025-05-022025-04-18
NCT06662123Pharmacokinetic and Safety Study of Subcutaneous and Intravenous Anifrolumab Delivered in Healthy Adult ParticipantsCOMPLETEDPHASE12024-10-212025-01-102025-01-10
NCT06651021A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese ParticipantsCOMPLETEDPHASE12024-10-212024-10-282024-10-28
NCT06599502A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D MutationRECRUITINGPHASE1, PHASE22024-10-182028-01-202028-01-20
NCT06590740Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients.COMPLETEDPHASE42024-10-182025-09-032025-09-03
NCT06340581A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a SpacerWITHDRAWNPHASE12024-10-172025-02-272025-02-27
NCT06432764Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.RECRUITINGPHASE12024-10-162026-08-142026-08-14
NCT06611423AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal ImpairmentTERMINATEDPHASE12024-10-152025-08-212025-08-21
NCT06564844A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological FeaturesRECRUITINGPHASE32024-10-152035-01-192033-05-19
NCT06579105Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.ACTIVE_NOT_RECRUITINGPHASE22024-10-082025-12-192025-12-19
NCT06579092Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related ComorbidityACTIVE_NOT_RECRUITINGPHASE22024-10-082025-12-092025-12-09
NCT06417814A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerRECRUITINGPHASE32024-10-042028-05-292026-06-11
NCT06595238A Study in Participants With Obesity or Overweight With at Least One Weight-related ComorbidityACTIVE_NOT_RECRUITINGPHASE22024-10-012025-12-082025-08-08
NCT06473779Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.RECRUITINGPHASE32024-09-302027-06-302027-06-30
NCT06639087A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal ImpairmentTERMINATEDPHASE12024-09-272025-05-292025-05-29
NCT06635447Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsRECRUITINGPHASE32024-09-262026-10-312026-10-31
NCT06671405An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug InteractionsCOMPLETEDPHASE12024-09-252025-02-172025-02-17
NCT06606847A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)ACTIVE_NOT_RECRUITINGPHASE22024-09-242027-06-302026-06-30
NCT06542250A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.RECRUITINGPHASE1, PHASE22024-09-182028-02-142028-02-14
NCT06563102Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild AsthmaRECRUITINGPHASE42024-09-112025-11-102025-11-10
NCT06529419A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsRECRUITINGPHASE22024-08-302026-04-062026-03-18
NCT06450197Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseRECRUITINGPHASE22024-08-282027-08-022026-06-12
NCT06547164A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female ParticipantsCOMPLETEDPHASE12024-08-272025-08-202025-08-20
NCT06448754Volrustomig Priming Regimens Exploratory Phase II Platform StudyRECRUITINGPHASE22024-08-272027-06-302027-06-30
NCT06610526A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney DiseaseRECRUITINGPHASE42024-08-232027-04-272027-04-27
NCT06535607Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid TumorsRECRUITINGPHASE22024-08-222027-10-072027-10-07
NCT06514157Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.COMPLETEDPHASE12024-08-192024-09-092024-09-09
NCT06555822A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy ParticipantsCOMPLETEDPHASE12024-08-152025-03-062025-03-06
NCT06467357Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract CancerRECRUITINGPHASE32024-08-122029-05-162028-06-12
NCT06576765Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780COMPLETEDPHASE12024-08-082024-11-082024-11-08
NCT06549595A Study of AZD0486 Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsRECRUITINGPHASE32024-08-072031-11-262031-11-26
NCT06527755A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese VolunteersCOMPLETEDPHASE12024-08-062024-11-152024-09-11
NCT06531811A Study to Investigate the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition in Healthy Participants.COMPLETEDPHASE12024-08-062024-10-032024-10-03
NCT06435273Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With AsthmaACTIVE_NOT_RECRUITINGPHASE22024-08-052025-10-132025-10-13
NCT06554821A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy ParticipantsCOMPLETEDPHASE12024-08-052024-10-082024-10-08
NCT06502379A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy ParticipantsRECRUITINGPHASE12024-08-022025-11-102025-11-10
NCT06592482A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780COMPLETEDPHASE12024-08-022024-12-012024-12-01
NCT05926349A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or ProcedureWITHDRAWNPHASE32024-08-022027-09-072027-01-05
NCT06380751Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerRECRUITINGPHASE32024-08-012030-10-182029-03-30
NCT06494644A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.COMPLETEDPHASE12024-07-232024-10-052024-10-05
NCT06502366A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With AsthmaRECRUITINGPHASE32024-07-222026-03-032026-03-03
NCT05952024Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCLRECRUITINGPHASE22024-07-162027-08-242027-08-24
NCT06491550A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy ParticipantsCOMPLETEDPHASE12024-07-152025-06-112025-06-11
NCT06519968A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.COMPLETEDPHASE12024-07-152024-12-272024-12-27
NCT06015737A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusRECRUITINGPHASE32024-06-292027-12-292027-12-29
NCT06469151A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy AdultsACTIVE_NOT_RECRUITINGPHASE12024-06-242025-11-072025-11-07
NCT06455449A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)RECRUITINGPHASE32024-06-202028-08-042027-05-14
NCT06471257A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With AsthmaRECRUITINGPHASE32024-06-172026-10-302026-10-30
NCT06336356A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled HypertensionCOMPLETEDPHASE22024-06-102024-12-042024-12-04
NCT06299826A Phase IIb Study of AZD5462 in Patients With Chronic Heart FailureACTIVE_NOT_RECRUITINGPHASE22024-06-042026-02-122026-02-12
NCT06307665Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaRECRUITINGPHASE32024-05-202027-10-132027-10-13
NCT06368440A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese ParticipantsCOMPLETEDPHASE12024-05-152024-12-232024-12-23
NCT06406400Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).TERMINATEDPHASE12024-05-132024-07-312024-07-31
NCT06422689Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareRECRUITINGPHASE42024-05-102026-04-292026-04-29
NCT06388616Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of BalcinrenoneCOMPLETEDPHASE12024-05-022024-09-052024-09-05
NCT06350123Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney DiseaseCOMPLETEDPHASE22024-05-012025-05-092025-05-09
NCT06297668A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a SpacerCOMPLETEDPHASE12024-04-292024-06-112024-06-11
NCT06350097Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung CancerRECRUITINGPHASE32024-04-292032-05-252028-03-21
NCT06194448To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsACTIVE_NOT_RECRUITINGPHASE22024-04-212027-07-072026-07-07
NCT06357520A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy ParticipantsCOMPLETEDPHASE12024-04-162024-06-172024-06-17
NCT06307652Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionRECRUITINGPHASE32024-04-122027-06-112027-06-11
NCT06348355A Positron-emission Tomography Study to Determine Brain Exposure of [11C]Savolitinib in Healthy VolunteersCOMPLETEDPHASE12024-04-122024-06-242024-06-24
NCT06357533Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsRECRUITINGPHASE32024-04-112030-05-242028-04-24
NCT06311760A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy ParticipantsCOMPLETEDPHASE12024-04-092025-02-202025-02-20
NCT06344104A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionACTIVE_NOT_RECRUITINGPHASE32024-04-082026-04-032025-11-24
NCT06304961A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy VolunteersCOMPLETEDPHASE12024-04-082024-09-092024-09-09
NCT06008093A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRASRECRUITINGPHASE32024-04-042031-03-202027-08-17
NCT06381466A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.SUSPENDEDPHASE12024-04-012025-09-162025-09-16
NCT06268873A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.RECRUITINGPHASE32024-03-292028-02-112028-02-11
NCT06218914Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsRECRUITINGPHASE12024-03-222044-04-152027-08-30
NCT06327815Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DMACTIVE_NOT_RECRUITINGPHASE42024-03-152025-06-302025-06-30
NCT05835310An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsRECRUITINGPHASE32024-03-142030-03-122028-10-05
NCT06267729Study of AZD0754 in Participants With Metastatic Prostate CancerRECRUITINGPHASE1, PHASE22024-03-122027-06-302027-06-30
NCT06346392AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2RECRUITINGPHASE32024-03-042027-04-192026-10-19
NCT06168409A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant HypertensionCOMPLETEDPHASE32024-03-012025-08-172025-08-17
NCT06194032A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy ParticipantsCOMPLETEDPHASE12024-02-292024-05-132024-05-13
NCT06465485STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic AsthmaACTIVE_NOT_RECRUITINGPHASE32024-02-282026-03-312025-10-31
NCT05925530Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)ACTIVE_NOT_RECRUITINGPHASE22024-02-222027-08-272026-01-12
NCT06283966A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRECRUITINGPHASE32024-02-212028-03-072028-03-07
NCT06271837A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing TumorsRECRUITINGPHASE22024-02-182027-04-012025-10-30
NCT06157255An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604COMPLETEDPHASE12024-02-162024-05-202024-05-20
NCT06269484A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKCOMPLETEDPHASE22024-02-152024-12-112024-12-11
NCT06040099A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARERECRUITINGPHASE22024-02-132026-10-232026-10-23
NCT06179511Study of AZD9829 in CD123+ Hematological MalignanciesRECRUITINGPHASE1, PHASE22024-01-312027-01-072027-01-07
NCT06137144AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.RECRUITINGPHASE1, PHASE22024-01-232026-05-082026-05-08
NCT06173570A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With DyslipidemiaCOMPLETEDPHASE22024-01-192024-09-302024-09-30
NCT05970263IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the USWITHDRAWNPHASE42024-01-192025-12-312025-12-31
NCT06130553A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid TumorsRECRUITINGPHASE1, PHASE22024-01-182026-05-272026-05-27
NCT06238466A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With DyslipidemiaACTIVE_NOT_RECRUITINGPHASE12024-01-162025-12-022025-12-02
NCT06075095A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPDCOMPLETEDPHASE32024-01-112025-08-122025-08-12
NCT06137118AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaRECRUITINGPHASE1, PHASE22023-12-292027-06-292026-11-13
NCT06245551A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With AsthmaCOMPLETEDPHASE32023-12-222024-06-292024-06-29
NCT06084884A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular CarcinomaACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-12-142027-12-132027-12-13
NCT06129864A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent ChemoradiotherapyRECRUITINGPHASE32023-12-142030-09-122028-04-18
NCT06219941AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RECRUITINGPHASE22023-12-132026-12-312025-12-30
NCT05951959A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment NaĂŻve Mantle Cell LymphomaACTIVE_NOT_RECRUITINGPHASE22023-12-132028-07-072028-07-07
NCT06106945AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple MyelomaRECRUITINGPHASE1, PHASE22023-12-052027-03-152027-03-15
NCT06188520A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid TumorsRECRUITINGPHASE1, PHASE22023-12-052026-06-172026-06-17
NCT06109779Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)RECRUITINGPHASE32023-12-042030-05-032029-01-02
NCT06194825EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid CardiomyopathyACTIVE_NOT_RECRUITINGPHASE32023-12-012027-01-052026-05-14
NCT06147063A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19COMPLETEDPHASE12023-11-272025-03-272024-04-30
NCT06103864A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast CancerRECRUITINGPHASE32023-11-232029-04-302026-10-31
NCT06034743A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionACTIVE_NOT_RECRUITINGPHASE32023-11-222025-10-132025-05-21
NCT06120491Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsRECRUITINGPHASE32023-11-212031-04-302028-01-11
NCT06138795A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy ParticipantsCOMPLETEDPHASE12023-11-202025-08-242025-08-24
NCT06020014Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABAACTIVE_NOT_RECRUITINGPHASE22023-11-162025-10-302025-10-30
NCT06139991Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.COMPLETEDPHASE12023-11-162024-05-042024-05-04
NCT06115967A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy ParticipantsACTIVE_NOT_RECRUITINGPHASE12023-11-152026-03-302026-03-30
NCT06112379A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerACTIVE_NOT_RECRUITINGPHASE32023-11-142032-09-232028-11-20
NCT06132841A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or ObeseACTIVE_NOT_RECRUITINGPHASE12023-11-132026-03-232026-03-04
NCT06097728MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaRECRUITINGPHASE32023-11-092028-03-132027-03-15
NCT05925803Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)RECRUITINGPHASE32023-11-082027-12-312026-10-09
NCT06087835Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)ACTIVE_NOT_RECRUITINGPHASE32023-11-072027-01-222027-01-22
NCT06122714A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy ParticipantsCOMPLETEDPHASE12023-11-072024-12-042024-12-04
NCT06103877A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy VolunteersACTIVE_NOT_RECRUITINGPHASE12023-11-012026-01-132026-01-13
NCT06093542A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.COMPLETEDPHASE12023-10-252024-03-202024-03-20
NCT06067828A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).RECRUITINGPHASE32023-10-242026-01-302026-01-30
NCT05984277A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.RECRUITINGPHASE32023-10-242029-03-232028-04-24
NCT05952557An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)RECRUITINGPHASE32023-10-052037-05-062030-03-04
NCT06057064Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19COMPLETEDPHASE22023-09-292024-05-172024-05-17
NCT06151964A Trial to Learn How Safe AZD9550 is in People With or Without Type 2 Diabetes Who Are Overweight or ObeseACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-09-292026-10-012026-10-01
NCT06053424Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's DiseaseCOMPLETEDPHASE12023-09-252024-10-082024-10-08
NCT06079671Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)RECRUITINGPHASE32023-09-222029-10-182026-11-17
NCT06040086Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsACTIVE_NOT_RECRUITINGPHASE32023-09-222026-05-222026-03-02
NCT05938270A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.RECRUITINGPHASE12023-09-212026-02-112026-02-11
NCT05825365Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, Phaseâ…ˇ, Double-Blinded, Placebo-Controlled StudyWITHDRAWNPHASE22023-08-312026-06-302026-06-30
NCT06023589A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRECRUITINGPHASE32023-08-242030-08-232028-05-31
NCT05771480Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)ACTIVE_NOT_RECRUITINGPHASE32023-08-162026-03-172025-09-17
NCT05943106BCG in Combination With Durvalumab in Adult BCG-naĂŻve, High-risk NMIBC ParticipantsACTIVE_NOT_RECRUITINGPHASE32023-08-112027-05-302025-06-16
NCT05932641Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12023-07-312024-12-052024-12-05
NCT06042049A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of NirsevimabACTIVE_NOT_RECRUITINGPHASE32023-07-272025-08-152024-09-10
NCT05955183Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..COMPLETEDPHASE12023-07-272023-12-042023-12-04
NCT05924880A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)COMPLETEDPHASE32023-07-212025-02-072025-02-07
NCT05850234A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple MyelomaRECRUITINGPHASE1, PHASE22023-07-202028-11-152027-08-31
NCT05801029A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsACTIVE_NOT_RECRUITINGPHASE22023-07-182027-10-012027-10-01
NCT05877599A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationRECRUITINGPHASE12023-07-122039-08-012028-09-01
NCT06005493Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsRECRUITINGPHASE1, PHASE22023-07-112027-06-152027-06-15
NCT05883644Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)ACTIVE_NOT_RECRUITINGPHASE32023-06-272026-03-312025-09-30
NCT05941897A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based ChemotherapyACTIVE_NOT_RECRUITINGPHASE22023-06-212027-01-012024-07-29
NCT05919069A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693COMPLETEDPHASE12023-06-162024-09-162024-09-16
NCT05755932Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy ParticipantsCOMPLETEDPHASE32023-06-142024-07-222024-07-22
NCT05797168Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid TumorsRECRUITINGPHASE1, PHASE22023-06-052028-01-062028-01-06
NCT05888207A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male SubjectsCOMPLETEDPHASE12023-06-022023-08-172023-08-17
NCT05644600A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.TERMINATEDPHASE12023-05-262023-07-172023-07-17
NCT05872958Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response StudyCOMPLETEDPHASE12023-05-192024-08-202024-08-20
NCT05629234Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)ACTIVE_NOT_RECRUITINGPHASE32023-05-082027-02-222027-02-22
NCT05850494Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled AsthmaCOMPLETEDPHASE32023-05-022023-08-212023-08-21
NCT05848440A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy ParticipantsCOMPLETEDPHASE12023-05-022023-11-132023-11-13
NCT05818514A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy ParticipantsCOMPLETEDEARLY_PHASE12023-04-272023-07-112023-07-11
NCT05768360A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male SubjectsCOMPLETEDPHASE12023-04-252023-06-242023-06-24
NCT05737940A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2COMPLETEDPHASE22023-04-242025-08-252025-07-15
NCT05775159Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary CancerRECRUITINGPHASE22023-04-242026-12-142025-12-31
NCT05817461An ADME Study of [14C]AZD0780 in Healthy Male SubjectsCOMPLETEDPHASE12023-04-192023-06-062023-06-06
NCT05794672A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese SubjectsTERMINATEDPHASE12023-04-112023-07-082023-07-08
NCT05692180A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)RECRUITINGPHASE32023-04-052032-05-162030-05-05
NCT05774951A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyRECRUITINGPHASE32023-03-312036-05-292027-04-20
NCT05864391A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.TERMINATEDPHASE12023-03-312024-03-202024-03-20
NCT05751759Pharmacokinetics of Mitiperstat in Participants With Hepatic ImpairmentCOMPLETEDPHASE12023-03-202024-11-212024-11-21
NCT05809934A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisACTIVE_NOT_RECRUITINGPHASE22023-03-152025-09-172025-07-14
NCT05787002A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.COMPLETEDPHASE12023-03-092023-05-152023-05-15
NCT05742802Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).RECRUITINGPHASE32023-03-062026-08-172026-06-16
NCT05526755A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)ACTIVE_NOT_RECRUITINGPHASE22023-03-062029-11-222029-11-22
NCT05755906A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)COMPLETEDPHASE32023-02-272024-11-192024-11-19
NCT05557838Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular CarinomaRECRUITINGPHASE32023-02-222025-03-312025-03-31
NCT05790304Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female SubjectsCOMPLETEDPHASE12023-02-202024-02-222024-02-22
NCT05546866Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRmACTIVE_NOT_RECRUITINGPHASE22023-02-092029-06-302029-06-30
NCT05702229Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRECRUITINGPHASE22023-01-162027-07-012026-07-03
NCT05668936A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy ParticipantsTERMINATEDPHASE12023-01-032023-03-102023-03-10
NCT05687266Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic AlterationsACTIVE_NOT_RECRUITINGPHASE32022-12-292027-11-012027-11-01
NCT05647122First in Human Study of AZD9592 in Solid TumorsRECRUITINGPHASE12022-12-222027-10-062027-10-06
NCT05694741A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186TERMINATEDPHASE12022-12-202023-05-102023-05-10
NCT05648110Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-studyCOMPLETEDPHASE2, PHASE32022-12-162025-02-112024-03-29
NCT05624450Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRECRUITINGPHASE32022-12-132026-06-192026-06-19
NCT05714254Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy VolunteersCOMPLETEDPHASE12022-12-122023-12-122023-12-12
NCT05685472MEDI5752 in Japanese Patients With Advanced Solid Tumors.COMPLETEDPHASE12022-12-082025-07-292023-08-08
NCT05662033A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State.COMPLETEDPHASE12022-12-052024-10-292024-10-29
NCT05629585A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)ACTIVE_NOT_RECRUITINGPHASE32022-11-282030-01-302027-09-20
NCT05374603Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLCACTIVE_NOT_RECRUITINGPHASE22022-11-232025-08-302025-08-30
NCT05492877An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.COMPLETEDPHASE22022-11-142024-08-122024-08-12
NCT05583227Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisACTIVE_NOT_RECRUITINGPHASE32022-11-102027-03-252026-07-16
NCT05498155Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerACTIVE_NOT_RECRUITINGPHASE22022-11-072026-12-312024-11-20
NCT05573724Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12022-11-072024-05-172023-04-17
NCT05630677A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects.COMPLETEDPHASE12022-11-042023-02-092023-02-09
NCT05516498Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)TERMINATEDPHASE22022-10-312025-07-172025-05-22
NCT05638737A Study in Participants With Non-cirrhotic NASH With FibrosisCOMPLETEDPHASE22022-10-262024-04-042024-04-04
NCT05569421A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA PropellantCOMPLETEDPHASE12022-10-112023-04-142023-04-14
NCT05552508BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory ImagingCOMPLETEDPHASE42022-10-112024-07-192024-07-19
NCT05551897A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With ItraconazoleCOMPLETEDPHASE12022-10-042022-12-282022-12-28
NCT05555290PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway ObstructionCOMPLETEDPHASE32022-09-282024-11-182024-11-18
NCT05573464A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE32022-09-272024-03-262024-03-26
NCT05514132A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid TumoursACTIVE_NOT_RECRUITINGPHASE12022-09-232025-10-012023-10-20
NCT05511025Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or ObeseCOMPLETEDPHASE12022-09-202023-12-192023-12-19
NCT05450692A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based ChemotherapyACTIVE_NOT_RECRUITINGPHASE32022-09-152025-10-062025-10-06
NCT05057494A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaACTIVE_NOT_RECRUITINGPHASE32022-09-122029-04-102027-07-15
NCT05489211Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)RECRUITINGPHASE22022-09-062026-08-192026-08-19
NCT05517226Pharmacokinetics of Cotadutide in Participants With Hepatic ImpairmentTERMINATEDPHASE12022-09-062023-02-272023-02-27
NCT05587998A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.COMPLETEDPHASE12022-08-312023-05-252023-05-25
NCT05512806A Bioavailability and Food Effect Study of AZD5462 in Healthy VolunteersCOMPLETEDPHASE12022-08-242022-11-072022-11-07
NCT05505162Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.COMPLETEDPHASE12022-08-242023-01-102023-01-10
NCT05560607Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver DiseaseCOMPLETEDPHASE12022-08-122024-02-272023-11-20
NCT05061134A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 InhibitionACTIVE_NOT_RECRUITINGPHASE22022-08-112026-11-022024-04-12
NCT05457270A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.COMPLETEDPHASE12022-08-112022-10-172022-10-17
NCT05065463To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.TERMINATEDPHASE12022-08-102022-11-232022-11-23
NCT05398263Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaTERMINATEDPHASE32022-08-092025-03-242025-03-24
NCT05261399Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib TreatmentRECRUITINGPHASE32022-08-032026-12-172025-06-26
NCT05477108Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA PropellantCOMPLETEDPHASE12022-07-292023-04-112023-04-11
NCT05457257Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 MutationsACTIVE_NOT_RECRUITINGPHASE42022-07-292025-09-302024-10-22
NCT05440097CARE FOR ALL：an Evaluation of an Asthma QIPCOMPLETEDPHASE42022-07-292024-09-032024-09-03
NCT05364931A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisCOMPLETEDPHASE22022-07-142024-04-192024-04-19
NCT05246514A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLCACTIVE_NOT_RECRUITINGPHASE22022-07-132026-03-162023-09-23
NCT05452304AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's DiseaseCOMPLETEDPHASE12022-07-122024-11-272024-11-14
NCT05460273A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)ACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-07-112025-12-312023-11-07
NCT04769869A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of AsthmaCOMPLETEDPHASE12022-07-082023-01-242023-01-24
NCT05215951Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLCTERMINATEDPHASE22022-07-062023-03-092023-03-09
NCT05205161A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin LymphomaTERMINATEDPHASE12022-07-052023-08-172023-08-17
NCT05966324Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese PopulationCOMPLETEDPHASE12022-07-052022-09-202022-09-20
NCT05267613Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.RECRUITINGPHASE32022-07-012027-09-062026-08-14
NCT05395117A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and DigoxinCOMPLETEDPHASE12022-06-302022-09-122022-09-12
NCT05417594Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRECRUITINGPHASE1, PHASE22022-06-242027-06-012027-06-01
NCT05438303Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female VolunteersCOMPLETEDPHASE12022-06-132022-12-132022-12-13
NCT05375760A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19TERMINATEDPHASE22022-06-092023-10-042023-10-04
NCT05469919An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12022-06-092024-03-122023-08-17
NCT05397171A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursTERMINATEDPHASE1, PHASE22022-06-072023-06-062023-06-06
NCT05367440Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate CancerRECRUITINGPHASE1, PHASE22022-06-022031-04-172031-04-17
NCT05384262A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy SubjectsCOMPLETEDPHASE12022-05-182024-06-142024-06-14
NCT05274815Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaCOMPLETEDPHASE32022-05-172024-09-092024-09-09
NCT05374512A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)ACTIVE_NOT_RECRUITINGPHASE32022-05-162025-12-032025-12-03
NCT05364255A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833COMPLETEDPHASE12022-05-102022-06-202022-06-20
NCT05329194Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesACTIVE_NOT_RECRUITINGPHASE42022-04-292025-10-022025-10-02
NCT05432167A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney DiseaseCOMPLETEDPHASE22022-04-292024-05-022024-05-02
NCT05303532Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabENROLLING_BY_INVITATIONPHASE32022-04-192026-12-312026-01-07
NCT05061550Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerRECRUITINGPHASE22022-04-142030-05-092030-05-09
NCT05419401A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)COMPLETEDPHASE12022-04-112022-07-122022-07-12
NCT05459688Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124COMPLETEDPHASE22022-04-062023-11-072023-11-07
NCT05351047A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African AncestryCOMPLETEDPHASE12022-04-042023-07-062023-07-06
NCT05294458A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy SubjectsCOMPLETEDPHASE12022-03-282022-09-122022-09-12
NCT05301842Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCACTIVE_NOT_RECRUITINGPHASE32022-03-282027-02-262025-12-31
NCT05348577Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)ACTIVE_NOT_RECRUITINGPHASE32022-03-252026-03-042026-03-04
NCT05347693Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge StudyCOMPLETEDPHASE42022-03-242024-12-102024-12-10
NCT05339100Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in AnifrolumabCOMPLETEDPHASE12022-03-222023-04-132023-04-13
NCT05281601AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in PediatricsCOMPLETEDPHASE12022-03-212024-04-162024-04-16
NCT05266404Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single ComponentsCOMPLETEDPHASE12022-03-212022-05-312022-05-31
NCT05216835Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin LymphomaCOMPLETEDPHASE12022-03-182025-09-042024-08-30
NCT05219162Real-World Study on Gene Profile in Patients With Advanced NSCLC Who Progressed on First-Line Osimertinib Therapy(GPS).COMPLETEDPHASE42022-02-252024-04-292024-04-29
NCT05437848Chinese Multiple Dose Escalation (MDE) High Dose StudyCOMPLETEDPHASE12022-02-252022-12-122022-12-12
NCT05120349A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour ResectionACTIVE_NOT_RECRUITINGPHASE32022-02-212032-11-012027-08-02
NCT05211895A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCRECRUITINGPHASE32022-02-182030-09-122028-06-23
NCT05236543A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With ItraconazoleCOMPLETEDPHASE12022-02-182022-08-122022-08-12
NCT05138133Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisRECRUITINGPHASE32022-02-152028-07-072026-09-30
NCT05221840A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32022-02-072030-07-022026-06-30
NCT05158387Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.ACTIVE_NOT_RECRUITINGPHASE32022-02-072026-03-232026-01-19
NCT05057897A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised AdultsTERMINATEDPHASE42022-01-312023-04-192023-04-19
NCT05251259Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaACTIVE_NOT_RECRUITINGPHASE22022-01-272026-01-292026-01-29
NCT05309668Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-01-212028-04-282024-04-08
NCT04949438A Study to Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy VolunteersCOMPLETEDPHASE12022-01-212022-03-042022-03-04
NCT05251909Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)TERMINATEDPHASE32022-01-182024-02-132024-02-13
NCT05202262A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)COMPLETEDPHASE32022-01-122025-02-262025-02-26
NCT05166889Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsACTIVE_NOT_RECRUITINGPHASE32022-01-032026-03-232026-01-19
NCT05233085A Safety Study of AZD4041 in Healthy ParticipantsCOMPLETEDPHASE12021-12-172022-06-072022-06-07
NCT05110976A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonistsCOMPLETEDPHASE12021-12-162023-08-022023-08-02
NCT05140382AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHLCOMPLETEDPHASE22021-12-152024-02-162023-08-25
NCT04999969Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid TumoursACTIVE_NOT_RECRUITINGPHASE22021-12-102025-08-292024-10-07
NCT05143905A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy ParticipantsCOMPLETEDPHASE12021-12-062022-11-092022-11-09
NCT05184062A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese AdultsCOMPLETEDPHASE22021-12-032023-05-062022-08-15
NCT05166421Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy ParticipantsCOMPLETEDPHASE12021-11-302023-07-192023-07-19
NCT04416633Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLCCOMPLETEDPHASE42021-11-302023-10-272023-10-27
NCT05107336Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy ParticipantsCOMPLETEDPHASE12021-11-252023-03-212023-03-21
NCT05110261Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in ChinaACTIVE_NOT_RECRUITINGPHASE32021-11-242025-11-242025-11-24
NCT04890548Study to Evaluate the Effects of AZD3427 in Patients With Heart FailureWITHDRAWNPHASE12021-11-232022-08-022022-08-02
NCT04924608Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform NeurofibromasACTIVE_NOT_RECRUITINGPHASE32021-11-192025-03-172024-08-05
NCT05384938FAsenra Safety Trial in IndiaCOMPLETEDPHASE42021-11-192023-07-012023-07-01
NCT05134727Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy ParticipantsCOMPLETEDPHASE12021-11-182023-03-312023-03-31
NCT05961384Phase 1 Study to Determine the Metabolism and Clearance of BaxdrostatCOMPLETEDPHASE12021-11-182022-01-152022-01-15
NCT04818632AZD9833 China PK StudyCOMPLETEDPHASE12021-11-122023-09-072023-09-07
NCT04774380Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung CancerCOMPLETEDPHASE32021-11-112025-01-022023-06-12
NCT05112419A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal ImpairmentCOMPLETEDPHASE12021-11-102021-12-152021-12-15
NCT05008055Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin LymphomaCOMPLETEDPHASE22021-11-032024-10-252023-08-22
NCT05048797A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 MutationsRECRUITINGPHASE32021-10-282027-07-302026-03-31
NCT05043090Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCCACTIVE_NOT_RECRUITINGPHASE32021-10-282025-10-302025-06-23
NCT05113251Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast CancerACTIVE_NOT_RECRUITINGPHASE32021-10-252027-04-302025-03-12
NCT05123482A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid MalignanciesRECRUITINGPHASE1, PHASE22021-10-182027-09-292027-09-29
NCT05104866A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)ACTIVE_NOT_RECRUITINGPHASE32021-10-182025-12-312024-07-24
NCT04958226A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid TumoursCOMPLETEDPHASE12021-10-152023-02-152023-02-06
NCT03276052A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese ParticipantsCOMPLETEDPHASE12021-10-142021-11-262021-11-26
NCT05033431Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White ParticipantsCOMPLETEDPHASE12021-10-112022-10-122022-10-12
NCT05437289A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese AdultsCOMPLETEDPHASE12021-10-092023-01-162021-11-27
NCT05052710Study to Assess the Effect of AZD4831 on the Pharmacokinetics (Drug Behavior in the Body) of MidazolamCOMPLETEDPHASE12021-10-052021-11-292021-11-29
NCT05008913Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]AdavosertibTERMINATEDPHASE12021-10-012021-11-162021-11-16
NCT05056727A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTERMINATEDPHASE32021-09-302024-02-072024-02-07
NCT04931654A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22021-09-282026-08-122024-12-04
NCT04995523A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCRECRUITINGPHASE1, PHASE22021-09-142028-03-162026-08-18
NCT04931563Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE32021-09-132025-06-102025-04-07
NCT04949425A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid TumoursTERMINATEDPHASE12021-09-132022-04-212022-04-21
NCT04765059A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITINGPHASE32021-09-122026-06-022024-10-28
NCT05062759Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaCOMPLETEDPHASE32021-08-232022-07-182022-03-21
NCT05070312Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese ParticipantsCOMPLETEDPHASE12021-08-232022-02-072022-02-07
NCT04989816Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior RegimensCOMPLETEDPHASE22021-08-202024-02-282023-06-16
NCT04997161Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With HyperkalaemiaTERMINATEDPHASE42021-08-172021-11-172021-11-17
NCT05961397Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic ImpairmentCOMPLETEDPHASE12021-08-102022-04-152022-04-15
NCT04960709Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse CisplatinACTIVE_NOT_RECRUITINGPHASE32021-08-052028-09-082026-04-30
NCT04991571Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy ParticipantsCOMPLETEDPHASE12021-07-292021-10-222021-10-22
NCT04994106A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy VolunteersCOMPLETEDPHASE12021-07-272022-09-202022-09-20
NCT05001698Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE12021-07-272022-06-022022-06-02
NCT04944771Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy ParticipantsCOMPLETEDPHASE12021-07-262022-05-042022-05-04
NCT05101148Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform NeurofibromasACTIVE_NOT_RECRUITINGPHASE12021-07-212026-01-122022-04-06
NCT05006573Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis BronchiectasisTERMINATEDPHASE32021-07-212024-04-162024-04-16
NCT04930536Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell LymphomaCOMPLETEDPHASE42021-07-142023-05-022023-05-02
NCT04964544Technology-Assisted Cholesterol Trial in Consumers (TACTiC)COMPLETEDPHASE32021-07-082023-03-012023-03-01
NCT04964557A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With HyperlipidaemiaCOMPLETEDPHASE22021-07-072022-07-152022-07-15
NCT04964934Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)ACTIVE_NOT_RECRUITINGPHASE32021-06-302027-11-262025-06-30
NCT04986202Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%COMPLETEDPHASE2, PHASE32021-06-302024-03-272024-03-27
NCT04798222Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy VolunteersCOMPLETEDPHASE12021-06-292021-09-032021-09-03
NCT04870112A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung CancerTERMINATEDPHASE12021-06-282023-08-302023-08-30
NCT04959266A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of AdavosertibTERMINATEDPHASE12021-06-282022-06-012022-06-01
NCT04973449Phase II/III Study of AZD2816, for the Prevention of COVID-19 in AdultsCOMPLETEDPHASE2, PHASE32021-06-272022-08-022022-02-04
NCT05171816Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)ACTIVE_NOT_RECRUITINGPHASE32021-06-242026-04-282024-01-22
NCT04739761A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast CancerACTIVE_NOT_RECRUITINGPHASE32021-06-222026-02-032024-02-08
NCT04840849Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese AdultsCOMPLETEDPHASE12021-06-222021-11-182021-11-18
NCT04865419Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesTERMINATEDPHASE12021-06-112023-08-082023-08-08
NCT04877691Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusACTIVE_NOT_RECRUITINGPHASE32021-06-082026-11-182025-08-22
NCT04884360D9319C00001- 1L OC Mono Global RCTACTIVE_NOT_RECRUITINGPHASE32021-05-312026-04-302025-04-30
NCT04862663Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)RECRUITINGPHASE32021-05-102029-08-142027-11-01
NCT03528681A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.COMPLETEDPHASE32021-05-062022-09-152022-09-15
NCT04847232Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)TERMINATEDPHASE32021-04-302024-03-072024-03-07
NCT04724837Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)COMPLETEDPHASE22021-04-282023-06-012023-06-01
NCT04868500Managing Asthma Patients With AMAZE™: A Novel Disease Management PlatformCOMPLETEDNA2021-04-272021-11-302021-11-30
NCT04784715Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)ACTIVE_NOT_RECRUITINGPHASE32021-04-262029-12-302026-07-06
NCT04851964Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal PolyposisCOMPLETEDPHASE32021-04-222024-12-112024-09-23
NCT04891978US PRECISION Implementation StudyCOMPLETEDNA2021-04-202023-04-302023-04-30
NCT04770428Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy VolunteersCOMPLETEDPHASE12021-04-202021-12-022021-12-02
NCT04550234A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and AllopurinolCOMPLETEDPHASE12021-04-132021-07-152021-07-15
NCT04856007A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.COMPLETEDPHASE12021-04-122021-06-142021-06-14
NCT04445714To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE42021-04-072023-03-142023-03-14
NCT04612790A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.TERMINATEDPHASE32021-03-312023-10-262023-10-26
NCT04788641Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCOMPLETEDPHASE12021-03-302021-09-162021-09-16
NCT04727528Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney DiseaseTERMINATEDPHASE32021-03-222022-09-142022-09-14
NCT04896541Phase I Double-blind, Placebo-controlled Study of AZD7442COMPLETEDPHASE12021-03-162022-06-142022-06-14
NCT04643158Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled CorticosteroidsTERMINATEDPHASE22021-03-122023-07-202023-07-20
NCT04686305Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCRECRUITINGPHASE12021-03-092027-06-302027-06-30
NCT04676646Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving SpironolactoneCOMPLETEDPHASE42021-03-082024-07-152024-07-15
NCT04605549A Study of CIN-107 in Adults With Primary AldosteronismCOMPLETEDPHASE22021-03-082024-10-282024-10-28
NCT04594642A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin LymphomaRECRUITINGPHASE12021-03-022028-04-192028-04-19
NCT04609904Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)COMPLETEDPHASE32021-03-012025-03-202025-03-20
NCT04768985Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib CapsuleCOMPLETEDPHASE12021-02-252021-05-102021-05-10
NCT04745689Study of AZD2811 + Durvalumab in ES-SCLCACTIVE_NOT_RECRUITINGPHASE22021-02-232025-12-012022-06-18
NCT04673630Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With AsthmaCOMPLETEDPHASE12021-02-232022-09-272022-09-27
NCT04655027A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)COMPLETEDPHASE42021-02-222021-10-122021-10-12
NCT04742036Capivasertib China PK StudyCOMPLETEDPHASE12021-02-222022-07-292022-07-29
NCT04630756AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood CancerCOMPLETEDPHASE1, PHASE22021-02-172025-02-272023-09-08
NCT04612751Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE12021-02-022026-04-302026-04-30
NCT04712396A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the BodyCOMPLETEDPHASE12021-02-012021-03-252021-03-25
NCT04734275Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy VolunteersCOMPLETEDPHASE12021-02-012021-03-252021-03-25
NCT04711252A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseACTIVE_NOT_RECRUITINGPHASE32021-01-282029-02-012026-08-24
NCT04723394Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient AdultsCOMPLETEDPHASE32021-01-282022-10-192021-08-21
NCT03971110A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.TERMINATEDPHASE42021-01-282022-11-092022-11-09
NCT04595370Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney DiseaseCOMPLETEDPHASE22021-01-262023-09-222023-09-22
NCT04823611A Study of AZD8233 in Participants With Dyslipidemia.COMPLETEDPHASE1, PHASE22021-01-202022-09-102022-09-10
NCT05470725Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal FunctionCOMPLETEDPHASE12021-01-122021-04-302021-04-30
NCT04639219A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating MutationsACTIVE_NOT_RECRUITINGPHASE22020-12-302026-07-142023-01-25
NCT04538742A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22020-12-282030-01-312025-01-31
NCT04564742Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.COMPLETEDPHASE32020-12-222023-07-052023-07-05
NCT04686591Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male SubjectsCOMPLETEDPHASE12020-12-212021-02-042021-02-04
NCT04556773A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast CancerACTIVE_NOT_RECRUITINGPHASE12020-12-172025-12-042023-08-16
NCT04590235A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)ACTIVE_NOT_RECRUITINGPHASE12020-12-162026-08-312022-08-16
NCT04351555A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32020-12-162029-06-132024-10-15
NCT04712903Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung CancerCOMPLETEDPHASE32020-12-162023-06-212023-06-21
NCT04609878Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)COMPLETEDPHASE32020-12-152025-03-212025-03-21
NCT04631016A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic BronchitisCOMPLETEDPHASE22020-12-142023-11-132023-05-30
NCT04449861Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)COMPLETEDPHASE32020-12-072023-03-302023-03-30
NCT04613492A Study of MEDI9253 in Combination With Durvalumab in Select Solid TumorsTERMINATEDPHASE12020-12-022024-05-312024-05-31
NCT04675034A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the KneeCOMPLETEDPHASE22020-12-022023-08-162023-08-16
NCT04625972Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in AdultsCOMPLETEDPHASE32020-12-022022-07-252021-04-07
NCT04564027A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerCOMPLETEDPHASE22020-12-012025-02-182025-02-18
NCT04642469Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.COMPLETEDPHASE32020-11-302024-01-152023-05-31
NCT04590248A Study of Adavosertib as Treatment for Uterine Serous CarcinomaCOMPLETEDPHASE22020-11-302023-02-072022-05-23
NCT04249362Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for ChemotherapyCOMPLETEDPHASE22020-11-262024-11-252023-03-30
NCT04556760Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 DiabetesCOMPLETEDPHASE22020-11-262021-06-092021-06-09
NCT04625725Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.COMPLETEDPHASE32020-11-212023-12-082022-08-16
NCT04592913Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction CancerACTIVE_NOT_RECRUITINGPHASE32020-11-172027-09-272024-12-20
NCT04630067Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427COMPLETEDPHASE12020-11-172022-09-142022-09-14
NCT04217590Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese SubjectsCOMPLETEDPHASE32020-11-162022-01-032022-01-03
NCT04675021Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male SubjectsCOMPLETEDPHASE12020-11-132021-01-112021-01-11
NCT04644068Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesACTIVE_NOT_RECRUITINGPHASE1, PHASE22020-11-122027-06-012027-06-01
NCT04605094Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisTERMINATEDPHASE22020-11-122022-09-132022-04-25
NCT04483947A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis PatientsCOMPLETEDPHASE12020-11-062023-12-182023-12-18
NCT04610892Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial InfarctionCOMPLETEDPHASE22020-11-042023-11-082023-11-08
NCT04588298A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast CancerCOMPLETEDPHASE22020-11-022023-06-192023-06-19
NCT05526690Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy SubjectsCOMPLETEDPHASE12020-10-282020-12-122020-12-12
NCT04641299A Study of AZD8233 in Participants With DyslipidemiaCOMPLETEDPHASE22020-10-282021-07-202021-07-20
NCT04612725A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)TERMINATEDPHASE22020-10-272023-03-282022-10-13
NCT04550260Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCCACTIVE_NOT_RECRUITINGPHASE32020-10-192026-11-302025-11-28
NCT04600505A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and FormoterolCOMPLETEDPHASE12020-10-192021-05-172021-05-17
NCT04588727Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese SubjectsCOMPLETEDPHASE12020-10-152022-01-192022-01-19
NCT04564040A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for RabeprazoleCOMPLETEDPHASE12020-10-122020-12-112020-12-11
NCT04590963Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck CancerACTIVE_NOT_RECRUITINGPHASE32020-10-022025-09-242022-05-11
NCT04492722A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseTERMINATEDPHASE22020-10-012022-09-062022-09-06
NCT04541433A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast CancerCOMPLETEDPHASE12020-09-292025-06-232022-07-29
NCT04606771A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLCACTIVE_NOT_RECRUITINGPHASE22020-09-282026-03-302022-12-21
NCT04543409A Study of Benralizumab in Patients With Eosinophilic EsophagitisTERMINATEDPHASE32020-09-222023-02-062022-09-19
NCT04570657Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe AsthmaCOMPLETEDPHASE22020-09-172023-02-062022-12-12
NCT04546347A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833COMPLETEDPHASE12020-09-172021-01-072021-01-07
NCT04532918Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy VolunteersCOMPLETEDPHASE12020-09-102020-11-232020-11-23
NCT04540393AZD1222 Vaccine for the Prevention of COVID-19WITHDRAWNPHASE32020-09-022022-05-112020-12-04
NCT04515849A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes MellitusCOMPLETEDPHASE22020-08-312022-03-082022-03-08
NCT04495127Selumetinib Paediatric NF1 Japan StudyCOMPLETEDPHASE12020-08-312023-03-242021-06-16
NCT04516746Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOMPLETEDPHASE32020-08-282023-02-102021-03-05
NCT04568031Study of AZD1222 for the Prevention of COVID-19 in JapanCOMPLETEDPHASE1, PHASE22020-08-232021-11-222021-11-22
NCT04484935Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised ChildrenCOMPLETEDPHASE22020-08-192023-02-172023-02-17
NCT04482309A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsRECRUITINGPHASE22020-08-182027-07-302027-07-30
NCT04504669First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursCOMPLETEDPHASE12020-08-182024-10-072024-10-07
NCT04507256AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19COMPLETEDPHASE12020-08-182021-10-192021-10-19
NCT04239014A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.WITHDRAWNPHASE22020-08-072021-01-252021-01-25
NCT04421963Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibENROLLING_BY_INVITATIONPHASE32020-08-042027-04-062027-04-06
NCT04495179A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.COMPLETEDPHASE22020-08-042022-08-082021-11-01
NCT04449484Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's DiseaseCOMPLETEDPHASE12020-08-042022-01-052022-01-05
NCT04492709A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy SubjectsCOMPLETEDPHASE12020-07-302020-10-192020-10-19
NCT04159519A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With BenralizumabCOMPLETEDPHASE42020-07-272023-01-312023-01-31
NCT04494425Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerACTIVE_NOT_RECRUITINGPHASE32020-07-242026-06-192024-03-18
NCT04365218A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney DiseaseCOMPLETEDPHASE12020-07-222021-01-032021-01-03
NCT04478513A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy VolunteersCOMPLETEDPHASE12020-07-212020-12-232020-12-23
NCT04191304A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)ACTIVE_NOT_RECRUITINGPHASE32020-07-202026-09-012025-05-07
NCT04489797A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy ParticipantsCOMPLETEDPHASE12020-07-202020-08-282020-08-28
NCT04385368Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)COMPLETEDPHASE32020-07-172023-08-312023-08-31
NCT04480879Evaluation of AZD8154 Concentrations in BloodTERMINATEDPHASE12020-07-172020-09-022020-09-02
NCT04493853Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyACTIVE_NOT_RECRUITINGPHASE32020-07-132027-03-292024-10-07
NCT04407091A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831COMPLETEDPHASE12020-06-302020-08-062020-08-06
NCT04293172Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.WITHDRAWNPHASE32020-06-302022-10-102022-10-10
NCT04001231Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes MellitusWITHDRAWNPHASE12020-06-302021-07-022021-07-02
NCT04462952Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid TumoursCOMPLETEDPHASE12020-06-242021-09-222021-09-22
NCT04488016A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy SubjectsCOMPLETEDPHASE12020-06-242021-01-202021-01-20
NCT04469907Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal ImpairmentCOMPLETEDPHASE12020-06-222021-10-282021-10-28
NCT04380688Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.COMPLETEDPHASE22020-06-132020-11-162020-11-16
NCT04346199Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.COMPLETEDPHASE22020-06-122020-11-172020-11-17
NCT04379596Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)RECRUITINGPHASE22020-06-032026-07-302026-07-30
NCT04330040Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerCOMPLETEDPHASE42020-05-252022-09-302022-09-30
NCT04435483A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in Healthy VolunteersCOMPLETEDPHASE12020-05-222020-06-262020-06-26
NCT04327024Study of Verinurad in Heart Failure With Preserved Ejection FractionCOMPLETEDPHASE22020-05-192022-04-292022-04-29
NCT04362410Tezepelumab Phase 1 PK Study in Healthy Chinese SubjectsCOMPLETEDPHASE12020-05-182020-10-092020-10-09
NCT04269200Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerACTIVE_NOT_RECRUITINGPHASE32020-05-052027-04-012024-07-08
NCT03932331Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell MalignanciesACTIVE_NOT_RECRUITINGPHASE1, PHASE22020-04-292026-06-242022-12-22
NCT04381494Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.TERMINATEDPHASE42020-04-272022-01-272022-01-27
NCT04214288A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast CancerACTIVE_NOT_RECRUITINGPHASE22020-04-222026-03-172022-08-30
NCT04305496Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerACTIVE_NOT_RECRUITINGPHASE32020-04-162024-06-072022-08-15
NCT03658213To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.WITHDRAWNPHASE32020-03-312021-11-042021-11-04
NCT05963009Baxdrostat Bioavailability and Bioequivalence StudyCOMPLETEDPHASE12020-03-112020-04-292020-04-29
NCT04277546Open-label Extension Study of Brazikumab in Ulcerative ColitisTERMINATEDPHASE22020-03-032023-10-102023-10-10
NCT04256629A Study to Assess the Effect of Verinurad on the Electric Activity of the HeartCOMPLETEDPHASE12020-03-032020-08-212020-08-21
NCT04269031A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.COMPLETEDPHASE12020-02-132021-08-312021-08-31
NCT04187508A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled AllergenWITHDRAWNPHASE22020-02-062021-11-102021-11-10
NCT04199598Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.TERMINATEDPHASE12020-01-282020-04-032020-04-03
NCT04208620Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes MelitusCOMPLETEDPHASE12020-01-212020-07-082020-07-08
NCT04075292Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic LeukemiaACTIVE_NOT_RECRUITINGPHASE32020-01-202027-01-012024-01-03
NCT04232345A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy VolunteersCOMPLETEDPHASE12020-01-162021-03-112021-03-11
NCT04236414Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid TumoursCOMPLETEDPHASE12020-01-142025-02-042025-02-04
NCT04210388A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy VolunteersCOMPLETEDPHASE12020-01-142020-03-092020-03-09
NCT03961815Open-label Extension Study of Brazikumab in Crohn's DiseaseTERMINATEDPHASE32020-01-062023-09-192023-09-19
NCT04187456A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the BodyCOMPLETEDPHASE12019-12-272020-03-062020-03-06
NCT05500820Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy SubjectsCOMPLETEDPHASE12019-12-192020-04-032020-04-03
NCT04214093A Study of AZD0466 in Patients With Advanced Hematologic or Solid TumorsTERMINATEDPHASE12019-12-162021-06-182021-06-18
NCT04179071A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With FamotidineCOMPLETEDPHASE12019-12-132020-03-112020-03-11
NCT04212169Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic DermatitisCOMPLETEDPHASE22019-12-092022-09-202022-07-21
NCT04198558A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy VolunteersCOMPLETEDPHASE12019-11-292022-02-232022-02-23
NCT04157335Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)TERMINATEDPHASE32019-11-252025-04-072024-08-06
NCT04305405PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic AsthmaCOMPLETEDPHASE32019-11-212022-09-122022-09-12
NCT04155645To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With DyslipidemiaCOMPLETEDPHASE12019-11-212021-06-072021-06-07
NCT04170543A Phase 2b Diabetic Kidney Disease StudyCOMPLETEDPHASE22019-11-182023-05-162023-05-16
NCT04121910A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With ItraconazoleCOMPLETEDPHASE12019-11-072020-01-122020-01-12
NCT04157348Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.ACTIVE_NOT_RECRUITINGPHASE32019-10-292026-03-312023-08-10
NCT04142424A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese SubjectsCOMPLETEDPHASE12019-10-282021-11-122021-11-12
NCT03953300Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsRECRUITINGPHASE42019-10-172026-09-092026-09-09
NCT04118842A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With RifampicinCOMPLETEDPHASE12019-10-172020-02-262020-02-26
NCT03907969A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.COMPLETEDPHASE1, PHASE22019-10-092022-12-072022-12-07
NCT04076540A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy VolunteersCOMPLETEDPHASE12019-10-032022-01-022022-01-02
NCT04087187A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718COMPLETEDPHASE12019-09-202019-10-312019-10-31
NCT04072562A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.COMPLETEDPHASE12019-09-192019-11-282019-11-28
NCT04008706Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia PatientsACTIVE_NOT_RECRUITINGPHASE32019-09-172025-09-012025-09-01
NCT04078126Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.COMPLETEDPHASE32019-09-102020-12-302020-12-30
NCT04078152Durvalumab Long-Term Safety and Efficacy StudyCOMPLETEDPHASE42019-09-052024-10-312022-10-31
NCT04089553An Open-label, Phase II Study of AZD4635 in Patients With Prostate CancerCOMPLETEDPHASE22019-08-292023-04-112021-06-16
NCT04053634Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsCOMPLETEDPHASE32019-08-262025-07-282025-07-28
NCT04087174A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate CancerCOMPLETEDPHASE12019-08-052021-06-222021-06-22
NCT03924635An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma PatientsCOMPLETEDPHASE42019-08-012022-12-162022-12-16
NCT04039113Tezepelumab COPD Exacerbation StudyCOMPLETEDPHASE22019-07-302024-01-312023-11-10
NCT03959488A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk ChildrenCOMPLETEDPHASE2, PHASE32019-07-302023-01-202021-05-03
NCT03976869A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With AsthmaCOMPLETEDPHASE12019-07-242020-07-092020-07-09
NCT04055168A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy SubjectsTERMINATEDPHASE12019-07-242020-02-102020-02-10
NCT03979313A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)COMPLETEDPHASE32019-07-232023-03-212021-03-11
NCT03990363A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and HyperuricaemiaCOMPLETEDPHASE22019-07-232021-11-222021-11-22
NCT04024501A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed ConditionCOMPLETEDPHASE12019-07-202019-09-182019-09-18
NCT03980821A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12019-07-042020-09-072020-09-07
NCT04035486A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)ACTIVE_NOT_RECRUITINGPHASE32019-07-022026-06-032023-04-03
NCT03997123Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCACTIVE_NOT_RECRUITINGPHASE32019-06-252026-03-162026-03-16
NCT03944772Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)ACTIVE_NOT_RECRUITINGPHASE22019-06-252025-05-062025-05-06
NCT03989544A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult SubjectsCOMPLETEDPHASE12019-06-192019-12-302019-12-30
NCT03927157Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled AsthmaCOMPLETEDPHASE32019-06-142024-08-132024-05-24
NCT04002427Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594COMPLETEDPHASE12019-06-112019-07-052019-07-05
NCT04048343Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe AsthmaCOMPLETEDPHASE32019-06-102021-03-182021-03-18
NCT03968978Tezepelumab Home Use StudyCOMPLETEDPHASE32019-05-212020-06-052020-06-05
NCT03934333A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)COMPLETEDPHASE12019-05-162019-09-102019-09-10
NCT03948451Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in VolunteersCOMPLETEDPHASE12019-04-302019-07-022019-07-02
NCT03847428Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentACTIVE_NOT_RECRUITINGPHASE32019-04-292027-05-312026-05-29
NCT03853551Osimertinib Study in Indian PatientsCOMPLETEDPHASE42019-04-182020-04-152020-04-15
NCT03875235Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)ACTIVE_NOT_RECRUITINGPHASE32019-04-162025-12-312021-08-11
NCT03693300A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung CancerCOMPLETEDPHASE22019-04-162023-04-212022-12-13
NCT03877237DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection FractionCOMPLETEDPHASE32019-04-092020-03-072020-03-07
NCT03877224DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection FractionCOMPLETEDPHASE32019-04-042020-07-092020-07-09
NCT03906045A Scintigraphy Study of PT010 in COPD PatientsCOMPLETEDPHASE12019-04-042020-03-052020-03-05
NCT03813407An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRECRUITINGPHASE32019-04-022026-06-292026-06-29
NCT03928262Pharmacokinetic Study of Benralizumab in Healthy Chinese SubjectsCOMPLETEDPHASE12019-04-022019-08-122019-08-12
NCT03921268Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402COMPLETEDPHASE12019-03-252019-06-132019-06-13
NCT03837899Durvalumab and Tremelimumab for Pediatric MalignanciesACTIVE_NOT_RECRUITINGPHASE1, PHASE22019-03-072024-12-302023-02-28
NCT03833154Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationACTIVE_NOT_RECRUITINGPHASE32019-03-062028-04-042027-04-16
NCT03608358Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinTERMINATEDPHASE32019-02-272020-08-042020-08-04
NCT03836677A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCOMPLETEDPHASE32019-02-262019-11-112019-11-11
NCT03843060A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy VolunteersCOMPLETEDPHASE12019-02-222019-04-012019-04-01
NCT03830866Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)COMPLETEDPHASE32019-02-152023-07-032022-01-20
NCT03804645A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male SubjectsCOMPLETEDPHASE12019-02-052019-04-162019-04-16
NCT03801967A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose AdministrationCOMPLETEDPHASE12019-01-242019-05-022019-05-02
NCT03772223A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.COMPLETEDPHASE12019-01-212019-05-102019-05-10
NCT03836599A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese SubjectsCOMPLETEDPHASE12019-01-162019-04-262019-04-26
NCT03778229Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibACTIVE_NOT_RECRUITINGPHASE22019-01-092025-05-282024-08-23
NCT03706079Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaCOMPLETEDPHASE32019-01-072022-05-182021-10-26
NCT03737643Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsACTIVE_NOT_RECRUITINGPHASE32019-01-042028-03-302025-03-28
NCT03622112A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic SubjectsCOMPLETEDPHASE22019-01-022019-09-302019-09-30
NCT03819465A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLCACTIVE_NOT_RECRUITINGPHASE12018-12-272026-03-262023-05-23
NCT03742102A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22018-12-212027-02-262024-11-29
NCT03775486Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)ACTIVE_NOT_RECRUITINGPHASE22018-12-212025-09-262021-01-11
NCT03756285Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.TERMINATEDPHASE22018-12-112020-05-072020-05-07
NCT03759288An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's DiseaseTERMINATEDPHASE2, PHASE32018-12-072023-10-182023-10-18
NCT03800134A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32018-12-062028-09-112022-11-10
NCT03778957A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular CarcinomaACTIVE_NOT_RECRUITINGPHASE32018-11-302026-08-312023-09-11
NCT03766399A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449COMPLETEDPHASE12018-11-302021-06-242021-06-24
NCT03706690A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer PatientsACTIVE_NOT_RECRUITINGPHASE32018-11-272027-02-262024-06-23
NCT03755934Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic NeuropathyTERMINATEDPHASE22018-11-192023-06-292023-06-29
NCT03732677Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBCACTIVE_NOT_RECRUITINGPHASE32018-11-162026-06-302024-04-29
NCT03736473A Phase I Study of MEDI9447 (Oleclumab) in Japanese PatientsCOMPLETEDPHASE12018-11-072019-06-192019-06-19
NCT03688074Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)COMPLETEDPHASE22018-11-022020-11-162020-11-16
NCT03710434AZD4635 Relative Bioavailability StudyCOMPLETEDPHASE12018-11-012019-04-022019-04-02
NCT03682497Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum PotassiumTERMINATEDPHASE12018-11-012020-03-312020-03-31
NCT03732820Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerACTIVE_NOT_RECRUITINGPHASE32018-10-312026-04-272021-07-30
NCT03463525Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain MetastasesCOMPLETEDPHASE12018-10-242020-10-052020-03-19
NCT03616587Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.ACTIVE_NOT_RECRUITINGPHASE12018-10-112025-11-282024-09-16
NCT03645434A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.COMPLETEDPHASE22018-10-102019-08-072019-08-07
NCT03682068Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial CancerACTIVE_NOT_RECRUITINGPHASE32018-09-272026-04-292026-04-29
NCT03703297Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation TherapyACTIVE_NOT_RECRUITINGPHASE32018-09-272026-03-052024-01-15
NCT03615924Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell DiseaseTERMINATEDPHASE32018-09-262020-08-132020-08-13
NCT03649165A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male ParticipantsCOMPLETEDPHASE12018-09-052018-10-212018-10-21
NCT03740373A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol FumarateCOMPLETEDPHASE12018-09-042018-10-112018-10-11
NCT03619213Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.COMPLETEDPHASE32018-08-272022-03-272022-03-27
NCT03645421Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 DiabetesCOMPLETEDPHASE22018-08-102019-01-172019-01-17
NCT03616821Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ColitisTERMINATEDPHASE22018-08-072023-10-232023-10-23
NCT03593785A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.COMPLETEDPHASE12018-08-032020-12-192020-12-19
NCT03557307Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaCOMPLETEDPHASE32018-08-012022-03-242021-04-16
NCT03436316A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.COMPLETEDPHASE12018-07-262019-07-292019-07-29
NCT03553563A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerCOMPLETEDPHASE32018-07-242022-12-272022-12-27
NCT03521154A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)ACTIVE_NOT_RECRUITINGPHASE32018-07-192027-04-132024-01-05
NCT03532009Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart FailureTERMINATEDPHASE22018-06-262020-05-222020-05-22
NCT03574142A Ph 1 Study of Epanova® in Healthy ChinesesCOMPLETEDPHASE12018-06-042018-06-272018-06-27
NCT03239340A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With OsimertinibCOMPLETEDPHASE22018-05-302023-09-192023-09-19
NCT03534453Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyCOMPLETEDPHASE32018-05-292025-01-272025-01-27
NCT03490669Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid TumorsCOMPLETEDPHASE12018-05-212019-09-232019-09-23
NCT03553108A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.COMPLETEDPHASE12018-05-162020-07-012019-03-12
NCT03528694Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder CancerACTIVE_NOT_RECRUITINGPHASE32018-05-142028-10-032025-04-03
NCT03509012Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCOMPLETEDPHASE12018-05-022025-01-082020-12-31
NCT03423628A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerRECRUITINGPHASE12018-04-022026-09-162026-09-16
NCT03519971Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32018-03-292025-12-012023-09-07
NCT03492931PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)COMPLETEDPHASE12018-03-282019-05-072019-05-07
NCT03450759A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male SubjectsCOMPLETEDPHASE12018-03-282018-06-062018-06-06
NCT03459846A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)ACTIVE_NOT_RECRUITINGPHASE22018-03-162025-12-312020-10-15
NCT03330847To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.ACTIVE_NOT_RECRUITINGPHASE22018-03-072025-12-102020-11-13
NCT03406078Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaCOMPLETEDPHASE32018-03-052020-09-252020-09-25
NCT03338855Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.COMPLETEDPHASE42018-03-052019-11-042019-11-04
NCT03387683A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes PatientsCOMPLETEDPHASE42018-02-282019-03-192019-03-19
NCT03435276Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male SubjectsCOMPLETEDPHASE12018-02-272018-06-132018-06-13
NCT03337477A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8COMPLETEDPHASE22018-02-132018-12-212018-12-21
NCT03421353AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerCOMPLETEDPHASE12018-02-072024-03-282020-01-17
NCT03370887AZD8601 Study in CABG PatientsCOMPLETEDPHASE22018-02-052021-06-302021-06-30
NCT03420092A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy VolunteersCOMPLETEDPHASE12018-02-052018-04-182018-04-18
NCT03402841Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer PatientsCOMPLETEDPHASE32018-01-302022-03-102020-10-02
NCT03394144Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12018-01-302019-04-122019-04-12
NCT03354429THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and DeathCOMPLETEDPHASE32018-01-222019-12-132019-12-13
NCT03368235Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid ArthritisCOMPLETEDPHASE22018-01-182019-11-122019-11-12
NCT03286842To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.COMPLETEDPHASE32018-01-172021-10-082021-10-08
NCT03400488A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese MenCOMPLETEDPHASE12018-01-162018-06-122018-06-12
NCT03401229Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal PolyposisCOMPLETEDPHASE32018-01-152020-07-312020-07-31
NCT03222427A Study of LY3314814 in Healthy ParticipantsCOMPLETEDPHASE12018-01-152018-02-162018-02-16
NCT03371459Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With AsthmaCOMPLETEDPHASE22017-12-292018-03-262018-03-26
NCT03334617Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing TherapyACTIVE_NOT_RECRUITINGPHASE22017-12-182026-09-112024-09-13
NCT03344341A Phase IV Study in Drug-Naive Patients With T2DM in ChinaTERMINATEDPHASE42017-12-152019-05-242019-05-24
NCT03364608Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With AsthmaCOMPLETEDPHASE22017-12-152018-03-302018-03-30
NCT03303521A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.COMPLETEDPHASE32017-12-142018-11-072018-11-07
NCT03181880To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary DiseaseWITHDRAWNPHASE42017-12-042018-12-032018-12-03
NCT03333824Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced CancerCOMPLETEDPHASE12017-12-012019-01-222019-01-22
NCT03310320Study to Determine if AZD0284 is Effective and Safe in Treating Plaque PsoriasisTERMINATEDPHASE12017-11-292018-04-182018-04-18
NCT03347279Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled AsthmaCOMPLETEDPHASE32017-11-232020-11-122020-09-08
NCT03276078Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE22017-11-232018-06-122018-06-12
NCT03317002AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).COMPLETEDPHASE22017-10-302020-04-082020-04-08
NCT03313336A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.COMPLETEDPHASE12017-10-302017-11-092017-11-09
NCT03313557AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology StudiesCOMPLETEDPHASE12017-10-272019-05-172019-05-17
NCT03316131A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UACOMPLETEDPHASE22017-10-252018-07-192018-07-19
NCT03263637Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCOMPLETEDPHASE12017-10-242021-09-302021-09-30
NCT03283267A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)COMPLETEDPHASE12017-10-242017-11-232017-11-23
NCT03272165Single Ascending Dose Study of MEDI1341 in Healthy VolunteersCOMPLETEDPHASE12017-10-172021-03-312021-03-31
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaACTIVE_NOT_RECRUITINGPHASE32017-10-112026-08-272021-08-27
NCT03199053Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years OldCOMPLETEDPHASE32017-10-112024-01-032023-02-01
NCT03215381AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy VolunteersCOMPLETEDPHASE12017-10-102018-02-192018-02-19
NCT03236974Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.COMPLETEDPHASE12017-10-052019-02-122019-02-12
NCT03315091Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid TumoursCOMPLETEDPHASE12017-09-292018-04-052018-04-05
NCT03216278The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed ConditionsCOMPLETEDPHASE12017-09-262018-05-222018-05-22
NCT03273127To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled CorticosteroidsCOMPLETEDPHASE12017-09-212017-11-092017-11-09
NCT03022409A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).COMPLETEDPHASE12017-09-182021-01-202021-01-20
NCT03186209Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)COMPLETEDPHASE32017-09-072023-01-302023-01-30
NCT03258515A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy VolunteersCOMPLETEDPHASE12017-09-062018-03-242018-03-24
NCT03172702Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With HyperkalemiaCOMPLETEDPHASE32017-09-042019-07-062019-07-06
NCT03218683Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.TERMINATEDPHASE12017-08-022021-10-082021-10-08
NCT03235050A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 DiabetesCOMPLETEDPHASE22017-08-022019-06-142018-05-03
NCT03217838Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.TERMINATEDPHASE12017-07-312021-03-252021-03-25
NCT03091192Savolitinib vs. Sunitinib in MET-driven PRCC.ACTIVE_NOT_RECRUITINGPHASE32017-07-252025-12-312019-08-18
NCT03152084The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.TERMINATEDPHASE42017-07-122020-03-202020-03-20
NCT03170271A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.COMPLETEDPHASE32017-07-072020-10-212019-09-25
NCT03205176AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasCOMPLETEDPHASE12017-06-302021-04-082021-03-01
NCT03198650A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell MalignanciesACTIVE_NOT_RECRUITINGPHASE12017-06-272025-12-312022-10-27
NCT03159442Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese SubjectsCOMPLETEDPHASE12017-06-192017-10-132017-10-13
NCT03127644ZS Ph2/3 Dose-response Study in JapanCOMPLETEDPHASE2, PHASE32017-06-142018-02-232018-02-23
NCT03106987A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.COMPLETEDPHASE32017-06-082022-02-172021-02-15
NCT03084471An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.COMPLETEDPHASE32017-06-052022-12-162020-03-31
NCT03164616Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).ACTIVE_NOT_RECRUITINGPHASE32017-06-012027-11-152021-03-12
NCT02950805A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic FibrosisCOMPLETEDPHASE12017-05-302018-04-122018-04-12
NCT03169959A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.COMPLETEDPHASE12017-05-292017-08-032017-08-03
NCT03162055Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE32017-05-252018-05-042018-05-04
NCT03138356Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy SubjectsCOMPLETEDPHASE12017-05-252017-11-282017-11-28
NCT03118739Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaCOMPLETEDPHASE22017-05-182018-08-132018-08-13
NCT03136991A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular DiseaseCOMPLETEDPHASE12017-05-152017-11-222017-11-22
NCT03101839Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid TumoursCOMPLETEDPHASE12017-05-152019-01-082019-01-08
NCT03126695A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are AdministeredCOMPLETEDPHASE12017-05-122017-07-242017-07-24
NCT03140072A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898TERMINATEDPHASE12017-05-102017-08-232017-08-23
NCT02923947Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney ImpairmentCOMPLETEDPHASE12017-05-042022-10-282018-09-20
NCT03097380PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and TiotropiumCOMPLETEDPHASE12017-04-262017-12-302017-12-30
NCT03043872Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)ACTIVE_NOT_RECRUITINGPHASE32017-03-272025-12-312020-01-27
NCT02972658A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaTERMINATEDPHASE32017-03-152018-10-022018-10-02
NCT02875834A Study to Investigate the Safety and Efficacy of ZS in Patients With HyperkalemiaCOMPLETEDPHASE32017-03-032018-02-142018-02-14
NCT02908750Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLCCOMPLETEDPHASE12017-03-022022-10-112017-07-31
NCT03060512To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced ConstipationCOMPLETEDPHASE42017-03-022017-08-232017-08-23
NCT03029741Bioavailability of AZD0284 and IV Microtracer StudyCOMPLETEDPHASE12017-02-212017-03-232017-03-23
NCT02962960A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin ManifestationsCOMPLETEDPHASE22017-02-142018-12-172018-01-22
NCT03036124Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart FailureCOMPLETEDPHASE32017-02-082019-07-172019-07-17
NCT02987543Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)COMPLETEDPHASE32017-02-062023-02-152019-06-04
NCT03022097Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD PatientsCOMPLETEDPHASE32017-02-022022-04-142022-04-14
NCT03036150A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney DiseaseCOMPLETEDPHASE32017-02-022020-06-122020-06-12
NCT02889900Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian CancerCOMPLETEDPHASE22017-01-172021-03-162019-08-27
NCT03019549A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With RosuvastatinCOMPLETEDPHASE12017-01-122017-05-222017-05-22
NCT02917031Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart FailureCOMPLETEDPHASE42017-01-102019-08-232019-08-23
NCT02968914Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy VolunteersCOMPLETEDPHASE12017-01-042017-07-132017-07-13
NCT03003962Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)ACTIVE_NOT_RECRUITINGPHASE32017-01-022026-06-302022-10-27
NCT02546661Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder CancerACTIVE_NOT_RECRUITINGPHASE12016-12-282026-01-092020-03-18
NCT02997501T790M Plasma Testing Methodology Comparison and Clinical ValidationCOMPLETEDPHASE32016-12-232018-10-242018-10-24
NCT02983799Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor StatusCOMPLETEDPHASE22016-12-222020-12-032020-12-03
NCT02963116A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release TabletCOMPLETEDPHASE12016-12-202017-03-012017-03-01
NCT02935712Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)COMPLETEDPHASE12016-12-162018-01-082017-08-04
NCT02971293Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871COMPLETEDPHASE22016-12-152017-08-182017-08-18
NCT02976831Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy SubjectsCOMPLETEDPHASE12016-12-092017-05-302017-05-30
NCT02978482A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced MalignanciesCOMPLETEDPHASE12016-12-012020-11-262018-01-28
NCT02937818A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung CancerCOMPLETEDPHASE22016-11-282023-11-272020-06-22
NCT02928354A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy VolunteersCOMPLETEDPHASE12016-11-252017-03-212017-03-21
NCT02967159A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male ParticipantsCOMPLETEDPHASE12016-11-242017-04-062017-04-06
NCT02902809A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaTERMINATEDPHASE32016-11-112018-01-192018-01-19
NCT02918071Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at HomeCOMPLETEDPHASE32016-11-102017-08-212017-08-21
NCT02869438A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic InflammationCOMPLETEDPHASE32016-11-092018-08-012018-08-01
NCT02934607A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy VolunteersCOMPLETEDPHASE12016-11-042017-03-272017-03-27
NCT02910089ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes MellitusCOMPLETEDPHASE42016-10-202017-12-202017-12-20
NCT02898662AZD1419 Ph2a StudyCOMPLETEDPHASE22016-10-122018-09-252018-09-25
NCT02821416Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic AsthmaticsCOMPLETEDPHASE32016-10-112019-10-222019-10-22
NCT02864342Adherence Study in COPD PatientsCOMPLETEDPHASE42016-08-122017-10-312017-10-31
NCT02826525AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.COMPLETEDPHASE12016-07-182019-10-112019-10-11
NCT02796677AMPLIFY - D6571C00001 Duaklir USA Phase III StudyCOMPLETEDPHASE32016-07-052017-06-082017-06-08
NCT02783573A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaTERMINATEDPHASE32016-07-012018-09-282018-09-28
NCT02814643Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe AsthmaCOMPLETEDPHASE32016-07-012017-01-242017-01-24
NCT02719132Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActiceWITHDRAWNPHASE42016-072017-112017-11
NCT02392676Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes MutationsWITHDRAWNPHASE32016-072019-062019-06
NCT02794285Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus ErythematosusCOMPLETEDPHASE32016-06-302021-12-212021-12-21
NCT02808819A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 AgonistCOMPLETEDPHASE32016-06-302020-06-182020-06-18
NCT02796651Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)COMPLETEDPHASE22016-06-302016-12-072016-12-07
NCT02725593Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 YearsCOMPLETEDPHASE32016-06-222020-04-062020-04-06
NCT02814656Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsCOMPLETEDPHASE12016-06-222016-11-282016-11-28
NCT02777827A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With AsthmaCOMPLETEDPHASE12016-06-212016-11-292016-11-29
NCT02740985A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12016-06-172023-03-312020-12-31
NCT02780713A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy SubjectsCOMPLETEDPHASE12016-06-022016-09-202016-09-20
NCT02712372A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male SubjectsTERMINATEDPHASE12016-062016-102016-10
NCT02780830AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell LymphomaWITHDRAWNPHASE12016-062019-042019-04
NCT02760316A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.COMPLETEDPHASE12016-05-022017-09-112017-09-11
NCT02658214Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCOMPLETEDPHASE12016-04-282019-11-142019-11-14
NCT02722239An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed ConditionsCOMPLETEDPHASE12016-03-302016-05-052016-05-05
NCT02583477Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal CarcinomaCOMPLETEDPHASE1, PHASE22016-03-252018-07-092018-07-09
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.ACTIVE_NOT_RECRUITINGPHASE1, PHASE22016-03-172025-09-172021-09-17
NCT02681094A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 DiabetesCOMPLETEDPHASE32016-02-262017-07-152017-07-15
NCT02679729To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose AdministrationCOMPLETEDPHASE12016-02-112016-10-242016-10-24
NCT02632526A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male SubjectsCOMPLETEDPHASE12016-02-102016-08-262016-08-26
NCT02663128A Study of Lanabecestat (LY3314814) in Healthy ParticipantsCOMPLETEDPHASE12016-01-312016-03-312016-03-31
NCT02533453A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.COMPLETEDPHASE42016-01-282016-12-072016-12-07
NCT02640755Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose PhaseCOMPLETEDPHASE12016-01-282017-07-062016-12-21
NCT02653872A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy SubjectsCOMPLETEDPHASE12016-01-222016-04-132016-04-13
NCT02645253A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese MenCOMPLETEDPHASE12016-01-122016-04-172016-04-17
NCT02648438A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male SubjectsCOMPLETEDPHASE12016-01-122016-06-012016-06-01
NCT02574637Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's DiseaseTERMINATEDPHASE22016-01-052018-01-292017-07-28
NCT02564926Foxiga Korea Local Phase 4 StudyCOMPLETEDPHASE42016-01-052018-01-152018-01-15
NCT02617277Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid TumoursACTIVE_NOT_RECRUITINGPHASE12015-12-282025-12-312019-04-22
NCT02586987A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid TumoursCOMPLETEDPHASE12015-12-282019-09-202018-07-25
NCT02637037A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy SubjectsCOMPLETEDPHASE12015-12-212016-04-072016-04-07
NCT02599714Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast CancerCOMPLETEDPHASE12015-12-072023-11-232018-03-30
NCT02610075Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.COMPLETEDPHASE12015-12-012018-04-262018-04-26
NCT02612662A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male SubjectsACTIVE_NOT_RECRUITINGPHASE12015-11-242025-08-292017-11-04
NCT02512575A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.COMPLETEDPHASE12015-11-182016-09-262016-09-26
NCT02508155A Study of MEDI7352 in Painful Osteoarthritis of the KneeCOMPLETEDPHASE12015-11-172020-12-232020-12-23
NCT02601625A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy SubjectsCOMPLETEDPHASE12015-11-162016-05-252016-05-25
NCT02558894Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal CarcinomaCOMPLETEDPHASE22015-11-162017-06-152017-06-15
NCT02588105Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced CancerCOMPLETEDPHASE12015-11-102022-07-262019-09-13
NCT02561832A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast CancerTERMINATEDPHASE12015-11-062017-02-012016-09-30
NCT02547922Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus NephritisCOMPLETEDPHASE22015-11-042021-01-182019-11-26
NCT02542293Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)ACTIVE_NOT_RECRUITINGPHASE32015-11-032025-12-312020-09-21
NCT02516241Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerACTIVE_NOT_RECRUITINGPHASE32015-11-022025-12-312020-01-27
NCT02527434Study of Tremelimumab in Patients With Advanced Solid TumorsCOMPLETEDPHASE22015-11-022023-03-282018-02-17
NCT02560363A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male SubjectsWITHDRAWNPHASE12015-112016-012016-01
NCT02568397A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy ParticipantsCOMPLETEDPHASE12015-10-312016-01-312016-01-31
NCT02579226A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.COMPLETEDPHASE12015-10-282020-04-032020-02-07
NCT02582814The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DMCOMPLETEDPHASE32015-10-262017-06-152017-06-15
NCT02511106AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.ACTIVE_NOT_RECRUITINGPHASE32015-10-212029-01-312022-04-11
NCT02551874A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on MetforminCOMPLETEDPHASE32015-10-202017-11-102017-05-08
NCT02551159Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck CancerCOMPLETEDPHASE32015-10-152021-05-212020-07-06
NCT02582840The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DMCOMPLETEDPHASE12015-102016-062016-06
NCT02573155Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD SubjectsCOMPLETEDPHASE12015-102016-082016-08
NCT02540668A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy ParticipantsCOMPLETEDPHASE12015-09-302016-01-312016-01-31
NCT02449473Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on CorticosteroidsCOMPLETEDPHASE22015-09-292017-06-212017-06-21
NCT02476968To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian CancerCOMPLETEDPHASE42015-09-282021-12-172020-04-17
NCT02547935A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDCOMPLETEDPHASE2, PHASE32015-09-212018-05-182018-05-18
NCT02471404Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaCOMPLETEDPHASE42015-09-212017-03-132017-03-13
NCT02474355Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLCCOMPLETEDPHASE32015-09-182019-04-182019-04-18
NCT02546323A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical AtherosclerosisCOMPLETEDPHASE32015-09-172019-01-292019-01-29
NCT02369874Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck CancerCOMPLETEDPHASE32015-09-092020-11-132018-09-10
NCT02354976A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.COMPLETEDPHASE22015-09-012016-05-262016-05-26
NCT02532998A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male SubjectsCOMPLETEDPHASE12015-092015-122015-12
NCT02533505Phase IV O2 Consumption Study in COPD Patients.COMPLETEDPHASE42015-08-252016-08-122016-08-12
NCT02529995Phase I, Study in Chinese NSCLC PatientsCOMPLETEDPHASE12015-08-242019-09-272016-01-28
NCT02500979Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusCOMPLETEDPHASE12015-08-172016-08-052016-08-05
NCT02419612A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCOMPLETEDPHASE32015-08-142019-09-182017-08-29
NCT02499328Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & NeckACTIVE_NOT_RECRUITINGPHASE1, PHASE22015-08-062025-08-122020-02-28
NCT02511795AZD1775 Combined With Olaparib in Patients With Refractory Solid TumorsCOMPLETEDPHASE12015-08-062019-10-162019-04-25
NCT02453282Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITINGPHASE32015-07-212025-12-312018-10-04
NCT02491684A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract InfectionCOMPLETEDPHASE22015-07-212016-11-242016-11-24
NCT02433288Rosuvastatin Adherence App Study in ChinaCOMPLETEDNA2015-07-202016-10-282016-10-28
NCT02454933Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive TumoursCOMPLETEDPHASE32015-07-152023-06-212017-08-21
NCT02446899Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCOMPLETEDPHASE32015-07-092018-09-272018-09-27
NCT02482298A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell DiseaseCOMPLETEDPHASE22015-07-092016-11-162016-11-16
NCT02460978Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesCOMPLETEDPHASE32015-07-082018-04-182017-09-02
NCT02482311Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid TumoursCOMPLETEDPHASE12015-07-012019-08-222018-01-25
NCT02484729A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy MalesCOMPLETEDPHASE12015-072015-112015-11
NCT02491944A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291COMPLETEDPHASE12015-072015-082015-08
NCT02479412A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate AsthmaCOMPLETEDPHASE22015-06-252016-02-082016-02-08
NCT02442349Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia PacificACTIVE_NOT_RECRUITINGPHASE22015-06-222025-12-312016-03-04
NCT02413398A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesCOMPLETEDPHASE32015-06-152017-11-072017-11-07
NCT02430311The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.COMPLETEDPHASE12015-06-102017-04-282016-07-27
NCT02463071AZD0585 Phase III Long-term Study in JapanCOMPLETEDPHASE32015-06-102017-03-112017-03-11
NCT02446912Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCOMPLETEDPHASE32015-06-092018-07-172018-07-17
NCT02434497A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial HypercholesterolemiaCOMPLETEDPHASE32015-06-062016-11-172016-11-17
NCT02406677Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction StudyCOMPLETEDPHASE42015-06-052017-10-232017-10-23
NCT02436577Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese SubjectsCOMPLETEDPHASE12015-062015-082015-08
NCT02400333Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR TabletCOMPLETEDPHASE12015-062015-072015-07
NCT02447328A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast CancerCOMPLETEDPHASE42015-05-292020-09-162016-05-06
NCT02429258Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or InsulinCOMPLETEDPHASE42015-052015-102015-10
NCT02446171A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and SolutionCOMPLETEDPHASE12015-052015-072015-07
NCT02406261A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy ParticipantsCOMPLETEDPHASE12015-04-302015-08-312015-08-31
NCT02417961Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at HomeCOMPLETEDPHASE32015-04-272016-03-142016-03-14
NCT02424344Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD PatientsCOMPLETEDPHASE42015-04-272016-07-252016-07-25
NCT02388295AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA PatientsCOMPLETEDPHASE22015-04-272016-09-192016-09-19
NCT02406248Brilinta Taiwan Post Approval Safety StudyCOMPLETEDPHASE42015-04-232017-02-092017-02-09
NCT02319044Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and NeckCOMPLETEDPHASE22015-04-152020-07-062016-09-26
NCT02403895AZD2014 and Weekly Paclitaxel in Squamous NSCLCTERMINATEDPHASE22015-04-152016-12-292016-12-29
NCT02426541Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE42015-03-232016-04-282016-04-28
NCT02398747Japanese Phase I Study of AZD2014 in Advanced Solid MalignanciesCOMPLETEDPHASE12015-03-172024-04-122024-04-12
NCT02317016Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung CancerCOMPLETEDPHASE12015-03-102018-05-222015-07-11
NCT02375724BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGHCOMPLETEDPHASE42015-032015-112015-11
NCT02322788Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3COMPLETEDPHASE32015-032015-112015-11
NCT02370537A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEICOMPLETEDPHASE22015-032015-112015-11
NCT02367066A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12015-032015-052015-05
NCT02372344A Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA of AZD0585 in Healthy Male Japanese SubjectsCOMPLETEDPHASE12015-032015-052015-05
NCT02281357Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent AsthmaCOMPLETEDPHASE32015-02-192017-09-072017-09-07
NCT02359045Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed ConditionsCOMPLETEDPHASE12015-02-122015-07-272015-07-27
NCT02282020Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum TreatmentsCOMPLETEDPHASE32015-02-062022-07-192018-10-10
NCT02322775Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent AsthmaCOMPLETEDPHASE32015-02-022015-10-072015-10-07
NCT02322749A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male VolunteersCOMPLETEDPHASE12015-022015-042015-04
NCT02272790Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCOMPLETEDPHASE22015-01-302023-03-082018-12-13
NCT02341456Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid TumoursCOMPLETEDPHASE12015-01-162018-07-092016-12-14
NCT02352948A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCOMPLETEDPHASE32015-01-132023-08-302018-02-09
NCT02279407A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic PatientsCOMPLETEDPHASE22015-012015-122015-12
NCT02197234Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLCCOMPLETEDPHASE12014-12-222024-06-032015-04-30
NCT02161770Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver ImpairmentCOMPLETEDPHASE12014-12-222017-08-222017-05-16
NCT02184195Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyCOMPLETEDPHASE32014-12-162023-01-272019-01-15
NCT02197247Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLCCOMPLETEDPHASE12014-12-042021-05-262015-07-09
NCT02296125AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32014-12-032025-12-312017-06-19
NCT02303574Single + Multiple Ascending Dose and Food Effect Study of AZD7986 in Healthy Volunteers, PK, PD and Safety StudyCOMPLETEDPHASE12014-12-032016-08-032016-08-03
NCT02273050Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlCOMPLETEDPHASE32014-122016-082016-08
NCT02288273Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.COMPLETEDPHASE42014-122015-082015-08
NCT02317861A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia PatientsCOMPLETEDPHASE1, PHASE22014-122015-062015-06
NCT02121288Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease PatientsWITHDRAWNPHASE42014-122016-022016-02
NCT02224157A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With AsthmaCOMPLETEDPHASE32014-11-282017-08-162017-08-16
NCT02258542A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABACOMPLETEDPHASE32014-11-192018-07-022017-10-18
NCT02163733Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung CancerCOMPLETEDPHASE12014-11-142023-01-242015-03-24
NCT02268214Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesCOMPLETEDPHASE32014-11-112017-08-252017-01-04
NCT02157883Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)COMPLETEDPHASE12014-11-062023-05-172015-04-03
NCT02228369Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung CancerCOMPLETEDPHASE12014-11-052020-10-282017-08-19
NCT02248818AZD8108 SAD/MAD in Healthy VolunteersCOMPLETEDPHASE12014-112015-092015-09
NCT02260661Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid TumoursCOMPLETEDPHASE12014-112016-072016-07
NCT02226198A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial HypercholesterolemiaCOMPLETEDPHASE32014-112015-072015-07
NCT02269488A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 YearsCOMPLETEDPHASE32014-112015-022015-02
NCT02264678Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsACTIVE_NOT_RECRUITINGPHASE1, PHASE22014-10-312025-12-312025-03-04
NCT02104817Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With HypertriglyceridemiaCOMPLETEDPHASE32014-10-302020-05-272020-05-27
NCT02194699A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaCOMPLETEDPHASE32014-10-302017-09-212017-05-10
NCT02238483A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance TherapyCOMPLETEDPHASE22014-10-282016-04-042016-04-04
NCT02207530Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCOMPLETEDPHASE22014-10-232020-07-062016-09-26
NCT02248090AZD9496 First Time in Patients Ascending Dose StudyCOMPLETEDPHASE12014-10-222019-04-032017-01-31
NCT02227368Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVRTERMINATEDPHASE22014-10-202016-05-232016-05-23
NCT02269475A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 YearsCOMPLETEDPHASE32014-102015-042015-04
NCT02189252An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of PancreatitisCOMPLETEDPHASE12014-102015-072015-07
NCT02238782A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.COMPLETEDPHASE12014-102014-112014-11
NCT02245737An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseTERMINATEDPHASE2, PHASE32014-09-302018-10-042018-10-04
NCT02214121A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell DiseaseCOMPLETEDPHASE22014-09-112017-02-272017-02-27
NCT02284893Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy AloneCOMPLETEDPHASE32014-09-092016-09-202016-09-20
NCT02229383Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes MellitusCOMPLETEDPHASE32014-09-062016-08-292016-08-29
NCT02229396Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching PlaceboCOMPLETEDPHASE32014-09-042017-12-282016-04-26
NCT02093351To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid CancerCOMPLETEDPHASE12014-09-012019-04-292015-04-30
NCT0224317624-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin MonotherapyCOMPLETEDPHASE42014-092015-092015-09
NCT02224053Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy VolunteersCOMPLETEDPHASE12014-092015-012015-01
NCT02052635Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.TERMINATEDPHASE42014-092015-042015-04
NCT02223065Bioequivalence Study Coadministered to Healthy Subjects in the Fasted StateCOMPLETEDPHASE12014-092014-122014-12
NCT02143466AZD9291 in Combination With Ascending Doses of Novel TherapeuticsACTIVE_NOT_RECRUITINGPHASE12014-08-052025-12-312020-03-04
NCT02151981AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung CancerCOMPLETEDPHASE32014-08-042023-12-152016-04-15
NCT02178059Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2COMPLETEDPHASE12014-082014-112014-11
NCT02155881Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in RussiaCOMPLETEDPHASE32014-082014-112014-10
NCT02185534Clopidogrel Bioequivalence Study in Healthy SubjectsCOMPLETEDPHASE12014-082014-102014-10
NCT02209766A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)COMPLETEDPHASE12014-082014-112014-11
NCT02179671Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung CancerCOMPLETEDPHASE22014-07-252016-06-112016-06-11
NCT02149199A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.COMPLETEDPHASE32014-07-072017-08-022017-08-02
NCT02174731Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.COMPLETEDPHASE32014-07-012018-09-262018-09-26
NCT02157376Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill PatientsCOMPLETEDPHASE32014-072016-022016-02
NCT02157935Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE32014-06-272016-02-082016-02-08
NCT02174627Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on DialysisCOMPLETEDPHASE32014-06-262018-10-042018-10-04
NCT02155660Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCOMPLETEDPHASE32014-06-252018-04-092018-04-09
NCT02138916Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCOMPLETEDPHASE32014-06-132018-04-102018-04-10
NCT02161757A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaCOMPLETEDPHASE32014-06-132017-07-182017-02-28
NCT02153398A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesCOMPLETEDPHASE32014-062016-042016-04
NCT02157298Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.COMPLETEDPHASE42014-062015-112015-02
NCT02141347Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ MesotheliomaCOMPLETEDPHASE12014-05-222017-01-272017-01-27
NCT02094261Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive TumoursCOMPLETEDPHASE22014-05-202023-11-072015-05-01
NCT02125461A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerCOMPLETEDPHASE32014-05-072023-08-242017-02-13
NCT02104804Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlCOMPLETEDPHASE32014-05-072016-02-262016-02-26
NCT02165826Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250ÎĽg and 500ÎĽg, as add-on to Standard COPD Treatment to Treat Severe COPDCOMPLETEDPHASE32014-05-012015-09-012015-09-01
NCT02144051Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor TumorsCOMPLETEDPHASE12014-052016-032016-03
NCT02096679Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD9291 in VolunteersCOMPLETEDPHASE12014-052014-082014-08
NCT02126514A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293COMPLETEDPHASE12014-052014-052014-05
NCT02127710A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)COMPLETEDPHASE22014-04-302020-04-202016-04-14
NCT02075255Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS TherapyCOMPLETEDPHASE32014-04-282016-08-082016-08-08
NCT02032823Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerACTIVE_NOT_RECRUITINGPHASE32014-04-222029-05-282020-03-27
NCT01972217Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.COMPLETEDPHASE22014-04-012023-08-242017-09-22
NCT02091986A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 ÎĽg and Symbicort pMDI 80/4.5 ÎĽg, Compared With Budesonide pMDI 80 ÎĽgCOMPLETEDPHASE32014-042016-042016-04
NCT01974752Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)COMPLETEDPHASE32014-042016-102015-05
NCT02153489A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 ÎĽg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE42014-042015-062015-06
NCT02093728To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersCOMPLETEDPHASE12014-042014-062014-06
NCT02096705Phase III Insulin Add-On Asia Regional Program - STCOMPLETEDPHASE32014-03-312016-01-282016-01-28
NCT02000622Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.ACTIVE_NOT_RECRUITINGPHASE32014-03-272025-12-312016-12-09
NCT01894243Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver ImpairmentCOMPLETEDPHASE12014-03-132017-03-302016-11-29
NCT02087241Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung CancerTERMINATEDPHASE22014-032015-062015-06
NCT02063230To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy SubjectsCOMPLETEDPHASE12014-032014-112014-11
NCT02087176A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung CancerTERMINATEDPHASE22014-032015-052015-05
NCT01890148Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069COMPLETEDPHASE12014-032014-082014-08
NCT02056392To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male VolunteersCOMPLETEDPHASE12014-032014-082014-08
NCT02063204To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy SubjectsCOMPLETEDPHASE12014-032014-072014-07
NCT02072993A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy MalesTERMINATEDPHASE12014-032014-072014-07
NCT02087423A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCOMPLETEDPHASE22014-02-252025-03-262016-06-03
NCT01991795A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32014-02-102019-01-252019-01-25
NCT02036645SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.COMPLETEDPHASE12014-02-042016-09-152016-09-15
NCT02064985Ticagrelor China Pharmacokinetic/Pharmacodynamic StudyCOMPLETEDPHASE42014-022014-112014-11
NCT02060201Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)COMPLETEDPHASE12014-022014-052014-05
NCT02039180Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female SubjectsCOMPLETEDPHASE12014-022014-032014-03
NCT02046850To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersCOMPLETEDPHASE12014-022014-042014-04
NCT01994720[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]COMPLETEDPHASE32014-01-072016-03-022016-03-02
NCT02078219Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic HyperuricemiaCOMPLETEDPHASE22014-01-052015-03-132015-03-13
NCT02036580D2212C00002 J-Phase II StudyCOMPLETEDPHASE22014-012015-112015-11
NCT02051335Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy AdultsCOMPLETEDPHASE12014-012014-052014-05
NCT02025348Explore the Performance of IntelliCap.COMPLETEDEARLY_PHASE12014-012014-032014-03
NCT01818869To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy SubjectsCOMPLETEDPHASE12014-012014-022014-02
NCT01989520Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069COMPLETEDPHASE12014-012014-042014-04
NCT02040987AZD3293 Thorough QT Study in Healthy Male VolunteersCOMPLETEDPHASE12014-012014-052014-05
NCT02022748Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy SubjectsCOMPLETEDPHASE12013-12-292016-05-092016-05-09
NCT02009865Epanova® for Lowering Very High Triglycerides II (EVOLVE II)COMPLETEDPHASE32013-12-162014-12-232014-12-23
NCT01929603Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid TumoursCOMPLETEDPHASE12013-122016-112014-05
NCT02005211A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly VolunteersCOMPLETEDPHASE12013-122014-072014-07
NCT01895946Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and TolerabilityCOMPLETEDPHASE12013-122015-072015-02
NCT02010970A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) SubstrateCOMPLETEDPHASE12013-122014-022014-02
NCT01959165MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis PatientsCOMPLETEDPHASE22013-11-212018-04-102015-08-11
NCT01894256Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney FunctionCOMPLETEDPHASE12013-112016-022015-03
NCT01928381Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting AbilityCOMPLETEDPHASE22013-112015-052015-05
NCT01958645To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.COMPLETEDPHASE12013-112014-102014-10
NCT01947946Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaTERMINATEDPHASE32013-112014-072014-07
NCT01962935Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069COMPLETEDPHASE12013-112014-062014-06
NCT01974349To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male VolunteersCOMPLETEDPHASE12013-112014-022014-02
NCT01955668AZD6738 First Time in Patient Multiple Ascending Dose StudyCOMPLETEDPHASE12013-112013-122013-12
NCT01966107Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.COMPLETEDPHASE42013-10-162017-09-212017-09-21
NCT01951599To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.COMPLETEDPHASE12013-10-092014-06-042014-06-04
NCT01900028To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid TumoursCOMPLETEDPHASE12013-102016-092014-04
NCT01949870Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 StudyTERMINATEDPHASE12013-102014-082014-08
NCT01961349Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal EndoscopyCOMPLETEDPHASE32013-102014-032014-03
NCT01931761Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in VolunteersCOMPLETEDPHASE12013-102013-112013-11
NCT01960374Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PKCOMPLETEDPHASE12013-102014-052014-05
NCT01937338Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin ChallengeCOMPLETEDPHASE12013-102014-042014-04
NCT01964131BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male SubjectsCOMPLETEDPHASE12013-102013-122013-12
NCT01933932Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLCACTIVE_NOT_RECRUITINGPHASE32013-09-252025-12-312016-06-07
NCT01921140To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid TumoursCOMPLETEDPHASE12013-09-242022-03-152014-04-08
NCT01928771Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaCOMPLETEDPHASE32013-09-192016-04-052016-04-05
NCT01938612A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid TumoursCOMPLETEDPHASE12013-09-122020-11-252018-03-01
NCT01874353Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyACTIVE_NOT_RECRUITINGPHASE32013-09-032025-12-312016-09-19
NCT01924533Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.COMPLETEDPHASE32013-09-032023-03-272016-04-04
NCT02059434Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPDCOMPLETEDPHASE12013-09-012014-10-062014-10-06
NCT02859129Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)COMPLETEDPHASE12013-092013-112013-11
NCT01908140Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32013-092014-082014-08
NCT01817855To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD PatientsCOMPLETEDPHASE12013-092014-102014-10
NCT01926366AZD6423 SAD/MAD Study in Healthy VolunteersCOMPLETEDPHASE12013-092014-032014-03
NCT01929629A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914COMPLETEDPHASE12013-092014-032014-03
NCT01843062Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid CancerTERMINATEDPHASE32013-08-272019-03-062018-05-18
NCT01844986Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.ACTIVE_NOT_RECRUITINGPHASE32013-08-262028-08-292018-05-17
NCT01914757Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 AgonistCOMPLETEDPHASE32013-082016-032016-03
NCT01904773Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's DisorderCOMPLETEDPHASE22013-082015-022015-02
NCT01913028A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese SubjectsCOMPLETEDPHASE12013-082014-012014-01
NCT01921920Prilosec Bioequivalence Study in Healthy VolunteersCOMPLETEDPHASE12013-082013-112013-11
NCT01884285AZD8186 First Time In Patient Ascending Dose StudyCOMPLETEDPHASE12013-07-092020-02-072019-03-31
NCT01851265D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid TumoursCOMPLETEDPHASE12013-07-042017-06-062013-10-18
NCT01880424A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)COMPLETEDPHASE32013-072015-052015-05
NCT01889160Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose LevelsCOMPLETEDPHASE12013-072013-122013-12
NCT01887626Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.COMPLETEDPHASE12013-072013-092013-09
NCT01870921Brilinta DaYu StudyCOMPLETEDPHASE42013-06-262015-09-302015-09-30
NCT01703260Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitisTERMINATEDPHASE22013-062014-092014-09
NCT01856764Topical Roflumilast in Adults With Atopic DermatitisCOMPLETEDPHASE22013-062014-032014-03
NCT01874262A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial InfarctionCOMPLETEDNA2013-062014-122014-12
NCT01872078A Study of AZD4901 in Females With Polycystic Ovary SyndromeCOMPLETEDPHASE22013-062014-072014-07
NCT01874080Bioequivalence StudyCOMPLETEDPHASE12013-062013-072013-07
NCT01838499Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis SuppurativaTERMINATEDPHASE22013-052014-102014-10
NCT01839604A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular CarcinomaCOMPLETEDPHASE12013-052015-022015-02
NCT01864005A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACSCOMPLETEDPHASE42013-052014-032014-03
NCT01730534Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsCOMPLETEDPHASE32013-04-252018-09-112018-09-11
NCT01809210Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung CancerCOMPLETEDPHASE12013-04-042016-01-042016-01-04
NCT01535677To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered SeparatelyCOMPLETEDPHASE12013-042013-072013-07
NCT01813474Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12013-03-252016-08-312016-08-31
NCT01802632AZD9291 First Time In Patients Ascending Dose StudyCOMPLETEDPHASE1, PHASE22013-03-042023-12-132015-05-01
NCT01795339A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's PatientsCOMPLETEDPHASE12013-032014-032014-03
NCT01788163Asia Pacific and Russia Diagnostic Study for EGFR TestingCOMPLETEDNA2013-02-272016-06-202014-08-25
NCT01714726Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.COMPLETEDPHASE22013-02-012016-12-142014-05-20
NCT01765192Roflumilast Plus Montelukast in Adults With Severe AsthmaCOMPLETEDPHASE22013-022013-102013-10
NCT01757275High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic UlcerCOMPLETEDPHASE32013-022014-122014-12
NCT01652729Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32013-022014-042014-04
NCT02349802Autoinjector Device Assessment StudyCOMPLETEDPHASE12013-022013-122013-12
NCT01755494A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-AdministrationCOMPLETEDPHASE12013-022013-042013-04
NCT01652716Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-012014-082014-08
NCT01754844A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy SubjectsCOMPLETEDPHASE12013-012013-082013-08
NCT01757262A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese PatientWITHDRAWNPHASE32013-012013-042013-04
NCT01750281Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.COMPLETEDPHASE22012-12-182022-10-312016-01-27
NCT01732822A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery DiseaseCOMPLETEDPHASE32012-12-042016-09-262016-09-26
NCT01735240Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.COMPLETEDPHASE12012-122013-022013-02
NCT01744288Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on PlateletsCOMPLETEDPHASE12012-122014-042014-04
NCT01739647A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy SubjectsCOMPLETEDPHASE12012-122013-052013-05
NCT01704495A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.COMPLETEDPHASE22012-112014-082014-08
NCT01608724The Efficacy and Safety Study in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE42012-112014-052014-05
NCT01708044Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DMCOMPLETEDPHASE12012-112013-092013-09
NCT01692262Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.COMPLETEDPHASE12012-112014-062014-06
NCT01725230Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With FostamatinibCOMPLETEDPHASE12012-112013-012013-01
NCT01666613A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different WaysWITHDRAWNPHASE12012-112013-032013-03
NCT01602380A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.ACTIVE_NOT_RECRUITINGPHASE32012-10-172027-08-062016-04-11
NCT01625286Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer PatientsCOMPLETEDPHASE1, PHASE22012-10-032022-10-032017-01-28
NCT01708057A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) PatientsTERMINATEDPHASE22012-102012-122012-12
NCT01603069A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's DiseaseCOMPLETEDPHASE22012-102013-062013-06
NCT01646320Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 DiabetesCOMPLETEDPHASE32012-092015-022014-08
NCT01525225Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DMTERMINATEDPHASE12012-092013-062013-06
NCT01636024To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594COMPLETEDPHASE12012-092013-062013-06
NCT01682408Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess BioavailabilityCOMPLETEDPHASE12012-092012-122012-12
NCT01669811Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)COMPLETEDPHASE32012-082014-052014-05
NCT01662999Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy ParticipantsCOMPLETEDPHASE12012-082012-112012-11
NCT01635985A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different WaysCOMPLETEDPHASE12012-082012-122012-12
NCT01525238PK Study of Dapagliflozin in Pediatric Subjects With T2DMCOMPLETEDPHASE12012-07-012014-09-012014-09-01
NCT01606007Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesCOMPLETEDPHASE32012-072014-012014-01
NCT01664624Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 DiabetesCOMPLETEDPHASE12012-072012-112012-11
NCT01530334Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous TreatmentCOMPLETEDPHASE22012-072014-072014-07
NCT01603082Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome PatientsCOMPLETEDPHASE42012-072014-062014-06
NCT01588548Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant LymphomaCOMPLETEDPHASE12012-072014-072014-07
NCT01623609Open Label, Healthy Volunteers, Bioequivalence Study With NaloxegolCOMPLETEDPHASE12012-072012-092012-09
NCT01640054A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid ArthritisTERMINATEDPHASE22012-072013-072013-07
NCT01645085A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of FostamatinibCOMPLETEDPHASE12012-072013-032013-03
NCT01635023A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244COMPLETEDPHASE12012-072012-102012-10
NCT01641081Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate AsthmaCOMPLETEDPHASE22012-062013-022013-02
NCT01605916Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung CancerCOMPLETEDPHASE12012-062015-052015-04
NCT01619059Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesCOMPLETEDPHASE32012-062015-012014-06
NCT01608542A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese SubjectsCOMPLETEDPHASE12012-062012-082012-08
NCT01596530Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin TreatmentTERMINATEDPHASE12012-062013-052013-03
NCT01584739AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) PatientsTERMINATEDPHASE12012-062012-112012-11
NCT01597388AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast CancerACTIVE_NOT_RECRUITINGPHASE12012-05-082028-09-052016-08-04
NCT01434186A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCOMPLETEDPHASE32012-052016-042016-04
NCT01560234AZD8848 Single Ascending Dose StudyCOMPLETEDPHASE12012-052014-072014-07
NCT01594619Study in Healthy Volunteers to Investigate the Effects of Diltiazem on the Pharmacokinetics of NaloxegolCOMPLETEDPHASE12012-052012-082012-08
NCT01595425Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male SubjectsCOMPLETEDPHASE12012-052012-062012-06
NCT01598571Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer DoseCOMPLETEDPHASE12012-052012-082012-08
NCT01588626Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male VolunteersCOMPLETEDPHASE12012-052012-062012-06
NCT01559090Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.COMPLETEDPHASE22012-04-202017-02-212014-08-19
NCT01572792Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32012-042013-062013-06
NCT01548287A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive ImpairmentCOMPLETEDPHASE22012-042013-012013-01
NCT01579578Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric CancerTERMINATEDPHASE22012-042013-032013-03
NCT01523366A Pharmacodynamic Study With Ticagrelor in Hispanic PatientsCOMPLETEDPHASE42012-042013-052013-05
NCT01563978Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid ArthritisCOMPLETEDPHASE22012-042013-012013-01
NCT01569074Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid ArthritisTERMINATEDPHASE22012-042013-072013-07
NCT01555099Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of FormoterolCOMPLETEDPHASE22012-042013-042013-04
NCT01527695PET Study in Parkinson's Disease PatientsCOMPLETEDPHASE22012-042013-012012-12
NCT01568281Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male SubjectsCOMPLETEDPHASE12012-042012-062012-06
NCT01544179A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy AloneCOMPLETEDPHASE32012-03-152019-11-202014-05-05
NCT01482884Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative ColitisCOMPLETEDPHASE22012-032013-062013-03
NCT01533155Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118COMPLETEDPHASE12012-032012-092012-09
NCT01533870Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118COMPLETEDPHASE12012-032012-052012-05
NCT01523392A Pharmacodynamic Study With Ticagrelor in African American PatientsCOMPLETEDPHASE42012-032013-092013-09
NCT01498081A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD PatientsCOMPLETEDPHASE22012-032012-102012-10
NCT01469923To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending DosesTERMINATEDPHASE12012-032012-122012-12
NCT01509677Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE32012-02-012016-02-012016-02-01
NCT01498185BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 DiabetesCOMPLETEDPHASE22012-022012-102012-10
NCT01514240Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in JapanCOMPLETEDPHASE32012-022014-092014-09
NCT01473758Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseTERMINATEDPHASE22012-022014-032014-03
NCT01489722Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) PatientsTERMINATEDPHASE12012-022014-052014-05
NCT01520896Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118COMPLETEDPHASE12012-022012-042012-04
NCT01551888Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22012-012012-032012-03
NCT01504906Study to Assess Effect of Cyclosporine on the Blood Levels of TicagrelorCOMPLETEDPHASE12012-012012-062012-06
NCT01494402Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male SubjectsCOMPLETEDPHASE12012-012012-032012-03
NCT01500018Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214WITHDRAWNPHASE12012-012012-042012-04
NCT01257412Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise AloneSUSPENDEDPHASE32012-012013-062013-06
NCT01482221A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive DisorderCOMPLETEDPHASE22011-12-162013-08-262013-08-26
NCT01554618Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 DiabetesCOMPLETEDPHASE32011-12-022021-05-052020-05-06
NCT01444430A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and AdolescentsCOMPLETEDPHASE32011-122015-102015-10
NCT01480739AZD5069 Neutrophil Function StudyCOMPLETEDPHASE12011-122012-072012-07
NCT01499303Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood CancerCOMPLETEDPHASE22011-122013-102013-10
NCT01457846Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal CancerTERMINATEDPHASE22011-112015-022013-08
NCT01455194Effect of High Dose Ciclesonide on Asthma ControlCOMPLETEDPHASE32011-112014-082014-08
NCT01462929Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32011-112012-052012-03
NCT01471171Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32011-112012-062012-06
NCT01486433The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal SubjectsCOMPLETEDPHASE12011-112012-032012-03
NCT01360021New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a DayCOMPLETEDPHASE32011-112012-082012-08
NCT01457807To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy VolunteersCOMPLETEDPHASE12011-112011-122011-12
NCT01448031A Healthy Female and Male Volunteers Aspirin StudyCOMPLETEDPHASE12011-112012-042012-04
NCT01458899Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214COMPLETEDPHASE12011-112012-012012-01
NCT01462942Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose CombinationCOMPLETEDPHASE32011-102013-012013-01
NCT01392677Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaCOMPLETEDPHASE32011-102013-082013-01
NCT01445782AZD2115 Multiple Ascending Dose StudyCOMPLETEDPHASE12011-102012-072012-07
NCT01419600To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Inhaled AZD8683COMPLETEDPHASE12011-102012-052012-05
NCT01441869Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin ProducCOMPLETEDPHASE12011-102011-122011-12
NCT01443845Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)COMPLETEDPHASE42011-09-302016-01-312015-11-30
NCT01437540Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE32011-09-192013-04-302013-03-31
NCT01415518Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE42011-09-012012-12-012012-12-01
NCT01437397Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32011-092013-022013-02
NCT01347580A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)COMPLETEDPHASE42011-092013-112013-11
NCT01396226A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in PatientsCOMPLETEDPHASE22011-092012-012012-01
NCT01331993A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen FormulationCOMPLETEDPHASE12011-092011-102011-10
NCT01425801Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.COMPLETEDPHASE22011-08-012012-02-012012-02-01
NCT01425814Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) PopulationCOMPLETEDPHASE22011-082012-032012-03
NCT01431690Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat MealsCOMPLETEDPHASE12011-082011-102011-10
NCT01408303[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROLCOMPLETEDPHASE32011-082012-062012-06
NCT01351688An Open Label Prostate Cancer Study in Japanese PatientsCOMPLETEDPHASE12011-082013-052013-03
NCT01370538Efficacy of Esomeprazole in Patients With Frequent HeartburnCOMPLETEDPHASE32011-082011-102011-10
NCT01370525Efficacy of Esomeprazole in Patients With Frequent HeartburnCOMPLETEDPHASE32011-082011-102011-10
NCT01397084To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleCOMPLETEDPHASE42011-082012-012012-01
NCT01325402An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's DiseaseCOMPLETEDPHASE12011-082012-112012-11
NCT01403922To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic HypertensionTERMINATEDPHASE12011-082012-082012-08
NCT01257048Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis TurbuhalerCOMPLETEDEARLY_PHASE12011-082012-062012-06
NCT01415778Bioequivalence of ICI176,334-1 in Japanese Healthy Male SubjectsCOMPLETEDPHASE12011-082011-122011-11
NCT01415791Oral Mucosal Absorption of ICI176,334-1COMPLETEDPHASE12011-082011-092011-09
NCT01387308Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib TabletsCOMPLETEDPHASE12011-082011-102011-10
NCT01395524A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCOMPLETEDPHASE32011-072012-092012-09
NCT01397890Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE42011-072013-062013-06
NCT01340040Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese SubjectsCOMPLETEDPHASE12011-072012-052012-04
NCT01392807Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic FunctionCOMPLETEDPHASE12011-072011-112011-11
NCT01392820A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female VolunteersCOMPLETEDPHASE12011-072011-102011-10
NCT01204775Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 DiabetesCOMPLETEDPHASE32011-062016-042016-04
NCT01353781Open Label Phase 1 Study in Japan for Patient With Advanced Solid MalignanciesCOMPLETEDPHASE12011-062014-072014-07
NCT01384292Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related PainTERMINATEDPHASE32011-062012-092012-09
NCT01365091Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-BrazilCOMPLETEDPHASE12011-062011-112011-11
NCT01338350Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male SubjectsCOMPLETEDPHASE12011-062011-122011-12
NCT01365000Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy SubjectsCOMPLETEDPHASE12011-062011-082011-08
NCT01372826Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal FunctionCOMPLETEDPHASE12011-062011-112011-10
NCT01348724Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118COMPLETEDPHASE12011-062011-092011-09
NCT01359618Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the HeartTERMINATEDPHASE12011-062012-042012-04
NCT01348737Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy VolunteersCOMPLETEDPHASE12011-062011-112011-11
NCT01355354Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy SubjectsCOMPLETEDPHASE12011-062011-092011-09
NCT01957579A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell MalignanciesCOMPLETEDPHASE12011-05-252015-09-152015-09-15
NCT01329029Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)COMPLETEDPHASE42011-052014-052014-03
NCT01354782Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese SubjectsCOMPLETEDPHASE12011-052011-092011-06
NCT01332903Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069COMPLETEDPHASE12011-052011-072011-07
NCT01348139Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With AsthmaCOMPLETEDPHASE22011-052012-022012-02
NCT01358383Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult VolunteersCOMPLETEDPHASE12011-052011-062011-06
NCT01350921Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy VolunteersCOMPLETEDPHASE12011-052012-032012-03
NCT01340183Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy SubjectsSUSPENDEDPHASE12011-052011-122011-12
NCT01332214To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending DosesCOMPLETEDPHASE12011-052011-112011-11
NCT01335451Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese SubjectsCOMPLETEDPHASE12011-042011-102011-10
NCT01310322A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different WaysCOMPLETEDPHASE12011-042011-102011-10
NCT01336205Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCOMPLETEDPHASE32011-042012-122012-12
NCT01325415A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male SubjectsCOMPLETEDPHASE12011-042011-072011-07
NCT01311635A Bioavailability Study Comparing 3 Different AZD1981 TabletsCOMPLETEDPHASE12011-042011-062011-05
NCT01330758A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and FemalesCOMPLETEDPHASE12011-042011-052011-05
NCT01336218Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.COMPLETEDPHASE12011-042011-072011-07
NCT01313494A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore:COMPLETEDPHASE32011-032012-052012-05
NCT01323790Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCOMPLETEDPHASE32011-032012-092012-09
NCT01309841Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCOMPLETEDPHASE32011-032012-082012-08
NCT01300351Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer WomenCOMPLETEDPHASE32011-032014-032014-03
NCT01284595Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931COMPLETEDPHASE12011-032011-052011-05
NCT01305551BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed StatesWITHDRAWNPHASE12011-032011-032011-03
NCT01311622Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy SubjectsCOMPLETEDPHASE12011-032011-052011-05
NCT01276262Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female SubjectsCOMPLETEDPHASE12011-032011-112011-11
NCT01318655Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy SubjectsCOMPLETEDPHASE12011-032011-072011-07
NCT01309854Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsCOMPLETEDPHASE12011-032011-052011-05
NCT01258205Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease SubjectsCOMPLETEDPHASE12011-02-282015-02-182015-02-18
NCT01255592Evaluation of the Effect of AZD5069 in Patients With BronchiectasisCOMPLETEDPHASE22011-022012-022012-02
NCT01297062A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy SubjectsCOMPLETEDPHASE12011-022011-052011-04
NCT01294423Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-022012-032012-03
NCT01294462Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)COMPLETEDPHASE32011-022012-072012-07
NCT02092961Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-StudyTERMINATEDPHASE22011-022013-072013-07
NCT01294436Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-022012-092012-09
NCT01288079A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.TERMINATEDPHASE22011-022012-082012-08
NCT01298310A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)COMPLETEDEARLY_PHASE12011-022012-052012-05
NCT01254461A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of PravastatinCOMPLETEDPHASE12011-022011-042011-04
NCT01164540Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous ThrombosisWITHDRAWNPHASE32011-022013-032013-03
NCT01242527Epanova® for Lowering Very High TriglyceridesCOMPLETEDPHASE2, PHASE32011-012012-042012-03
NCT01235741A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese SubjectsTERMINATEDPHASE22011-012011-092011-09
NCT01264770Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)TERMINATEDPHASE22011-012013-082012-10
NCT01242514Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)TERMINATEDPHASE32011-012015-012015-01
NCT01275781Study in Healthy Males to Assess Distribution, Metabolism, and Excretion of Radio-labelled AZD9742 Administered as a 2-hour InfusionWITHDRAWNPHASE12011-012011-022011-02
NCT01283984AZD2115 Single Ascending Dose StudyCOMPLETEDPHASE12011-012011-082011-08
NCT01265641To Investigate the Effects of AZD1981 on the QT IntervalCOMPLETEDPHASE12011-012011-042011-04
NCT01264250A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male VolunteersCOMPLETEDPHASE12011-012011-052011-05
NCT01239771A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly SubjectsCOMPLETEDPHASE12011-012011-052011-05
NCT01226316Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesCOMPLETEDPHASE12010-12-012024-12-032019-04-26
NCT01256177Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar DepressionCOMPLETEDPHASE32010-122012-112012-11
NCT01202591Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer PatientsCOMPLETEDPHASE1, PHASE22010-122014-102014-09
NCT01254721A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,StudyTERMINATEDPHASE42010-122012-102012-10
NCT01173471A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular PressureCOMPLETEDPHASE22010-122012-112012-11
NCT01226602Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.COMPLETEDPHASE12010-122011-042011-04
NCT01240148Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy VolunteersCOMPLETEDPHASE12010-122011-032011-03
NCT01247103Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy SubjectsWITHDRAWNPHASE12010-122011-062011-06
NCT01213160Study to Assess Safety and Tolerability of AZD4547 in Japanese PatientCOMPLETEDPHASE12010-112013-062013-06
NCT01233232A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22010-112011-032011-03
NCT01203124A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on BiomarkersCOMPLETEDPHASE12010-112012-022011-03
NCT01225549The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled AllergenCOMPLETEDPHASE22010-112011-122011-12
NCT01194986Evaluation of Histamine H3 Receptor Radioligand [11C]AZ12807110 and Histamine H3 Receptor Occupancy of AZD5213 After Oral AdministrationCOMPLETEDPHASE12010-112011-062011-06
NCT01217892Evaluation of Dapagliflozin Taken Twice-dailyCOMPLETEDPHASE32010-112011-082011-08
NCT01240967To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal FunctionCOMPLETEDPHASE12010-112011-072011-07
NCT01214122A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of WarfarinWITHDRAWNPHASE12010-112010-122010-12
NCT01219543A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.TERMINATEDPHASE12010-112012-122012-12
NCT01249651To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleCOMPLETEDPHASE42010-112011-062011-06
NCT01247168An Open-Label, Dose-Escalation Study of AZD2461COMPLETEDPHASE12010-112011-052011-05
NCT01213836Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable SchizophreniaCOMPLETEDPHASE42010-112011-082011-08
NCT01217905Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687COMPLETEDPHASE12010-112011-072011-07
NCT01210339An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of ClopidogrelCOMPLETEDPHASE12010-112011-082011-08
NCT01245790A Study of Fostamatinib in Subjects With Impaired Kidney FunctionCOMPLETEDPHASE12010-112011-062011-06
NCT01233830Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese VolunteersCOMPLETEDPHASE12010-112011-032011-03
NCT01225939A Study Conducted Over 3 Periods to Look at the Drug in the BodyCOMPLETEDPHASE12010-112010-122010-12
NCT01222442To Evaluate the Effect of AZD3199 on the Electrical Activity in the HeartCOMPLETEDPHASE12010-112011-022011-02
NCT01195662A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationCOMPLETEDPHASE32010-102013-022013-02
NCT01225562Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinCOMPLETEDPHASE32010-102014-122014-12
NCT01153321Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22010-102011-072011-07
NCT01215279AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)COMPLETEDPHASE22010-102011-032011-03
NCT01145560A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic ShockCOMPLETEDPHASE22010-102012-052012-05
NCT01213173Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina PatientsCOMPLETEDPHASE42010-102011-092011-09
NCT01200524A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..COMPLETEDPHASE22010-102012-042012-04
NCT01205269The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22010-102010-122010-12
NCT01197794Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic PatientsCOMPLETEDPHASE22010-102012-022012-02
NCT01222455A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) FunctionCOMPLETEDPHASE12010-102011-062011-06
NCT01196689Pharmacokinetics in AdolescentsCOMPLETEDPHASE12010-102011-022011-02
NCT01199341A Drug-Drug Interaction Study to Study the Effect of AZD1981 on WarfarinCOMPLETEDPHASE12010-102010-122010-12
NCT01221545A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM PatientsCOMPLETEDPHASE12010-102011-012011-01
NCT01224587Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed ConditionsCOMPLETEDPHASE12010-102010-112010-11
NCT01203917Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLCCOMPLETEDPHASE42010-092016-062012-08
NCT01211145Zomig - Treatment of Acute Migraine Headache in AdolescentsCOMPLETEDPHASE42010-092013-102013-10
NCT01185080Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848COMPLETEDPHASE22010-092012-012010-12
NCT01205867Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient SubjectsCOMPLETEDPHASE12010-092012-012011-02
NCT01208961Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, EvaluationCOMPLETEDPHASE22010-092010-112010-11
NCT01217645Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous AdministrationCOMPLETEDPHASE12010-092010-102010-10
NCT01201317A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic PolyneuropathyCOMPLETEDPHASE22010-092011-062011-06
NCT01197508A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.COMPLETEDPHASE32010-092012-012012-01
NCT01197534Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.COMPLETEDPHASE32010-092013-032013-03
NCT01180400A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCOMPLETEDPHASE32010-092011-092011-09
NCT01197755Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha AntagonistCOMPLETEDPHASE32010-092013-022013-02
NCT01197521Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.COMPLETEDPHASE32010-092012-112012-11
NCT01136655A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating EfficacyCOMPLETEDPHASE22010-092011-122011-12
NCT01221519A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) PatientsCOMPLETEDPHASE12010-092011-012011-01
NCT01185314To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)COMPLETEDNA2010-092011-072011-07
NCT01207089To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329COMPLETEDPHASE12010-092010-122010-12
NCT01199315A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated DosesCOMPLETEDPHASE12010-092010-122010-12
NCT01208155Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib TabletsCOMPLETEDPHASE12010-092010-112010-11
NCT01199328Study to Evaluate the Interaction Between Aspirin and NexiumCOMPLETEDPHASE12010-092010-112010-11
NCT01197781Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy VolunteersCOMPLETEDPHASE12010-092010-102010-10
NCT01165268Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12010-082010-122010-12
NCT01162395Open Label Prostate Cancer StudyCOMPLETEDPHASE12010-082015-102013-03
NCT01189604Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper & Lower Endoscopic TestsCOMPLETEDPHASE22010-082010-112010-11
NCT01166698Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy SubjectsCOMPLETEDPHASE12010-082011-012011-01
NCT01196676Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451COMPLETEDPHASE12010-082011-042011-04
NCT01137474A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerCOMPLETEDPHASE32010-072013-022013-02
NCT01171105Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female SubjectsCOMPLETEDPHASE12010-072011-052011-05
NCT01144624A Study to Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic ShockCOMPLETEDPHASE22010-072011-082011-08
NCT01136382A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With PlaceboCOMPLETEDPHASE22010-072013-042013-04
NCT01175564To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese SubjectsCOMPLETEDPHASE12010-072010-092010-09
NCT01167868A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White SubjectsCOMPLETEDPHASE12010-072011-052011-05
NCT01176097To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 DiabetesCOMPLETEDPHASE12010-072011-022011-02
NCT01416870Bioequivalence of Bicalutamide New Formulation in JapanTERMINATEDPHASE12010-072010-112010-11
NCT01416883Oral Mucosal Absorption Study of Bicalutamide New FormulationTERMINATEDPHASE12010-072010-082010-08
NCT01159145Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male SubjectsCOMPLETEDPHASE12010-072010-092010-09
NCT01144338Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32010-06-182017-04-242017-04-21
NCT01095666A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCOMPLETEDPHASE32010-062013-032013-03
NCT01095653A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseCOMPLETEDPHASE32010-062012-032012-03
NCT01151215Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast CancerTERMINATEDPHASE22010-062013-012013-01
NCT01152554A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCOMPLETEDPHASE32010-062012-022012-02
NCT01157078A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)COMPLETEDPHASE32010-062011-112011-11
NCT01153347A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCOMPLETEDPHASE32010-062012-012012-01
NCT01128153Saxagliptin Triple Oral TherapyCOMPLETEDPHASE32010-062011-062011-06
NCT01156246Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy VolunteersCOMPLETEDPHASE12010-062010-082010-08
NCT01128114Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current TherapyTERMINATEDPHASE42010-062011-032011-03
NCT01125683To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's DiseaseTERMINATEDPHASE22010-062011-032011-03
NCT01148095To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy VolunteersCOMPLETEDPHASE12010-062010-072010-07
NCT01161355Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy SubjectCOMPLETEDPHASE12010-062010-062010-06
NCT01103622Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE12010-062010-122010-12
NCT01147549Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male VolunteersCOMPLETEDPHASE12010-062010-072010-07
NCT01163630Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mgCOMPLETEDPHASE12010-062010-092010-09
NCT01145768To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 DaysCOMPLETEDPHASE12010-062010-082010-08
NCT01150812Oral AZD8165 After Single Oral Ascending Doses in Healthy Male SubjectsTERMINATEDPHASE12010-062010-082010-08
NCT01154621Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female SubjectsCOMPLETEDPHASE12010-062010-072010-07
NCT01120093Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.COMPLETEDPHASE22010-052010-082010-08
NCT01135446Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy SubjectsCOMPLETEDPHASE12010-052010-062010-06
NCT01104701A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly SuspensionCOMPLETEDPHASE22010-052010-122010-12
NCT01100047Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069COMPLETEDPHASE12010-052011-022011-02
NCT01121302Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female SubjectsCOMPLETEDPHASE12010-052010-122010-12
NCT01130909A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765TERMINATEDPHASE12010-052011-012011-01
NCT01107886Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsCOMPLETEDPHASE42010-052013-052013-05
NCT011457556-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive DisorderTERMINATEDPHASE22010-052010-112010-11
NCT01154634Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male SubjectsCOMPLETEDPHASE22010-052010-092010-09
NCT01152385Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE22010-052011-052011-05
NCT01147588Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of ClopidogrelCOMPLETEDPHASE12010-052011-052011-05
NCT01110525A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral ContraceptivesCOMPLETEDPHASE12010-052010-102010-10
NCT01085123Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male VolunteersCOMPLETEDPHASE12010-052010-102010-10
NCT01124760Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy VolunteersCOMPLETEDPHASE12010-052010-072010-07
NCT01094093Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe PsoriasisCOMPLETEDPHASE12010-04-112011-07-262011-07-26
NCT01118325An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery DiseaseCOMPLETEDPHASE22010-042011-032011-03
NCT01112397Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid TumoursTERMINATEDPHASE12010-042012-092012-09
NCT01116271Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecCOMPLETEDPHASE22010-042012-072012-07
NCT01119768Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis PatientsCOMPLETEDPHASE42010-042011-062011-06
NCT01119352AZD7687 Multiple Ascending Dose StudyCOMPLETEDPHASE12010-042011-032011-03
NCT01103609Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) PatientsCOMPLETEDPHASE12010-042010-082010-08
NCT01116011Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male VolunteersCOMPLETEDPHASE12010-042010-072010-07
NCT01116258A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 DaysCOMPLETEDPHASE12010-042010-102010-10
NCT01114152AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese SubjectsCOMPLETEDPHASE12010-042010-072010-07
NCT01068756Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy SubjectsTERMINATEDPHASE12010-032010-042010-04
NCT01068717Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy ParticipantsCOMPLETEDPHASE12010-032010-032010-03
NCT01042977Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseCOMPLETEDPHASE32010-032012-122011-05
NCT01102400A Study of MEDI-575 in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12010-032012-112012-11
NCT01086813Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043WITHDRAWNPHASE12010-032010-042010-04
NCT01096017To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind StudyCOMPLETEDPHASE32010-032010-042010-04
NCT01096563A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese SubjectsTERMINATEDPHASE12010-032010-062010-06
NCT01069926To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE12010-032010-102010-10
NCT01096004Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose TissueCOMPLETEDPHASE12010-032010-052010-05
NCT01094483A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose AspirinCOMPLETEDPHASE12010-032010-052010-05
NCT01096940Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With SimvastatinCOMPLETEDPHASE12010-032010-082010-08
NCT01095991Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12010-032010-052010-05
NCT01083212To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656COMPLETEDPHASE12010-032010-062010-06
NCT01073865Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast CancerCOMPLETEDPHASE32010-02-262017-11-202012-09-19
NCT01078662Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation PatsCOMPLETEDPHASE22010-02-212024-08-122012-07-31
NCT01081951Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian CancerACTIVE_NOT_RECRUITINGPHASE22010-02-042025-12-312011-10-10
NCT01063517Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer PatientsCOMPLETEDPHASE22010-02-022023-06-292012-05-11
NCT01078623Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol FumarateCOMPLETEDPHASE22010-022010-092010-09
NCT01083238This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral DoseCOMPLETEDPHASE12010-022010-072010-07
NCT01068743Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-AdministeredCOMPLETEDPHASE12010-022010-032010-03
NCT01078675An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial HypercholesterolaemiaCOMPLETEDPHASE32010-022013-022013-02
NCT01068730Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy SubjectsCOMPLETEDPHASE12010-022010-042010-04
NCT01069822A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood LevelsCOMPLETEDPHASE12010-022010-052010-05
NCT01031680Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionCOMPLETEDPHASE32010-022012-122011-05
NCT01072591Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the KneeTERMINATEDPHASE12010-022010-092010-09
NCT00991419To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid BurdenCOMPLETEDPHASE22010-022011-082011-08
NCT01069939Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose AspirinCOMPLETEDPHASE32010-022011-112011-11
NCT01064388A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 DaysCOMPLETEDPHASE12010-022010-082010-08
NCT01072578A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood GlucoseCOMPLETEDPHASE12010-022010-042010-04
NCT00985933The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy VolunteersCOMPLETEDEARLY_PHASE12010-022011-042011-04
NCT01058447Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male VolunteersCOMPLETEDPHASE12010-022010-032010-03
NCT01068184A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)TERMINATEDPHASE12010-022010-052010-05
NCT01092299A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting ConditionsCOMPLETEDPHASE12010-022010-072010-07
NCT01082120Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes MellitusCOMPLETEDPHASE12010-022010-052010-05
NCT01051505A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy VolunteersCOMPLETEDPHASE12010-012010-042010-04
NCT01029886Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-012011-042011-01
NCT01037504AZD5423 Multiple Ascending Dose StudyCOMPLETEDPHASE12010-012010-042010-04
NCT01070784A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in JapanCOMPLETEDPHASE32010-012011-102011-10
NCT01048333Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®COMPLETEDPHASE22010-012010-052010-05
NCT01069289Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE32010-012011-032011-03
NCT01054170Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22010-012010-112010-11
NCT01055691A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate TabletsCOMPLETEDPHASE12010-012010-042010-04
NCT01055652Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE12010-012010-042010-04
NCT01000896Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelWITHDRAWNPHASE12010-012011-032010-09
NCT01049360Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and PlaceboCOMPLETEDPHASE22009-122010-082010-08
NCT01026402Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014COMPLETEDPHASE12009-122014-082014-08
NCT00986479This is a Study to Determine the Antidepressant Effects of AZD6765COMPLETEDPHASE22009-122011-122011-12
NCT01046630Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female SubjectsCOMPLETEDPHASE12009-122011-032011-03
NCT01047553Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE32009-122011-072011-01
NCT01043185A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May ExperienceCOMPLETEDPHASE22009-122010-052010-05
NCT01024660The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With DonepezilCOMPLETEDEARLY_PHASE12009-122011-012011-01
NCT01028040AZD Single Ascending Dose Study In Healthy Japanese SubjectsCOMPLETEDPHASE12009-122010-082010-08
NCT01016951A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary DiseaseTERMINATEDPHASE12009-122010-062010-06
NCT010397014 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22009-122010-072010-07
NCT01037725Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy VolunteersCOMPLETEDPHASE12009-122010-04
NCT01021189Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese SubjectCOMPLETEDPHASE12009-122010-062010-06
NCT01044342A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of CognitionCOMPLETEDPHASE12009-122010-042010-04
NCT00812045Study to Assess Efficacy of AZD1236 in Patients With Cystic FibrosisWITHDRAWNPHASE22009-122010-08
NCT01031836A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.COMPLETEDPHASE22009-11-252016-07-112012-11-07
NCT01044459Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)COMPLETEDPHASE32009-112011-042011-04
NCT01002807Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted StateCOMPLETEDPHASE12009-112010-012009-12
NCT01192139Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)COMPLETEDPHASE12009-112009-122009-12
NCT01192152Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 Ă— 500 mg Glucophage XRCOMPLETEDPHASE12009-112009-122009-12
NCT01019928Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE22009-112011-012011-01
NCT01023516Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/FormoterolCOMPLETEDPHASE22009-112010-082010-08
NCT01020799AZD7268 Safety and Tolerability StudyCOMPLETEDPHASE22009-112010-042010-04
NCT01046357A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687COMPLETEDPHASE12009-112010-062010-06
NCT01015729Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken SeparatelyTERMINATEDPHASE12009-112010-03
NCT00986531The Effects AZD8529 on Cognition and Negative Symptoms in SchizophrenicsCOMPLETEDPHASE12009-112011-102011-10
NCT01019161An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)COMPLETEDPHASE12009-112010-062010-06
NCT01012375Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.COMPLETEDPHASE22009-112010-082010-08
NCT01027234This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral DosesTERMINATEDPHASE12009-112010-032010-03
NCT01030224This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy SubjectsCOMPLETEDPHASE12009-112010-032010-03
NCT01035411AZD9668 Relative BioavailabilityCOMPLETEDPHASE12009-112009-122009-12
NCT01034982AZD9668 Relative BioavailabilityCOMPLETEDPHASE12009-112009-122009-12
NCT00979134Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced TumoursTERMINATEDPHASE12009-10-212015-03-052014-02-12
NCT00976495Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesCOMPLETEDPHASE22009-102010-112010-11
NCT01001494Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE32009-102010-112010-11
NCT00999466The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled AllergenCOMPLETEDPHASE22009-102011-122011-02
NCT01003184Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesCOMPLETEDPHASE32009-102011-122011-07
NCT01003158Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.COMPLETEDPHASE12009-102012-042012-04
NCT00984867Dapagliflozin DPPIV Inhibitor add-on StudyCOMPLETEDPHASE32009-102011-092011-03
NCT01006603Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminCOMPLETEDPHASE42009-102012-062012-06
NCT01020123Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) PatientsCOMPLETEDPHASE22009-102011-022011-02
NCT00999882Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer PatientsCOMPLETEDPHASE12009-102011-122011-12
NCT01006590Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 DiabetesCOMPLETEDPHASE42009-102010-12
NCT0099794510mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12009-102011-042010-09
NCT01005251Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPICOMPLETEDPHASE22009-102010-072010-07
NCT00970918Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering DrugsCOMPLETEDNA2009-102010-082010-08
NCT00977626Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy VolunteersCOMPLETEDPHASE12009-102010-052010-05
NCT00979849AZD8683 Single Ascending Dose StudyCOMPLETEDPHASE12009-102010-012010-01
NCT00995787Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and SulfonylureaCOMPLETEDPHASE12009-102010-022010-02
NCT00997308A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy VolunteersCOMPLETEDPHASE12009-102009-122009-12
NCT01007929Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male SubjectsTERMINATEDPHASE12009-102009-11
NCT00960661A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 DiabetesCOMPLETEDPHASE32009-092012-082012-08
NCT00954122Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute SchizophreniaCOMPLETEDPHASE42009-092010-042010-03
NCT00989833Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma PatientsCOMPLETEDPHASE22009-092010-072010-07
NCT00981721A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12009-092011-042010-05
NCT00998075Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken SeparatelyCOMPLETEDPHASE12009-092009-122009-12
NCT00972049Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy SubjectsCOMPLETEDPHASE12009-092009-122009-12
NCT00992381Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn AloneCOMPLETEDPHASE12009-092009-10
NCT00984477Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male SubjectsCOMPLETEDPHASE12009-092009-11
NCT00984880Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043COMPLETEDPHASE12009-092009-12
NCT00975754Lung Deposition Via Different Inhalation DevicesCOMPLETEDPHASE12009-092009-11
NCT00976534Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic PainTERMINATEDPHASE22009-092010-02
NCT00970268Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)COMPLETEDPHASE32009-082010-102010-10
NCT00918138Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mgCOMPLETEDPHASE32009-082010-052010-05
NCT00963183AZD5423 Single Ascending Dose StudyCOMPLETEDPHASE12009-082009-112009-11
NCT00972244Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE22009-082010-052010-05
NCT00939094AZD2066 Neuropathic Pain - Mechanical HypersensitivityTERMINATEDPHASE22009-082010-112010-11
NCT00960076An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesCOMPLETEDPHASE32009-082010-102010-10
NCT00960349Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer PatientsCOMPLETEDPHASE12009-082011-032010-01
NCT00973076Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055COMPLETEDPHASE12009-082010-122010-12
NCT00940641Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral AdministrationSUSPENDEDPHASE12009-082009-102009-10
NCT01000740A Study on the Long Term Survivals in an Expand Access Program (EAP) of IressaCOMPLETEDPHASE42009-082010-042010-04
NCT00970775AZD2423 Single Ascending Dose Study in Healthy Japanese SubjectsCOMPLETEDPHASE12009-082009-122009-12
NCT00945178Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy VolunteersTERMINATEDPHASE12009-082009-092009-09
NCT00957437Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305COMPLETEDPHASE12009-082009-11
NCT00967356AZD5985 Single Ascending Dose StudyTERMINATEDPHASE12009-082009-11
NCT00952588Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) PatientsCOMPLETEDPHASE2, PHASE32009-072011-062011-06
NCT00908271Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy SubjectsCOMPLETEDPHASE12009-072009-082009-08
NCT00930865Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy SubjectsCOMPLETEDPHASE12009-072009-092009-09
NCT00936221Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma PatientsCOMPLETEDPHASE22009-072014-112011-11
NCT00953888Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female SubjectsCOMPLETEDPHASE12009-072009-122009-12
NCT00935532Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes MellitusCOMPLETEDPHASE32009-072011-072010-09
NCT00935467Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy SubjectsCOMPLETEDPHASE12009-072009-082009-08
NCT00917267A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian SubjectsCOMPLETEDPHASE32009-072011-042010-09
NCT00949975A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With TiotropiumCOMPLETEDPHASE22009-072010-082010-08
NCT00939341Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across AsiaCOMPLETEDPHASE42009-072010-082010-08
NCT00945425AZD7325 Japan Multiple Ascending Dose (MAD) StudyTERMINATEDPHASE12009-072009-11
NCT00937664Safety and Tolerability Study of AZD7762 in Combination With GemcitabineTERMINATEDPHASE12009-072011-022011-02
NCT00935025AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian SubjectsTERMINATEDPHASE12009-072009-112009-11
NCT00940212Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy VolunteersCOMPLETEDPHASE12009-072009-112009-11
NCT00935662A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral DosesCOMPLETEDPHASE12009-072010-082010-08
NCT00960791Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12009-072009-09
NCT00726505Renal Mechanism of Action/Splay vs. TmGTERMINATEDPHASE12009-062009-082009-08
NCT00904176Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy SubjectsCOMPLETEDPHASE12009-062009-082009-08
NCT00900627Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)COMPLETEDPHASE1, PHASE22009-062015-022012-04
NCT00897390Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)COMPLETEDPHASE12009-062009-072009-07
NCT00899470Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)COMPLETEDPHASE12009-062009-082009-08
NCT00929708Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22009-062010-032010-03
NCT00929162ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian CancerTERMINATEDPHASE22009-062011-062011-06
NCT00931723Adult Bipolar ManiaCOMPLETEDPHASE42009-062010-112010-11
NCT00939211The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE22009-062009-112009-11
NCT00926731Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)COMPLETEDPHASE12009-062011-052010-08
NCT00926393Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar DepressionCOMPLETEDPHASE42009-062009-082009-08
NCT00921804Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia PatientsCOMPLETEDPHASE22009-062010-052010-05
NCT00914303Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241COMPLETEDPHASE12009-062010-032010-03
NCT00919607Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic PatientsCOMPLETEDPHASE12009-062010-032010-03
NCT00928629Audit and Screening Study to Determine the Prevalence of Peripheral Arterial DiseaseCOMPLETEDNA2009-062009-10
NCT00930306AZD2066 Cocktail StudyCOMPLETEDPHASE12009-062009-09
NCT00930215Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy MalesCOMPLETEDPHASE12009-062009-08
NCT00931541AZD6088 Single Ascending Dose StudyCOMPLETEDPHASE12009-062009-08
NCT00918398AZD1981 Bioavailability Study of Intravenous (IV) and Oral FormulationsCOMPLETEDPHASE12009-062009-07
NCT00910728Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative DiseasesCOMPLETEDPHASE12009-052014-082012-03
NCT00912743Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) StatusCOMPLETEDPHASE22009-052012-032012-03
NCT00885378Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes MellitusCOMPLETEDPHASE32009-052010-022010-02
NCT00857584Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on TherapyCOMPLETEDPHASE32009-052011-022011-02
NCT00915356Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305COMPLETEDPHASE22009-052009-122009-12
NCT00918879Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic ControlCOMPLETEDPHASE32009-052010-072010-07
NCT00920608A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis PatientsWITHDRAWNPHASE12009-052009-09
NCT00907400Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn ECOMPLETEDPHASE12009-052009-092009-09
NCT00912353AZD7268 Single Ascending Dose Study in Healthy Japanese SubjectsCOMPLETEDPHASE12009-052009-102009-10
NCT00916604To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) PatientsCOMPLETEDPHASE12009-052009-10
NCT00901290Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female SubjectsSUSPENDEDPHASE12009-052009-092009-09
NCT00902772Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant UsersCOMPLETEDPHASE12009-052009-09
NCT00918515Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043COMPLETEDPHASE12009-052009-08
NCT00908934AZD9056 Relative Bioavailability StudyCOMPLETEDPHASE12009-052009-07
NCT00904800AZD0837 Extended Release (ER) Japan StudyCOMPLETEDPHASE12009-052009-06
NCT00890825AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC PatientsCOMPLETEDPHASE22009-04-202016-11-022011-05-11
NCT00831779Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 DiabetesCOMPLETEDPHASE22009-042010-082010-08
NCT00891462Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)COMPLETEDPHASE32009-042009-112009-11
NCT00859898Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesCOMPLETEDPHASE32009-042010-052010-05
NCT00894322A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly SuspensionCOMPLETEDPHASE1, PHASE22009-042009-082009-08
NCT00883493Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar DepressionCOMPLETEDPHASE32009-042011-032011-03
NCT00882518Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic PatientsCOMPLETEDPHASE32009-042010-072010-07
NCT00886366Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic PatientsTERMINATEDPHASE12009-042009-092009-09
NCT00861718Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy VolunteersCOMPLETEDPHASE12009-042009-10
NCT00892944An Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516COMPLETEDPHASE12009-042009-10
NCT00886067Positron Emission Tomography (PET) StudyCOMPLETEDPHASE12009-042009-082009-08
NCT00902993Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446COMPLETEDPHASE12009-042009-09
NCT00886756AZD8529 Single Ascending Dose Study in Healthy Japanese SubjectsCOMPLETEDPHASE12009-042009-07
NCT00887770A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the HeartCOMPLETEDPHASE12009-042009-07
NCT00878618Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837COMPLETEDPHASE12009-042009-05
NCT01045161Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)COMPLETEDPHASE32009-032011-062011-06
NCT00842556Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy SubjectsCOMPLETEDPHASE12009-032009-052009-05
NCT00868231Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22009-032009-072009-07
NCT00877890A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)COMPLETEDPHASE32009-032010-012009-10
NCT00870194A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus MetforminCOMPLETEDPHASE42009-032010-042010-04
NCT00878501Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the KneeTERMINATEDPHASE22009-032009-072009-07
NCT00863161Renal Impairment StudyCOMPLETEDPHASE12009-032010-022010-02
NCT00844324Bioequivalence Study in Healthy SubjectsCOMPLETEDPHASE12009-032009-062009-06
NCT00879736A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient CommunicationCOMPLETEDNA2009-032010-082010-08
NCT00860821A Methodology Study in Healthy Subjects to Evaluate the Effect of AZD8309 After Nasal Administration of Lipopolysaccharide (LPS)COMPLETEDNA2009-032009-10
NCT00879346A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 TabletsCOMPLETEDPHASE12009-032009-07
NCT00866385AZD8566 Food Effect/Microtracer StudyCOMPLETEDPHASE12009-032009-042009-03
NCT00871767AZD5672 Bioavailability Study in Healthy Male and Female SubjectsCOMPLETEDPHASE12009-032009-05
NCT00853983Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male VolunteersCOMPLETEDPHASE12009-032009-04
NCT00859352AZD1981 Midazolam CYP4503A Induction StudyCOMPLETEDPHASE12009-032009-04
NCT00867685Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet FormulationCOMPLETEDPHASE12009-032009-04
NCT00839683Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy SubjectsCOMPLETEDPHASE12009-022009-032009-03
NCT00855166Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 DiabetesCOMPLETEDPHASE32009-022011-122010-06
NCT00839800Study to Investigate the Efficacy of Symbicort® SMART.COMPLETEDPHASE32009-022011-022011-02
NCT00856908Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 DiabetesCOMPLETEDPHASE22009-022009-082009-08
NCT00857623Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic NeuropathyCOMPLETEDPHASE22009-022009-082009-08
NCT00852631Seroquel XR in Adults With SchizophreniaTERMINATEDPHASE32009-022010-052010-05
NCT00855959Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic PatientsCOMPLETEDPHASE32009-022009-082009-08
NCT00860353Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551TERMINATEDPHASE12009-022009-05
NCT00858325Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in ChinaCOMPLETEDPHASE12009-022009-03
NCT00847249AZD9164 Single Ascending Dose Study in Healthy Male SubjectsCOMPLETEDPHASE12009-022009-04
NCT00841048Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral DosesCOMPLETEDPHASE12009-022009-05
NCT00853450Bleeding Time Study With AZD6482, Clopidogrel and ASACOMPLETEDPHASE12009-022009-07
NCT00817271To Evaluate the Response to Glucagon During HypoglycemiaCOMPLETEDPHASE12009-022009-042009-04
NCT00819221AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid TumoursTERMINATEDPHASE12009-01-052021-12-222011-11-30
NCT00811473Pediatric Bipolar DepressionCOMPLETEDPHASE32009-012010-112010-11
NCT00759395Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)COMPLETEDPHASE22009-012011-102011-10
NCT00817778Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCOMPLETEDPHASE22009-012009-072009-07
NCT00837967Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese PatientsCOMPLETEDPHASE32009-012009-072009-07
NCT00829127AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male VolunteersWITHDRAWNPHASE12009-012009-012009-01
NCT00838877Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ AmyloidCOMPLETEDPHASE12009-012009-10
NCT00832221Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUELCOMPLETEDPHASE12009-012009-09
NCT00824057Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)COMPLETEDPHASE12009-012009-03
NCT00819884To Evaluate 24-hr Glucose After OD vs BD AZD1656COMPLETEDPHASE12009-012009-052009-05
NCT00832169Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386COMPLETEDPHASE12009-012009-02
NCT00844103Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.COMPLETEDPHASE12009-012009-042009-04
NCT00812643Excretion of Radiolabelled AZD0837COMPLETEDPHASE12009-012009-02
NCT00829088Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066COMPLETEDPHASE12009-012009-02
NCT00785408Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight SubjectsCOMPLETEDPHASE22008-122009-092009-09
NCT00713765Pharmacokinetic Interaction Between AZD3480 and DonepezilTERMINATEDPHASE12008-122008-122008-12
NCT00808678Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin CalciumCOMPLETEDPHASE12008-122009-01
NCT00815659Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic SyndromeCOMPLETEDPHASE42008-122010-032010-03
NCT00944918Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)COMPLETEDPHASE32008-122011-062011-06
NCT00808249AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)COMPLETEDPHASE22008-122009-052009-05
NCT0081330614473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter RelaxationsCOMPLETEDPHASE1, PHASE22008-122009-11
NCT00812344Effect of Ketoconazole on Biliary Excretion of AZD0837COMPLETEDPHASE12008-122009-032009-03
NCT00807937Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325COMPLETEDPHASE22008-122009-052009-05
NCT00817505To Evaluate the Bioavailability of a Tablet of AZD1656COMPLETEDPHASE12008-122009-092009-03
NCT00796965Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy SubjectsCOMPLETEDPHASE12008-122009-03
NCT00818129Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in JapaneseCOMPLETEDPHASE12008-122009-05
NCT00799747Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.COMPLETEDPHASE12008-122009-04
NCT00803855Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy VolunteersCOMPLETEDPHASE12008-122009-042009-04
NCT00782574Phase I AZD2281/Cisplatin in Advanced Solid Tumour PatientsCOMPLETEDPHASE12008-11-122023-12-072012-02-01
NCT00746382A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)WITHDRAWNPHASE22008-112009-092009-06
NCT00746434A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque PsoriasisWITHDRAWNPHASE22008-112009-092009-06
NCT00757588Safety and Efficacy of Saxagliptin Plus Insulin With or Without MetforminCOMPLETEDPHASE32008-112010-042010-04
NCT00676338Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)COMPLETEDPHASE32008-112011-012010-07
NCT00819234Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With MetreleptinCOMPLETEDPHASE22008-112009-112009-10
NCT00785915AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian SubjectsCOMPLETEDPHASE12008-112009-032009-03
NCT00963365AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)WITHDRAWNPHASE12008-112010-032009-02
NCT0076641514729-D9831C00002- 1 Month Biopsy StudyCOMPLETEDPHASE22008-112009-06
NCT00826358Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mgCOMPLETEDPHASE12008-112008-11
NCT00812955Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and TriglyceridesCOMPLETEDPHASE32008-112009-062009-06
NCT00789854Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsCOMPLETEDPHASE32008-112009-082009-08
NCT00779506Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)COMPLETEDPHASE42008-112009-072009-07
NCT00819104A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual ComponentsCOMPLETEDPHASE42008-112009-08
NCT00799331Exploratory Study to Assess the Pharmacokinetics of AZD5985COMPLETEDPHASE12008-112009-022009-02
NCT00771979Relative Bioavailability of Phase II and Phase III Formulations of AZD0530COMPLETEDPHASE12008-112009-03
NCT00791752Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017COMPLETEDPHASE12008-112009-03
NCT00790153To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 SuspensionCOMPLETEDPHASE12008-112009-02
NCT00777582Phase I Comparative Bioavailability StudyACTIVE_NOT_RECRUITINGPHASE12008-10-272025-03-312009-02-06
NCT00777153Cediranib in Combination With Lomustine Chemotherapy in Recurrent GlioblastomaCOMPLETEDPHASE32008-102016-092010-04
NCT00765817Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusCOMPLETEDPHASE32008-102010-012010-01
NCT00753896Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With MetforminCOMPLETEDPHASE32008-102009-112009-07
NCT00757848A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic FibrosisCOMPLETEDPHASE22008-102009-082009-08
NCT00781742AZD6765 Severe Major Depressive Disorder (MDD) IVCOMPLETEDPHASE22008-102010-032010-03
NCT00905333Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific MealCOMPLETEDPHASE12008-102008-112008-11
NCT00787072AZD8075 Single Ascending Dose StudyTERMINATEDPHASE12008-102009-012009-01
NCT00777361Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy VolunteersTERMINATEDPHASE12008-102009-102009-10
NCT00774553To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of MetforminCOMPLETEDPHASE12008-102010-01
NCT00770302Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of SaxagliptinCOMPLETEDPHASE12008-102008-102008-10
NCT00783042Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function MeasurementsCOMPLETEDEARLY_PHASE12008-102009-05
NCT00765492AZD8529 Multiple Ascending Dose Study in Healthy SubjectsCOMPLETEDPHASE12008-102009-03
NCT00772759Assess Safety, Tolerability and PK of AZD3199 in JapaneseCOMPLETEDPHASE12008-102009-02
NCT00769899AZD7325 Single Ascending Dose Study in Healthy Male Japanese SubjectsCOMPLETEDPHASE12008-102009-032009-03
NCT00736879Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesCOMPLETEDPHASE32008-09-222009-12-292009-12-29
NCT00707707Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast CancerCOMPLETEDPHASE12008-09-152018-02-192009-11-09
NCT00750841Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid TumoursACTIVE_NOT_RECRUITINGPHASE12008-09-092025-12-312009-07-30
NCT00826969Ciclesonide for the Treatment of Airway HyperresponsivenessCOMPLETEDPHASE42008-092011-102010-07
NCT00770003Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848COMPLETEDPHASE12008-092010-022009-03
NCT00758706A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22008-092009-052009-05
NCT00772447China Registration Study in Patients With Skin InfectionsCOMPLETEDPHASE32008-092010-092010-09
NCT00758589One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled SteroidsCOMPLETEDPHASE22008-092009-07
NCT00769119A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With BronchiectasisCOMPLETEDPHASE22008-092009-042009-04
NCT00770588Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE42008-092011-022011-01
NCT00758459Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22008-092009-03
NCT00757419AZD3355 Dose-escalation Study in Healthy MalesCOMPLETEDPHASE12008-092008-122008-12
NCT00761501Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn ECOMPLETEDPHASE12008-092008-122008-12
NCT00768105To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of InsulinCOMPLETEDPHASE12008-092009-032009-03
NCT00660595Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible DoseTERMINATEDPHASE32008-092008-122008-12
NCT00766012Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese SubjectsCOMPLETEDPHASE12008-092009-07
NCT00767052Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236COMPLETEDPHASE12008-092008-12
NCT00750802A Sedation/Cognition/EEG Study Using AZD6280 and ComparatorCOMPLETEDPHASE12008-092008-12
NCT00755378AZD8529 Single Ascending Dose StudyCOMPLETEDPHASE12008-092009-03
NCT00766025Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving RosuvastatinCOMPLETEDPHASE12008-092009-02
NCT00754715Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy VolunteersCOMPLETEDPHASE12008-092008-122008-11
NCT00752830To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328COMPLETEDPHASE12008-092008-102008-10
NCT00753545Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian CancerCOMPLETEDPHASE22008-08-282023-10-122010-06-30
NCT00701935Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With MetforminTERMINATEDPHASE22008-082012-012012-01
NCT00729326Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a ThiazolidinedioneCOMPLETEDPHASE42008-082009-102009-10
NCT00805467Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 StudiesTERMINATEDPHASE22008-082013-082013-08
NCT00736489Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199COMPLETEDPHASE22008-082008-122008-12
NCT00713271Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy MenCOMPLETEDPHASE12008-082008-112008-11
NCT00728780Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.COMPLETEDPHASE12008-082008-09
NCT00745875ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer StudyCOMPLETEDPHASE22008-082010-012010-01
NCT00748891DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)COMPLETEDPHASE12008-082010-112010-02
NCT00748982Investigate the Effect of AZD1305 on Patients With Left Ventricular DysfunctionCOMPLETEDPHASE22008-082009-072009-07
NCT00750425Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursCOMPLETEDPHASE12008-082011-012009-04
NCT00736788Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female VolunteersTERMINATEDPHASE12008-082008-092008-09
NCT00733031Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TERMINATEDPHASE12008-082009-032009-03
NCT00712465An Interaction Study With Digoxin and AZD1305COMPLETEDPHASE12008-082008-112008-11
NCT00741689A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy VolunteersCOMPLETEDPHASE12008-082008-122008-12
NCT00747175A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 DiabetesCOMPLETEDPHASE12008-082009-042009-04
NCT00698282Single and Multiple Ascending Doses of AZD1981 in JapanCOMPLETEDPHASE12008-082008-102008-10
NCT00736606A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy VolunteersCOMPLETEDPHASE12008-082008-092008-09
NCT00788645The Use of a Forecasting System for Predicting Exacerbations of COPDCOMPLETEDEARLY_PHASE12008-082009-032009-03
NCT00746837AZD5672 Absolute Bioavailability StudyCOMPLETEDPHASE12008-082009-012009-01
NCT00749333Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.COMPLETEDPHASE12008-082009-022009-02
NCT00628251Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian CancerCOMPLETEDPHASE22008-07-302018-09-192009-09-15
NCT00679783Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast CancerCOMPLETEDPHASE22008-07-082022-07-202010-03-26
NCT00683878Add-on to Thiazolidinedione (TZD) FailuresCOMPLETEDPHASE32008-072010-062010-01
NCT00683657Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR AloneCOMPLETEDPHASE32008-072009-022009-02
NCT00710515Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12008-072010-062009-04
NCT00719693Assessment of the Effect of Food on ABT-143 BioavailabilityCOMPLETEDPHASE12008-072008-09
NCT00731263A Study of Tor Kinase Inhibitor in Advanced TumorsCOMPLETEDPHASE12008-072010-112010-11
NCT00681629Schizophrenic Patients in Integrated CareTERMINATEDPHASE42008-072008-112008-11
NCT00713544A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid ArthritisCOMPLETEDPHASE22008-072009-042009-04
NCT00707551An Interaction Study of Ketoconazole/Verapamil Versus AZD1305COMPLETEDPHASE12008-072008-112008-11
NCT00726427A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy VolunteersCOMPLETEDPHASE12008-072008-092008-09
NCT00722956Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and AtorvastatinCOMPLETEDPHASE12008-072008-082008-08
NCT00723424Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of DigoxinCOMPLETEDPHASE12008-072008-122008-12
NCT00709553Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)COMPLETEDPHASE12008-072008-082008-08
NCT00702676Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation ComparisonCOMPLETEDPHASE12008-072008-082008-08
NCT00738322To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese SubjectsCOMPLETEDPHASE12008-072008-10
NCT00715702Safety Study of AZD5672 in Renally Impaired SubjectsCOMPLETEDPHASE12008-072009-022009-02
NCT00729443Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy VolunteersCOMPLETEDPHASE12008-072008-112008-11
NCT00790114Determine the Effect of Multiple Doses of AZD7325, CYP StudyCOMPLETEDPHASE12008-072008-092008-09
NCT00706914Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)TERMINATEDPHASE22008-06-302008-11-112008-11-11
NCT00643851An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsCOMPLETEDPHASE32008-062009-082009-08
NCT00663260Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentCOMPLETEDPHASE2, PHASE32008-062011-062009-12
NCT00710268Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid TumoursCOMPLETEDPHASE12008-062009-112009-03
NCT00702325Phase4/Symbicort® Versus Pulmicort Flexhaler® in African AmericansCOMPLETEDPHASE42008-062009-092009-09
NCT0068001730 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney DiseaseCOMPLETEDPHASE32008-062011-042011-04
NCT00556023A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic CancerCOMPLETEDPHASE12008-062011-082011-08
NCT00661362Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 DiabetesCOMPLETEDPHASE32008-062009-092009-09
NCT00703391A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22008-062008-092008-09
NCT00698932Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic ControlCOMPLETEDPHASE32008-062009-102009-10
NCT00704366AZD0530 Study 21 - Phase I Study in Patients With Solid TumoursCOMPLETEDPHASE12008-062011-052011-01
NCT00721448An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy VolunteersCOMPLETEDPHASE12008-062008-082008-08
NCT00714337Formulation and Food Effect Study of AZD1386 in Healthy VolunteersCOMPLETEDPHASE12008-062008-082008-08
NCT00713791Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.COMPLETEDPHASE12008-062008-08
NCT00700986Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056COMPLETEDPHASE12008-062008-082008-08
NCT00710047Food Effect Study of a Single Dose of ZD4054 (Zibotentan)COMPLETEDPHASE12008-062008-082008-08
NCT00713336Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc IntervalCOMPLETEDPHASE12008-062008-11
NCT00736658AZD1386 Japanese Multiple Ascending Dosing StudyCOMPLETEDPHASE12008-062008-09
NCT00711048Esophageal Hypersensitivity Study in Healthy VolunteersCOMPLETEDPHASE12008-062009-07
NCT00711074Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male VolunteersCOMPLETEDPHASE12008-062008-07
NCT00720421A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.COMPLETEDPHASE12008-062008-082008-08
NCT00738959Safety, Tolerability & PK of AZD0328 in Caucasian & JapaneseCOMPLETEDPHASE12008-062008-102008-10
NCT00658021Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 DiabetesCOMPLETEDPHASE32008-05-302020-04-012019-04-18
NCT00562250Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsCOMPLETEDPHASE12008-052008-082008-08
NCT00690482Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22008-052008-122008-12
NCT00686998Phase IIA Study in Patients With SchizophreniaCOMPLETEDPHASE22008-052009-032009-03
NCT00681395Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin CalciumCOMPLETEDPHASE12008-052008-08
NCT00521365Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.COMPLETEDPHASE42008-052009-082009-08
NCT00683618Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With HypercholesterolemiaCOMPLETEDPHASE32008-052009-072009-07
NCT00642811A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-respondersCOMPLETEDPHASE22008-052009-032009-03
NCT00747149A Diabetes Study to Treat A Population Previously Not at TargetCOMPLETEDPHASE42008-052009-082009-08
NCT00703534Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) SymptomsCOMPLETEDPHASE22008-052009-012009-01
NCT00738842Uric Acid Study in Healthy Male VolunteersCOMPLETEDPHASE12008-052008-072008-07
NCT00661609A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerCOMPLETEDPHASE22008-052009-122009-05
NCT00683462An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22008-052009-07
NCT00696865AZD2624 Multiple Ascending Dose Study in JapanCOMPLETEDPHASE12008-052008-08
NCT00641056Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)COMPLETEDPHASE32008-042009-112009-05
NCT00673387Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight SubjectsCOMPLETEDPHASE22008-042009-102009-04
NCT00660660Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study USCOMPLETEDPHASE42008-042008-072008-07
NCT00672399Electrophysiological Effects of a Single 10 ÎĽg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy SubjectsCOMPLETEDPHASE12008-042008-072008-07
NCT00673231Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinCOMPLETEDPHASE32008-042011-012009-05
NCT00680745Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsCOMPLETEDPHASE32008-042010-052009-11
NCT00610714AZD0530 Phase II Study in Patients With Advanced Ovarian CancerCOMPLETEDPHASE22008-042012-012009-08
NCT00667992Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate AsthmaCOMPLETEDPHASE32008-042009-052009-05
NCT00672490Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar DisorderCOMPLETEDPHASE42008-042009-072009-07
NCT00672646Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386COMPLETEDPHASE22008-042008-062008-06
NCT00688402Study to Compare Different Formulations of AZD3355COMPLETEDPHASE12008-042008-062008-06
NCT00689247To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305COMPLETEDPHASE12008-042008-052008-05
NCT00690404AZD 2066 Single Dose Formulation and Food Effect Study in Healthy VolunteersCOMPLETEDPHASE12008-042008-062008-06
NCT00685906AZD6140 Oral Contraceptive Interaction StudyCOMPLETEDPHASE12008-042008-102008-10
NCT00672581Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic ImpairmentCOMPLETEDPHASE12008-042009-03
NCT00669903Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With SchizophreniaTERMINATEDPHASE22008-042008-112008-11
NCT0066645818-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)COMPLETEDPHASE32008-042009-032009-03
NCT00676117Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese MalesCOMPLETEDPHASE12008-042008-072008-07
NCT00688428Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free CombinationCOMPLETEDPHASE12008-042008-042008-04
NCT00633269Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic TumoursCOMPLETEDPHASE12008-042008-102008-10
NCT00686504Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066COMPLETEDPHASE12008-042008-062008-06
NCT00660907Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsCOMPLETEDPHASE32008-032013-012009-12
NCT00640601Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaCOMPLETEDPHASE32008-032010-072010-07
NCT00643448Explorative Study of AZD1305 in Atrial Fibrillation PatientsCOMPLETEDPHASE22008-032008-082008-08
NCT00681317AZD6280 Multiple Ascending Dose StudyCOMPLETEDPHASE12008-032008-072008-07
NCT00689780Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940COMPLETEDPHASE12008-032008-112008-11
NCT00681915AZD7325 Multiple Ascending Dose StudyCOMPLETEDPHASE12008-032008-072008-07
NCT00684190Drug Interaction Study Between AZD3355 and NexiumCOMPLETEDPHASE12008-032008-062008-06
NCT00689559Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy SubjectsCOMPLETEDPHASE12008-032009-04
NCT00692042Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704COMPLETEDPHASE12008-032008-062008-06
NCT00626522Aclidinium/Formoterol Fixed Combination Dose Finding StudyCOMPLETEDPHASE22008-022008-112008-11
NCT00558272Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseCOMPLETEDPHASE22008-022012-082010-01
NCT00637039Study of AZD8931 in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12008-022012-122009-06
NCT00621361Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer PatientsCOMPLETEDPHASE12008-022012-022009-08
NCT00640562Quetiapine Extended Release Depression SymptomsCOMPLETEDPHASE32008-022010-022010-02
NCT00690287A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic PatientsCOMPLETEDPHASE12008-022008-062008-06
NCT00689403Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305COMPLETEDPHASE12008-022008-072008-07
NCT00659490Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940COMPLETEDPHASE22008-022008-052008-05
NCT00621153Candesartan Effect in Second Stage Arterial HypertensionCOMPLETEDPHASE42008-022009-032009-03
NCT00690079Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386COMPLETEDPHASE12008-022008-102008-10
NCT00681746Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280COMPLETEDPHASE12008-022008-092008-09
NCT00681720Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325COMPLETEDPHASE12008-022008-072008-07
NCT00688779Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of SeasonCOMPLETEDPHASE12008-012009-042008-05
NCT00637273A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)COMPLETEDPHASE32008-012009-072009-02
NCT00603239Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and MetforminCOMPLETEDPHASE32008-012009-072009-07
NCT00577824Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)COMPLETEDPHASE32008-012008-112008-11
NCT00621725Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid TumoursCOMPLETEDPHASE12008-012014-012010-07
NCT00615017AZD9773 Dose Escalation StudyCOMPLETEDPHASE22008-012009-072009-07
NCT00600756Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to RisperidoneCOMPLETEDPHASE32008-012009-102009-10
NCT00585143Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCOMPLETEDPHASE12008-012008-102008-10
NCT00620542CRESTOR Athero Imaging Head to Head IVUS StudyCOMPLETEDPHASE32008-012011-062011-06
NCT00617669A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate CancerCOMPLETEDPHASE32008-012011-072011-05
NCT00626548A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerTERMINATEDPHASE32008-012011-052011-01
NCT00616629Cardiac Electrophysiological StudyCOMPLETEDPHASE22008-012008-062008-06
NCT00614939Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal ImpairmentCOMPLETEDPHASE32008-012010-032009-06
NCT00688831Single Ascending Dose Study (SAD) iv FormulationCOMPLETEDPHASE12008-012008-052008-05
NCT00629239Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22008-012008-082008-06
NCT00687232Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male VolunteersCOMPLETEDPHASE12008-012008-052008-05
NCT00576316Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in MalaysiaCOMPLETEDPHASE42008-012008-11
NCT00634114Reflux Esophagitis Phase III Study (Maintenance Treatment)COMPLETEDPHASE32008-012009-05
NCT00613652A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult PatientsCOMPLETEDPHASE12008-012009-062009-06
NCT00692705Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β AmyloidCOMPLETEDPHASE12008-012008-122008-12
NCT00684502Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy SubjectsCOMPLETEDPHASE12008-012008-112008-11
NCT00686413Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male SubjectsCOMPLETEDPHASE12008-012008-082008-08
NCT00686179Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 DaysCOMPLETEDPHASE12008-012008-082008-08
NCT00692146Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)COMPLETEDPHASE12008-012008-052008-05
NCT00688714Study to Investigate Safety and Tolerability of a Single Dose of AZD6482COMPLETEDPHASE12008-012008-052008-05
NCT00600496A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)ACTIVE_NOT_RECRUITINGPHASE12007-12-142025-12-312010-08-20
NCT00600119A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)COMPLETEDPHASE22007-122009-042009-03
NCT00628862Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EUCOMPLETEDPHASE32007-122009-042009-04
NCT00585000A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced MelanomaTERMINATEDPHASE12007-122010-012010-01
NCT0057558852-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension PeriodCOMPLETEDPHASE32007-122010-082009-08
NCT00573430ARIA (Atacand Renoprotection In NephropAthy Pt.)COMPLETEDPHASE42007-122009-082009-08
NCT00633932Reflux Esophagitis Phase III Study (Initial Treatment)COMPLETEDPHASE32007-122008-12
NCT00689416Effects of Crestor on Inflammation of Atherosclerotic PlaquesCOMPLETEDEARLY_PHASE12007-122009-06
NCT00546741Drug Interaction With MetforminCOMPLETEDPHASE12007-112008-022008-02
NCT00538174Phase I Multiple-Ascending Dose (Japan)COMPLETEDPHASE12007-112008-052008-05
NCT00734097A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)COMPLETEDPHASE42007-112008-102008-10
NCT00554229A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesCOMPLETEDPHASE32007-112011-082010-07
NCT00530699Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)COMPLETEDPHASE12007-112009-082009-08
NCT00572364Open Label, Dose Escalation Phase I Study of AZD2281COMPLETEDPHASE12007-112009-062009-03
NCT00692510Drug Interaction Study Between AZD3480 and Cytochrome P450COMPLETEDPHASE12007-112008-092008-09
NCT00687141Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy SubjectsCOMPLETEDPHASE12007-112008-062008-06
NCT00536107Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)TERMINATEDPHASE42007-102009-082009-08
NCT00605267Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal TreatmentCOMPLETEDPHASE32007-102010-122009-11
NCT00595517Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced UlcerCOMPLETEDPHASE32007-102009-092009-09
NCT00623779Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)COMPLETEDPHASE22007-102008-102008-10
NCT00645853Long-term Safety in Atrial Fibrillation PatientsCOMPLETEDPHASE22007-102009-052009-05
NCT00528411A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With AspirinCOMPLETEDPHASE22007-102009-032009-03
NCT00631189Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic PatientsCOMPLETEDPHASE42007-102008-102008-10
NCT00474019Phase 1 Pharmacokinetics of Intravenous Nexium in ChildrenCOMPLETEDPHASE12007-102009-10
NCT00528879A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCOMPLETEDPHASE32007-092010-052008-11
NCT00528372A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseCOMPLETEDPHASE32007-092010-072009-02
NCT00516074A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 DiabetesCOMPLETEDPHASE32007-092008-042008-04
NCT00612794A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 DiabetesCOMPLETEDPHASE12007-092008-052008-05
NCT00537771Liver Safety Under Upfront Arimidex vs TamoxifenCOMPLETEDPHASE42007-092011-122011-12
NCT00536731Symbicort Rapihaler Therapeutic Equivalence StudyCOMPLETEDPHASE32007-092008-042008-04
NCT00542880Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®COMPLETEDPHASE42007-092008-082008-08
NCT00536913Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With AsthmaCOMPLETEDPHASE32007-092008-022008-02
NCT00690612Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)COMPLETEDPHASE32007-092009-092009-09
NCT00539331Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer PatientsTERMINATEDPHASE12007-092008-092008-09
NCT00503204Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain TumourCOMPLETEDPHASE12007-092008-122008-12
NCT00689637Drug Interaction Study Between AZD3480 and WarfarinCOMPLETEDPHASE12007-092009-02
NCT00516048An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 DiabetesCOMPLETEDPHASE32007-082008-042008-04
NCT00515866Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic CancerCOMPLETEDPHASE12007-082012-072011-10
NCT00520572A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)COMPLETEDPHASE22007-082009-03
NCT0052582412-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With EzetimibeCOMPLETEDPHASE32007-082008-092008-09
NCT00534599Generalized Anxiety Disorder Adjunct StudyCOMPLETEDPHASE32007-082008-092008-09
NCT00681668Quetiapine in Postpartum DepressionTERMINATEDPHASE22007-082008-102008-10
NCT00542789Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAIDCOMPLETEDPHASE32007-082009-02
NCT00528905Proof of Concept Study of Cognitive Improvement in Patients With SchizophreniaCOMPLETEDPHASE22007-082008-112008-10
NCT00500318A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32007-072010-092008-12
NCT00501111Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's DiseaseCOMPLETEDPHASE22007-072008-082008-08
NCT00489853Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPDCOMPLETEDPHASE42007-072008-082008-08
NCT00688493Effects of Single Oral Dose Dapagliflozin QT StudyCOMPLETEDPHASE12007-072008-04
NCT00491686AZD6765 for Treatment Resistant DepressionCOMPLETEDPHASE22007-072007-112007-11
NCT00516438Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With TopotecanCOMPLETEDPHASE12007-072009-112009-03
NCT00486265Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)TERMINATEDPHASE12007-072009-07
NCT00457899Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTERMINATEDPHASE32007-072007-09
NCT00516724Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelCOMPLETEDPHASE12007-06-222024-04-112013-01-04
NCT00494234Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast CancerCOMPLETEDPHASE22007-06-152022-12-212009-02-27
NCT00494442Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerCOMPLETEDPHASE22007-06-112017-07-202009-03-17
NCT00500370A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese PatientsCOMPLETEDPHASE22007-062008-022008-02
NCT00494221A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXCOMPLETEDPHASE1, PHASE22007-062012-082009-10
NCT00487136Interaction Between ABT-335, Rosuvastatin and WarfarinCOMPLETEDPHASE12007-062007-072007-07
NCT00477581A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE42007-052007-092007-09
NCT00467649A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesCOMPLETEDPHASE42007-052008-042008-04
NCT00496470Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.COMPLETEDPHASE42007-052008-062008-06
NCT00473616Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and IrinotecanTERMINATEDPHASE12007-052011-012011-01
NCT00475956Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCOMPLETEDPHASE12007-052009-102008-10
NCT00486798FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTERMINATEDPHASE32007-052007-082007-08
NCT00689208Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve ActivityCOMPLETEDEARLY_PHASE12007-052008-112008-10
NCT00807053Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)COMPLETEDPHASE22007-042007-072007-06
NCT00468559Phase 3/Safety & Efficacy of Esomeprazole in InfantsCOMPLETEDPHASE32007-042008-062008-06
NCT00463606A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With DyslipidemiaCOMPLETEDPHASE32007-042008-022008-02
NCT00689039Study of an Extended Release (ER) Tablet, Single and Repeated DosingCOMPLETEDPHASE12007-042008-072008-07
NCT00471367Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877TERMINATEDPHASE12007-042008-12
NCT00463814AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid MalignanciesACTIVE_NOT_RECRUITINGPHASE12007-03-082025-12-312008-06-17
NCT00378482A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.COMPLETEDPHASE22007-03-052023-10-272023-10-27
NCT00454805AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.COMPLETEDPHASE22007-032016-042008-12
NCT00444275Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD PatientsCOMPLETEDPHASE42007-032008-102008-10
NCT00454090AZD8330 First Time in Man in Patients With Advanced MalignanciesCOMPLETEDPHASE12007-032011-032010-10
NCT00460460Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic MalignanciesTERMINATEDPHASE12007-032007-08
NCT00449527A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult SubjectsCOMPLETEDPHASE32007-032007-08
NCT00449501A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult SubjectsCOMPLETEDPHASE32007-032007-11
NCT00496028Phase I Study in Patients With Solid TumoursCOMPLETEDPHASE12007-032010-032010-01
NCT00463866Local Phase 4 Pan-European SMART StudyCOMPLETEDPHASE42007-032008-12
NCT00435760Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE32007-022007-082007-08
NCT00434954Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 DiabetesCOMPLETEDPHASE32007-022009-062009-06
NCT00743444TLESR-impedance Study in PatientsCOMPLETEDPHASE22007-022008-022008-02
NCT00419952A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.COMPLETEDPHASE32007-022009-112009-11
NCT00441727Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)COMPLETEDPHASE32007-022008-082008-08
NCT00684307Prevention of Stroke and Systemic Embolic Events in Patients With Atrial FibrillationCOMPLETEDPHASE22007-022008-062008-06
NCT00733265Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy VolunteersCOMPLETEDPHASE12007-022008-092008-09
NCT00423332Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell CarcinomaCOMPLETEDPHASE22007-012016-102008-03
NCT00424268Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)COMPLETEDPHASE32007-012008-072008-01
NCT00419757An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent AsthmaCOMPLETEDPHASE32007-012008-062008-06
NCT00608868SELINE: Second-Line Iressa Phase IV Study in NSCLC PatientsCOMPLETEDPHASE42007-012009-012009-01
NCT00434967Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboCOMPLETEDPHASE32007-012008-012008-01
NCT00473655Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic PatientsCOMPLETEDPHASE42007-012009-022009-02
NCT00419744A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDCOMPLETEDPHASE32007-012009-082009-08
NCT00516802A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With DacarbazineCOMPLETEDPHASE12007-012009-012009-01
NCT00422123Phase 3 /Seroquel SR Acute Mania Monotherapy - USCOMPLETEDPHASE32007-012007-07
NCT00509028Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial AsthmaCOMPLETEDPHASE32006-122008-102008-10
NCT00413686Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12006-122010-052010-05
NCT00427960Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mgTERMINATEDPHASE42006-122008-022008-02
NCT00422214Phase III/Seroquel SR Bipolar Depression Monotherapy - USCOMPLETEDPHASE32006-122007-06
NCT00428350Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute SchizophrenicCOMPLETEDPHASE42006-122007-092007-09
NCT00806754Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)COMPLETEDPHASE42006-112007-082007-05
NCT00399035Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerCOMPLETEDPHASE32006-112016-082010-03
NCT00404547Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)COMPLETEDPHASE42006-112008-122008-04
NCT00402077A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCOMPLETEDPHASE22006-112007-082007-08
NCT00394472Symptom Improvements in Gastroesophageal Reflux Disease (GERD) PatientsCOMPLETEDPHASE22006-112007-062007-06
NCT00372853Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell CarcinomaCOMPLETEDPHASE12006-112010-052010-05
NCT00357370A Pilot Study of BMS-512148 in Subjects With Type 2 DiabetesCOMPLETEDPHASE2, PHASE32006-102008-032008-03
NCT00384475A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)COMPLETEDPHASE32006-102007-012007-01
NCT00392925A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese SubjectsCOMPLETEDPHASE22006-102007-092007-09
NCT00573469Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's DiseaseCOMPLETEDPHASE22006-102008-032008-03
NCT00391846Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs AloneCOMPLETEDPHASE42006-102009-012009-01
NCT00391872A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary SyndromeCOMPLETEDPHASE32006-102009-032009-03
NCT00504062Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaCOMPLETEDPHASE32006-102007-10
NCT00428701An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving NexiumCOMPLETEDPHASE42006-102006-112006-11
NCT00427635Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal PatientsCOMPLETEDPHASE32006-102009-04
NCT00410592Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCOMPLETEDPHASE42006-102007-05
NCT00384189A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With AsthmaCOMPLETEDPHASE32006-092008-082007-08
NCT00392288Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.COMPLETEDPHASE32006-092008-022008-02
NCT00359762Exenatide Versus Glimepiride in Patients With Type 2 DiabetesCOMPLETEDPHASE32006-092011-032011-03
NCT00375492Effect on Weight Loss of Exenatide Versus PlaceboCOMPLETEDPHASE32006-092008-022008-02
NCT00374907A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCOMPLETEDPHASE32006-092009-122008-01
NCT00359879Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesCOMPLETEDPHASE32006-092007-072007-07
NCT00381342Safety and Efficacy of Exenatide as MonotherapyCOMPLETEDPHASE32006-092007-092007-09
NCT00382239A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesCOMPLETEDPHASE22006-092007-052007-05
NCT00514761Phase II Efficacy Study of AZD6244 in Colorectal CancerCOMPLETEDPHASE22006-092008-072007-06
NCT00385203The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).COMPLETEDPHASE22006-092009-122008-06
NCT00389064Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety DisorderCOMPLETEDPHASE32006-092008-042008-04
NCT00395486ROMEO (Rosuvastatin in Metabolic syndrOme)COMPLETEDPHASE42006-092008-062008-06
NCT00379028Airway Clearance StudyCOMPLETEDPHASE42006-092007-07
NCT00385593Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in AdultsTERMINATEDPHASE32006-092008-10
NCT00388973Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive DisorderCOMPLETEDPHASE32006-092007-122007-12
NCT00389389Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid TumorsCOMPLETEDPHASE12006-092008-102008-08
NCT00421122Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPDCOMPLETEDPHASE32006-092007-11
NCT00384592PPI Sequencing StudyCOMPLETEDPHASE42006-092007-052007-05
NCT00383929Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgCOMPLETEDPHASE32006-092007-102007-08
NCT00384176First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOXCOMPLETEDPHASE2, PHASE32006-08-302015-08-192009-11-15
NCT00358436Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)COMPLETEDPHASE32006-082008-062008-06
NCT01140542Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical StudyCOMPLETEDPHASE22006-082008-032007-11
NCT00372788AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy RegimenCOMPLETEDPHASE22006-082008-122007-07
NCT00372944AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine TherapyCOMPLETEDPHASE22006-082008-102008-04
NCT00343161Symptom Adapted Therapy in GERD PatientsCOMPLETEDPHASE42006-082007-082007-08
NCT00497679AZD1152 in Patients With Advanced Solid Malignancies-Study 3TERMINATEDPHASE12006-082007-07
NCT00402259Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal BleedingCOMPLETEDPHASE32006-082007-10
NCT00687245Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE12006-082008-052008-05
NCT00363896A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32006-072008-052008-05
NCT00338130Randomised Study to Compare the Efficacy of AZD6244 vs TMZCOMPLETEDPHASE22006-072013-072007-09
NCT00355615PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatinCOMPLETEDPHASE32006-072008-072008-07
NCT00316082Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCOMPLETEDPHASE32006-062008-112007-11
NCT00360334A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes PatientsCOMPLETEDPHASE32006-062008-042008-04
NCT00306891Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)COMPLETEDPHASE22006-062008-092008-01
NCT00431275Study to Compare Two Formulations of CP-675,206 Monoclonal AntibodyCOMPLETEDPHASE12006-062008-022008-02
NCT00348686Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)COMPLETEDPHASE42006-062008-062008-06
NCT00323479Arthralgia During Anastrozole Therapy for Breast CancerCOMPLETEDPHASE42006-062009-012009-01
NCT00302770Efficacy of Quetiapine in Generalised Social Anxiety DisorderTERMINATEDPHASE32006-062006-122006-12
NCT00313170A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mgCOMPLETEDPHASE22006-05-302019-03-132008-06-13
NCT00338182AZD1152 in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12006-05-232017-03-012008-06-06
NCT00306163Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)COMPLETEDPHASE32006-052008-092008-08
NCT00327015A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCOMPLETEDPHASE32006-052008-122007-11
NCT00313794Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After TreatmentCOMPLETEDPHASE22006-052008-062008-06
NCT00312975Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22006-052010-022008-04
NCT00351910Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCOMPLETEDPHASE32006-052007-04
NCT00326053Prevention of Asthma Relapse After Discharge From EmergencyCOMPLETEDPHASE32006-052007-05
NCT00497991Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid LeukemiaCOMPLETEDPHASE12006-052010-042009-10
NCT00318968Nexium RESPONSE TrialCOMPLETEDPHASE42006-052007-11
NCT00351169Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCOMPLETEDPHASE32006-052007-06
NCT00322595Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety DisorderCOMPLETEDPHASE32006-052007-05
NCT00313209Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)COMPLETEDPHASE32006-042008-022007-07
NCT00308139Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)COMPLETEDPHASE32006-042014-082008-07
NCT00313313A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasCOMPLETEDPHASE32006-042008-092007-09
NCT00313183A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE22006-042007-082007-08
NCT00317044Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux AsthmaCOMPLETEDPHASE22006-042008-072008-07
NCT00357110Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast CancerCOMPLETEDPHASE22006-042008-102008-10
NCT00322348Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal WomenCOMPLETEDPHASE22006-042009-11
NCT00329446Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderCOMPLETEDPHASE32006-042007-09
NCT00358280Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb SurgeryCOMPLETEDPHASE32006-042006-09
NCT00321490Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderCOMPLETEDPHASE32006-042007-05
NCT00320268Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderCOMPLETEDPHASE32006-042007-05
NCT00326144Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersCOMPLETEDPHASE32006-042007-05
NCT00326105Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersCOMPLETEDPHASE32006-042007-07
NCT00329264Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety DisorderCOMPLETEDPHASE32006-042007-08
NCT00554450Renal Impairment in Type 2 Diabetic SubjectsCOMPLETEDPHASE12006-032008-102008-10
NCT00305487Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)COMPLETEDPHASE32006-032006-102006-10
NCT00297115Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)COMPLETEDPHASE32006-032008-082008-04
NCT00295633A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneCOMPLETEDPHASE32006-032008-102007-10
NCT00322452First Line IRESSA™ Versus Carboplatin/Paclitaxel in AsiaCOMPLETEDPHASE32006-032010-062008-04
NCT00257205CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior TherapyCOMPLETEDPHASE32006-032010-082010-08
NCT00305448A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mgCOMPLETEDPHASE22006-032012-022008-03
NCT00344773First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) MutationCOMPLETEDPHASE22006-032007-122007-12
NCT00401752Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric UlcerCOMPLETEDPHASE32006-032008-11
NCT00314782Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPCCOMPLETEDPHASE12006-032009-032008-03
NCT00314210Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.COMPLETEDPHASE32006-032007-08
NCT00733668Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive DisorderCOMPLETEDPHASE22006-032007-112007-11
NCT00274469A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast CancerCOMPLETEDPHASE22006-02-062017-01-132008-01-10
NCT00297102Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)COMPLETEDPHASE32006-022008-092008-07
NCT00305461Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)COMPLETEDPHASE32006-022008-022007-03
NCT00254254A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22006-022007-022007-02
NCT00296374Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal DiseaseCOMPLETEDPHASE22006-022009-032009-03
NCT00296400Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal DiseaseCOMPLETEDPHASE22006-022009-062009-06
NCT00272727Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and CaregiverCOMPLETEDNA2006-022007-05
NCT00303524Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal PatientsCOMPLETEDPHASE22006-022009-022007-08
NCT00278915Faslodex in McCune-Albright SyndromeCOMPLETEDPHASE22006-01-312023-07-202009-12-08
NCT00324363Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminCOMPLETEDPHASE32006-012007-042007-04
NCT00114686Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar DisorderCOMPLETEDPHASE32006-012007-04
NCT00090675Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung CancerWITHDRAWNPHASE32006-012007-112007-11
NCT00278889Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)COMPLETEDPHASE22006-012009-102007-11
NCT00352261An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus PatientsCOMPLETEDPHASE42006-012007-04
NCT00296387Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary SyndromeCOMPLETEDPHASE32006-012007-10
NCT00263276A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE22005-122007-022007-02
NCT02336607The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.COMPLETEDNA2005-122006-082006-06
NCT00243347The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck CancerCOMPLETEDPHASE12005-122009-072008-05
NCT00628758A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent AsthmaCOMPLETEDPHASE32005-122008-092008-09
NCT00254579Study of CP-675,206 in Refractory MelanomaCOMPLETEDPHASE22005-122009-122009-12
NCT00687310Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) TrialCOMPLETEDPHASE42005-122007-01
NCT00278941Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderCOMPLETEDPHASE32005-122007-08
NCT00272701Esomeprazole in PPI Failures - IMPROVECOMPLETEDPHASE42005-122007-02
NCT00163449Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)COMPLETEDPHASE32005-112007-052006-11
NCT00261287Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)COMPLETEDPHASE32005-112006-062006-06
NCT00254800The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCOMPLETEDPHASE12005-112006-082006-08
NCT00264004Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid TumoursCOMPLETEDPHASE22005-112011-042007-01
NCT00327769Faslodex Advanced Breast Cancer Local Chinese StudyCOMPLETEDPHASE32005-112007-09
NCT00608712Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)COMPLETEDPHASE42005-112006-082006-08
NCT00255255Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCOMPLETEDPHASE32005-112007-062006-12
NCT00503412Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic TumorsCOMPLETEDPHASE12005-112006-05
NCT00135330An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32005-102008-072008-07
NCT00240253A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesCOMPLETEDPHASE42005-102006-062006-06
NCT00241423Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesCOMPLETEDPHASE22005-102007-062007-06
NCT00329160Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart DiseaseCOMPLETEDPHASE42005-102008-102008-10
NCT00251979A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic UlcerCOMPLETEDPHASE32005-102007-122007-12
NCT00252785Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsCOMPLETEDPHASE32005-102006-11
NCT00503477A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in JapanCOMPLETEDPHASE12005-102009-012007-07
NCT00861016Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate HypertensionCOMPLETEDPHASE42005-102006-052006-04
NCT00242736An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE42005-102006-01
NCT00300105GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 DiabetesTERMINATEDPHASE32005-102006-12
NCT00392002Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for ResponseCOMPLETEDPHASE42005-102007-05
NCT00262548C-Reactive Protein (CRP) in Obese Diabetic WomenCOMPLETEDPHASE42005-10
NCT00163436Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)COMPLETEDPHASE32005-092006-012006-01
NCT00163371Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)COMPLETEDPHASE32005-092005-122005-12
NCT00189514A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsCOMPLETEDPHASE22005-092007-062007-06
NCT00230516Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer SubjectsCOMPLETEDPHASE42005-092006-02
NCT00478049Iressa as Second Line Therapy in Advanced NSCLC-AsiaCOMPLETEDPHASE32005-092009-022007-05
NCT00259779Comparison Between Symbicort® and Prednisolone in COPDCOMPLETEDPHASE32005-092007-07
NCT00206089Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic EventsTERMINATEDPHASE32005-092006-082006-08
NCT00255515Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With SchizophreniaCOMPLETEDPHASE42005-092007-122007-12
NCT00319306Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyCOMPLETEDPHASE32005-092006-12
NCT00291746Validation of RDQ QuestionnaireCOMPLETEDPHASE42005-092006-11
NCT00255281Efficacy and Safety of AZD7009 in the Treatment of Atrial FibrillationCOMPLETEDPHASE22005-092006-05
NCT00242320Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)COMPLETEDPHASE32005-082007-082007-05
NCT00121667Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneCOMPLETEDPHASE32005-082010-022006-10
NCT00206141Seroquel in Bipolar Depression Versus LithiumCOMPLETEDPHASE32005-082007-05
NCT00448578Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder PatientsCOMPLETEDPHASE32005-082006-06
NCT00263965ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin SensitivityTERMINATEDPHASE22005-082006-07
NCT00335699Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic SyndromeCOMPLETEDPHASE42005-082007-01
NCT00516373A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)COMPLETEDPHASE12005-07-112023-04-262008-12-17
NCT00314509Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)COMPLETEDPHASE22005-072006-012006-01
NCT00121641Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCOMPLETEDPHASE32005-072010-022006-08
NCT00139074Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic PatientsTERMINATEDPHASE42005-072006-062006-06
NCT00252824STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent AsthmaCOMPLETEDPHASE32005-072006-12
NCT00127829Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or MetastaticCOMPLETEDPHASE12005-072008-01
NCT00544986A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast CancerCOMPLETEDPHASE42005-062007-112007-11
NCT00241436Open Label Arimidex in GynecomastiaCOMPLETEDPHASE22005-062006-112006-11
NCT00254787Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic PatientsCOMPLETEDPHASE22005-062006-01
NCT00246935Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)COMPLETEDPHASE32005-052007-102007-01
NCT00112021A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsCOMPLETEDPHASE22005-052005-112005-11
NCT00119652Seroquel in Bipolar Depression Versus SSRICOMPLETEDPHASE32005-052007-05
NCT00242775Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgCOMPLETEDPHASE32005-052006-05
NCT00244608A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®COMPLETEDPHASE32005-052007-03
NCT00497731AZD1152 in Patients With Advanced Solid Malignancies-Study 1TERMINATEDPHASE12005-052009-042008-06
NCT00162305A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic SubjectsCOMPLETEDPHASE22005-042005-082005-08
NCT00206154A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsCOMPLETEDPHASE32005-042006-12
NCT00243724HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCOMPLETEDPHASE32005-042007-062007-06
NCT00206167A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDCOMPLETEDPHASE32005-042007-09
NCT00252837GALLANT 22 Tesaglitazar vs. PlaceboTERMINATEDPHASE32005-042006-12
NCT00099580PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart FailureCOMPLETEDPHASE22005-032006-092006-09
NCT00228462Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or PlaceboCOMPLETEDPHASE32005-032006-04
NCT00226330GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusTERMINATEDPHASE32005-032006-122006-12
NCT00261352GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTERMINATEDPHASE32005-032006-12
NCT00314184Quetiapine Fumarate Bipolar Maintenance MonotherapyCOMPLETEDPHASE32005-032007-07
NCT00252876GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesTERMINATEDPHASE32005-032007-01
NCT00099437Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.ACTIVE_NOT_RECRUITINGPHASE32005-02-132025-12-312009-02-27
NCT00659503Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)COMPLETEDPHASE32005-022005-112005-04
NCT00103935Study Examining Exenatide Long-Acting Release in Subjects With Type 2 DiabetesCOMPLETEDPHASE22005-022005-102005-10
NCT00229710GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 DiabetesTERMINATEDPHASE32005-022006-122006-12
NCT00214604Type III DysbetalipoproteinemiaCOMPLETEDPHASE32005-022007-022007-02
NCT00163293Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101)COMPLETEDPHASE32005-01-012010-04-012009-06-01
NCT00163488Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)COMPLETEDPHASE32005-012005-082005-08
NCT00357734Iressa Follow-up TrialCOMPLETEDPHASE32005-012015-052015-05
NCT00517283A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 DiabetesCOMPLETEDPHASE12005-012005-062005-06
NCT00502567A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid TumorsCOMPLETEDPHASE12005-012011-062007-11
NCT00659048Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)COMPLETEDPHASE32004-122005-122005-04
NCT00246922Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)COMPLETEDPHASE32004-122007-102007-01
NCT01365533A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic AsthmaCOMPLETEDPHASE22004-122005-072005-07
NCT00290264SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaCOMPLETEDPHASE32004-122006-08
NCT00306540Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress DisorderCOMPLETEDPHASE32004-122008-082007-09
NCT00252863DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsCOMPLETEDPHASE32004-122006-05
NCT00094328Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]COMPLETEDPHASE22004-11-222017-12-062008-05-22
NCT00163423Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)COMPLETEDPHASE32004-112006-012006-01
NCT00659594Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)COMPLETEDPHASE32004-112005-092005-02
NCT00163319Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)COMPLETEDPHASE32004-112005-11
NCT00242294Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)COMPLETEDPHASE2, PHASE32004-112007-032006-09
NCT00234377Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With SchizophreniaCOMPLETEDPHASE32004-112006-05
NCT00206115SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32004-112005-12
NCT00206128Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With SchizophreniaCOMPLETEDPHASE32004-112006-022006-02
NCT00244621Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of AgeCOMPLETEDPHASE32004-112008-082008-08
NCT00206024Acid-Associated Heartburn Symptoms and Dose of EsomeprazoleCOMPLETEDPHASE42004-112005-07
NCT00229723IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell CarcinomaCOMPLETEDPHASE22004-112008-06
NCT00163462Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)COMPLETEDPHASE32004-102005-112005-11
NCT00108823The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)COMPLETEDPHASE32004-10
NCT00239343Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast CancerCOMPLETEDPHASE22004-102007-052007-05
NCT00288379SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild AsthmaCOMPLETEDPHASE32004-102006-05
NCT00254813Fast Titration Of Quetiapine Versus Currently Approved TitrationCOMPLETEDPHASE32004-102005-09
NCT00228527Esomeprazole for Treatment of GERD in Pediatric PatientsCOMPLETEDPHASE42004-102005-10
NCT00264498Phase II Iressa & Carbo/Gem in NSCLCCOMPLETEDPHASE22004-102008-06
NCT00658918To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)COMPLETEDPHASE32004-092005-112005-04
NCT00259064Iressa v BSC (Best Supportive Care) in First Line NSCLCCOMPLETEDPHASE2, PHASE32004-092016-042007-02
NCT00097500Effects of Exenatide and Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32004-092009-122009-12
NCT00099619Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCOMPLETEDPHASE32004-092005-082005-08
NCT00090324Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With SchizophreniaCOMPLETEDPHASE32004-092007-06
NCT00229684ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)TERMINATEDPHASE22004-092006-062006-06
NCT00228475A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic WomenCOMPLETEDPHASE42004-092005-10
NCT00242411MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and AdultsCOMPLETEDPHASE42004-092006-102006-10
NCT00259792SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and AdultsCOMPLETEDPHASE32004-092006-01
NCT00206050Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg poCOMPLETEDPHASE42004-092004-122004-12
NCT00252772GALLANT 2 Tesaglitazar vs. PlaceboTERMINATEDPHASE32004-092006-11
NCT00298688A Study of IRESSA in Relapsed and Refractory Small Cell Lung CancerCOMPLETEDPHASE22004-092007-03
NCT00255541GALLANT 4 Tesaglitazar vs. GlibenclamideTERMINATEDPHASE32004-092006-12
NCT00333294Phase II Iressa + Irradiation Followed by Chemo in NSCLCCOMPLETEDPHASE22004-092006-01
NCT00444561Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese SubjectsCOMPLETEDPHASE22004-082005-052005-05
NCT00075959Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCOMPLETEDPHASE22004-082006-012006-01
NCT00227305Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I DisorderCOMPLETEDPHASE32004-082007-122007-12
NCT00214591GALLANT 5 Tesaglitazar Versus MetforminTERMINATEDPHASE32004-082006-122006-12
NCT00214565GALLANT 6 Tesaglitazar vs. PioglitazoneTERMINATEDPHASE32004-082006-102006-10
NCT00502060Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced CancerCOMPLETEDPHASE12004-082006-062006-06
NCT00242372GALLANT 9 Tesaglitazar vs. Placebo in Combination With InsulinTERMINATEDPHASE32004-082006-03
NCT00304473Fast Titration in the Treatment of Schizophrenia, TaiwanCOMPLETEDPHASE32004-082006-04
NCT00255268CMAB vs IMAB in Metastatic Prostate CancerWITHDRAWNPHASE42004-08
NCT00090311Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaCOMPLETEDPHASE32004-072006-07
NCT00090363ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)COMPLETEDPHASE22004-072011-082008-12
NCT00088790AZD5438 in Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12004-072005-122005-12
NCT00233623Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWITHDRAWNPHASE22004-072006-012006-01
NCT00234442Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerTERMINATEDPHASE22004-072006-02
NCT00256711Phase II Iressa Versus Vinorelbine (INVITE)COMPLETEDPHASE22004-072006-02
NCT00637286ZAP, US. Zomig for Appropriate for Primary CareCOMPLETEDPHASE42004-072005-05
NCT00251953GALLANT 8 Tesaglitazar Add-on to MetforminTERMINATEDPHASE32004-072006-03
NCT00251940GALLANT 7 Tesaglitazar Add-on to SulphonylureaTERMINATEDPHASE32004-072006-03
NCT00083954Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar DepressionCOMPLETEDPHASE32004-062005-08
NCT00254748Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered PatientsCOMPLETEDPHASE22004-062007-06
NCT00085891Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With SchizophreniaCOMPLETEDPHASE32004-062005-09
NCT00206180NEXIUM® in the Treatment of Moderate and Severe Erosive EsophagitisCOMPLETEDPHASE42004-062005-08
NCT00653445Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mgCOMPLETEDPHASE32004-062005-06
NCT00093002Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast CancerCOMPLETEDPHASE22004-062007-07
NCT00625274A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using PatientsCOMPLETEDPHASE42004-062004-112004-11
NCT00228488Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck CarcinomaCOMPLETEDPHASE22004-062005-12
NCT00163514Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)COMPLETEDPHASE32004-052005-072005-07
NCT00163475Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)COMPLETEDPHASE32004-052005-082005-08
NCT00242307Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)COMPLETEDPHASE2, PHASE32004-052007-062006-09
NCT00099320Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminCOMPLETEDPHASE32004-052005-082005-08
NCT00206284A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.COMPLETEDPHASE22004-052005-04
NCT00206245A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.COMPLETEDPHASE22004-052005-03
NCT00251901Chest Pain Pilot StudyCOMPLETEDPHASE32004-052005-072005-07
NCT00255489A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung CancerCOMPLETEDPHASE12004-052006-06
NCT00261417Dose Response Study in Japanese PatientsTERMINATEDPHASE22004-052005-10
NCT00234403A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast CancerCOMPLETEDPHASE22004-052007-10
NCT00251966ASTERIX: Low Dose ASA and NexiumCOMPLETEDPHASE32004-052005-09
NCT00238784SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & AdultsCOMPLETEDPHASE32004-052005-102005-10
NCT00940329Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled FormoterolCOMPLETEDPHASE12004-042004-122004-07
NCT00214578Seroquel on Glucose MetabolismCOMPLETEDPHASE42004-042005-10
NCT00259090Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast CancerCOMPLETEDPHASE22004-042008-102008-10
NCT00272753Effect of Budesonide / Formoterol Combination in Repeated AMP ProvocationsCOMPLETEDPHASE42004-042005-11
NCT00502385Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AMLCOMPLETEDPHASE12004-04
NCT00641693Assess the Efficacy and Safety of Rhinocort AquaCOMPLETEDPHASE22004-042005-052005-05
NCT00082277Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast CancerCOMPLETEDPHASE42004-042007-102007-10
NCT00259766SHARE - Symbicort and Health Economics in a Real Life EvaluationCOMPLETEDPHASE32004-042007-05
NCT00328120Faslodex 500mg Multiple Dose Tolerability Study in BC PatientsCOMPLETEDPHASE12004-042010-062006-04
NCT00107731Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCOMPLETEDPHASE32004-042006-10
NCT00240305A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic SyndromeCOMPLETEDPHASE32004-042006-05
NCT00295620Secondary Adjuvant Long Term Study With ArimidexCOMPLETEDPHASE32004-03-012017-06-302017-06-30
NCT00075192CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate CancerCOMPLETEDPHASE1, PHASE22004-032006-03
NCT00502164Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate CancerCOMPLETEDPHASE12004-03
NCT00081380Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCOMPLETEDPHASE32004-032006-09
NCT00099333Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsCOMPLETEDPHASE22004-022005-082005-08
NCT00076388Iressa Versus Docetaxel (Taxotere)COMPLETEDPHASE32004-022007-102007-03
NCT00252811A Study of ZD1839 Effects on Cell Proliferation in Breast CancerWITHDRAWNPHASE22004-02
NCT00241501Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent PatientsCOMPLETEDPHASE32004-022005-04
NCT00228514Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub StudyCOMPLETEDPHASE32004-022007-07
NCT00681967Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck CancerCOMPLETEDPHASE12004-022009-102009-10
NCT00242788IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCOMPLETEDPHASE1, PHASE22004-022005-11
NCT00255476The IRESSA Novel Head and Neck Chemotherapy Evaluation StudyCOMPLETEDPHASE22004-022007-07
NCT00163397Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)COMPLETEDPHASE32004-012005-072005-07
NCT00163384Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)COMPLETEDPHASE32004-012005-052005-05
NCT00077025Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast CancerCOMPLETEDPHASE22004-012013-052013-05
NCT00256698Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyCOMPLETEDPHASE32004-012012-022009-04
NCT00234468Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLCTERMINATEDPHASE32004-012007-08
NCT00259051A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCOMPLETEDPHASE32004-012004-082004-08
NCT00235950Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart DiseaseCOMPLETEDPHASE42004-012006-032006-03
NCT00255463Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa StudyCOMPLETEDPHASE22004-012005-11
NCT00232648Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaCOMPLETEDPHASE32004-012006-112006-11
NCT00659750To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)COMPLETEDPHASE32003-122005-042004-05
NCT00659841To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)COMPLETEDPHASE32003-122005-022004-12
NCT00163501Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)COMPLETEDPHASE32003-122005-042005-04
NCT00076076The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)COMPLETEDPHASE32003-122005-06
NCT00076089OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)COMPLETEDPHASE32003-122005-122005-12
NCT01876849An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32003-122008-072008-07
NCT00318539Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg StudyCOMPLETEDPHASE22003-122006-08
NCT00233610Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate CancerCOMPLETEDPHASE32003-122007-102007-10
NCT00319787Combination Casodex® and Iressa™ in Locally Advanced Prostate CancerCOMPLETEDPHASE22003-122006-08
NCT00214630LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary SyndromesCOMPLETEDPHASE32003-122007-082007-08
NCT00241475Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or RadiotherapyCOMPLETEDPHASE22003-122005-10
NCT00073177Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)COMPLETEDPHASE32003-11
NCT00082407Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and MetforminCOMPLETEDPHASE32003-112008-072008-07
NCT00206219Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)COMPLETEDPHASE32003-112007-092007-09
NCT00079833Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison SyndromeCOMPLETEDPHASE32003-112005-07
NCT00646594Atlantis SymbicortCOMPLETEDPHASE32003-112005-01
NCT00329173PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.COMPLETEDPHASE32003-112004-08
NCT00234429A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCOMPLETEDPHASE2, PHASE32003-112006-06
NCT00229697Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyCOMPLETEDPHASE22003-102015-062006-12
NCT00259077Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCOMPLETEDPHASE32003-102004-072004-07
NCT00646516Gemini Symbicort pMDICOMPLETEDPHASE32003-102005-02
NCT00328978Seroquel STACK Study in Schizophrenic or Schizoaffective SubjectsCOMPLETEDPHASE32003-102005-09
NCT00163345Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)COMPLETEDPHASE32003-092006-052006-05
NCT00163358Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)COMPLETEDPHASE32003-092005-102005-10
NCT00085969Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22003-092004-012004-01
NCT00206102A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE42003-092008-102008-10
NCT00787410An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant MesotheliomaCOMPLETEDPHASE22003-092008-042008-04
NCT00065117Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TERMINATEDPHASE22003-092004-022004-02
NCT00235911Symbicort Single Inhaler Therapy for Asthma in a General Practice SettingCOMPLETEDPHASE32003-092006-122006-10
NCT00206310Crestor Versus Placebo in Subjects With Heart FailureCOMPLETEDPHASE32003-092007-072007-07
NCT00244595Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of AgeCOMPLETEDPHASE32003-092006-11
NCT00252707Iressa 2nd Line Phase III Study in JapanCOMPLETEDPHASE32003-092006-11
NCT00244634Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of AgeCOMPLETEDPHASE32003-092005-11
NCT00065325The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerCOMPLETEDPHASE32003-082014-092006-06
NCT00086489CP-675,206 In Patients With Advanced MelanomaCOMPLETEDPHASE22003-082009-052007-05
NCT00651768Titratable Dosing in Moderate to Severe AsthmaticsCOMPLETEDPHASE32003-082005-01
NCT00065572Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)SUSPENDEDPHASE22003-082004-022004-02
NCT00240266Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)COMPLETEDPHASE32003-082004-122004-11
NCT00064714Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCOMPLETEDPHASE22003-072008-032008-03
NCT00242762ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCOMPLETEDPHASE22003-072006-032006-03
NCT00449397Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode PsychosisCOMPLETEDPHASE32003-072006-012006-01
NCT00233636Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and NeckWITHDRAWNPHASE22003-07
NCT00242801Iressa vs Best Supportive Care - 2nd/3rd Line Survival StudyCOMPLETEDPHASE32003-072005-04
NCT00237900Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTERMINATEDPHASE1, PHASE22003-072004-02
NCT00637026Ph II Early BC Pre-Surgical Biologic StudyCOMPLETEDPHASE22003-072005-02
NCT00062582Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)COMPLETEDPHASE32003-06
NCT00082381Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and MetforminCOMPLETEDPHASE32003-062008-072008-07
NCT00055471A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate CancerCOMPLETEDPHASE22003-062005-102005-10
NCT00119626Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCOMPLETEDPHASE32003-062005-022005-02
NCT00239330Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin TherapyCOMPLETEDPHASE32003-062005-022005-02
NCT00642096Factorial Study of Metoprolol Succinate TOPROL-XL (324A)COMPLETEDPHASE32003-062004-072004-07
NCT00241488DISCOVERY Asia - Crestor in Type IIa and IIb HypercholesteremiaCOMPLETEDPHASE32003-062007-022005-12
NCT00590213Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEXCOMPLETEDPHASE42003-06
NCT00319618Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast CancerCOMPLETEDPHASE22003-062006-06
NCT00239304Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerCOMPLETEDPHASE1, PHASE22003-062006-03
NCT00950599Study of Multiple Doses of Saxagliptin (BMS-477118)COMPLETEDPHASE22003-052004-052004-05
NCT00061022Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCOMPLETEDPHASE32003-052006-092006-09
NCT00653965Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)COMPLETEDPHASE32003-052005-02
NCT00246974Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCTCOMPLETEDPHASE22003-052007-122007-10
NCT00163410Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)COMPLETEDPHASE32003-042004-122004-12
NCT00163527Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)COMPLETEDPHASE32003-042005-112005-11
NCT00108004Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusCOMPLETEDPHASE32003-042005-062005-06
NCT00646321Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUTCOMPLETEDPHASE32003-042004-08
NCT00642122Adults With Moderate to Severe AsthmaCOMPLETEDPHASE32003-042004-122004-12
NCT00652392Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEMCOMPLETEDPHASE32003-042004-06
NCT00641680Rhinocort Aqua Versus Placebo and Fluticasone PropionateCOMPLETEDPHASE32003-042003-072003-07
NCT00646620Symbicort Onset of Action 1COMPLETEDPHASE32003-042003-09
NCT00653588Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 WeeksCOMPLETEDPHASE32003-042004-09
NCT00628342A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE42003-042003-082003-08
NCT00242346High Doses of Candesartan Cilexetil on the Reduction of ProteinuriaCOMPLETEDPHASE32003-042006-12
NCT00163332Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)COMPLETEDPHASE32003-03
NCT00646009Symbicort Onset of Action 2COMPLETEDPHASE32003-032003-08
NCT00626535A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)COMPLETEDPHASE32003-032004-022004-02
NCT00239681JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) EventsTERMINATEDPHASE32003-022008-092008-09
NCT00238797A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma MultiformeCOMPLETEDPHASE22003-022006-03
NCT00240292Rosuvastatin Impact on Ventricular Remodelling Lipids and CytokinesCOMPLETEDPHASE32003-02
NCT00240357Effect of an Internet Based Compliance Enhancement Tool in Subjects With HypercholesterolemiaWITHDRAWNPHASE42003-02
NCT00501605Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver MetastasesCOMPLETEDPHASE12003-022006-022005-04
NCT00430729Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)COMPLETEDPHASE32003-01
NCT00265070Trial of Iressa in Prostate Cancer PatientsCOMPLETEDPHASE22003-012011-08
NCT00240331AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)COMPLETEDPHASE32003-012008-102008-10
NCT00240279The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA StudyCOMPLETEDPHASE32003-012008-102008-10
NCT00239291Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate CancerCOMPLETEDPHASE1, PHASE22003-012006-05
NCT00318084PPI Test in GP PatientsCOMPLETEDPHASE42003-01
NCT00334295Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.COMPLETEDPHASE22002-122011-012011-01
NCT00251914Nexium Dyspepsia/ASTCOMPLETEDPHASE32002-122005-012005-01
NCT00251992Nexium Dyspepsia/ASTCOMPLETEDPHASE32002-122005-012005-01
NCT00242749IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck CarcinomaCOMPLETEDPHASE22002-122007-07
NCT00644735Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been HealedCOMPLETEDPHASE42002-122004-012004-01
NCT00641602A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive EsophagitisCOMPLETEDPHASE42002-122003-082003-08
NCT00107107Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE32002-112005-062005-06
NCT00111540Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCOMPLETEDPHASE32002-112006-092006-09
NCT00637871Casodex - Nolvadex CombinationCOMPLETEDPHASE22002-112005-082005-06
NCT00642161New Version Pulmicort Turbuhaler USA ChildrenCOMPLETEDPHASE32002-112004-092004-09
NCT00800800Effects of Rosuvastatin on Aortic Stenosis ProgressionCOMPLETEDPHASE32002-112008-092008-09
NCT00240318A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)COMPLETEDPHASE32002-112005-112005-11
NCT00658255Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis TurbuhalerCOMPLETEDPHASE22002-102003-05
NCT00641472Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, ChildrenCOMPLETEDPHASE42002-102005-022005-02
NCT00654225Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)COMPLETEDPHASE32002-102005-03
NCT00628953Adult Asthmatics and Acid RefluxCOMPLETEDPHASE22002-102004-042004-04
NCT01789957Extension Study for 2993-112COMPLETEDPHASE32002-092004-062004-06
NCT00060489Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar DepressionCOMPLETEDPHASE32002-092003-092003-09
NCT00629564An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE42002-092002-102002-10
NCT00625495Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE42002-092002-112002-11
NCT00247481ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast CancerCOMPLETEDPHASE22002-092005-06
NCT00617747Efficacy and Tolerability of Zolmitriptan Nasal SprayCOMPLETEDPHASE32002-092003-06
NCT00621647Seroquel- Agitation Associated With DementiaCOMPLETEDPHASE32002-092003-112003-11
NCT00654446IIIb 6 Week Open Label Multicentre Rosuvastatin & SimvastatinCOMPLETEDPHASE32002-092004-04
NCT00055302Arimidex in McCune Albright SyndromeCOMPLETEDPHASE22002-082015-082006-02
NCT00044707Evaluation of an Orally Administered Medication When Taken in Conjunction With PramlintideCOMPLETEDPHASE22002-082002-092002-09
NCT00044668Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCOMPLETEDPHASE32002-082005-092005-09
NCT00044694Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE22002-082003-052003-05
NCT00635414Open, Randomized, Two Way Crossover 40mg, Orally and IntravenouslyCOMPLETEDPHASE42002-082002-102002-10
NCT00651651Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5COMPLETEDPHASE32002-082003-09
NCT00225589A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)COMPLETEDPHASE32002-082006-052006-05
NCT00234416IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic CancerCOMPLETEDPHASE1, PHASE22002-082005-03
NCT00590278A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal CancerCOMPLETEDPHASE22002-08
NCT00042601Evaluation of the Effect of Pramlintide on Satiety and Food IntakeCOMPLETEDPHASE22002-072003-102003-10
NCT00642187New Version Pulmicort Turbuhaler USA AdultsCOMPLETEDPHASE32002-072004-102004-10
NCT00626262Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and ivCOMPLETEDPHASE42002-072002-102002-10
NCT00652002Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5COMPLETEDPHASE32002-072004-01
NCT00651547Symbicort in Asthmatic Children - SEEDLINGCOMPLETEDPHASE32002-072003-10
NCT00646529Long-Term Safety of Symbicort in Asthmatic Children - SAPLINGCOMPLETEDPHASE32002-072003-10
NCT00252798ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung CancerCOMPLETEDPHASE12002-072005-10
NCT00255528Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric SubjectsCOMPLETEDPHASE32002-07
NCT00255502307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric SubjectsCOMPLETEDPHASE32002-07
NCT00042471Evaluation of the Bioavailability of PramlintideCOMPLETEDPHASE22002-062002-122002-12
NCT00637845Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)COMPLETEDPHASE42002-062003-022003-02
NCT00654173Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)COMPLETEDPHASE32002-062004-09
NCT00035984Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32002-052003-082003-08
NCT00254241Safety and Efficacy of Seroquel in First Episode SchizophreniaCOMPLETEDPHASE42002-052006-06
NCT00654485COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome SubjectsCOMPLETEDPHASE32002-052005-02
NCT00546520Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)COMPLETEDPHASE32002-042002-062002-06
NCT00042458Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose ControlCOMPLETEDPHASE32002-042003-032003-03
NCT00641979New Nasal Applicator / New Formulation - User StudyCOMPLETEDPHASE22002-042002-082002-08
NCT00637988Barrett's Esophagus - 315 - 3 Way Cross OverCOMPLETEDPHASE42002-042003-062003-06
NCT00254735Quetiapine Augmentation in Severe Obsessive Compulsive DisorderCOMPLETEDPHASE32002-042006-03
NCT00280865GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesCOMPLETEDPHASE22002-042003-06
NCT00039013Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCOMPLETEDPHASE32002-032003-062003-06
NCT00034892CAFE Comparison of Atypicals in First Episode of PsychosisCOMPLETEDPHASE32002-032005-032005-03
NCT00637559Barrett's Esophagus - 315 - 3 Way Cross-OverCOMPLETEDPHASE42002-032003-042003-04
NCT00653744Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)COMPLETEDPHASE32002-032004-03
NCT00039026Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaCOMPLETEDPHASE32002-022003-082003-08
NCT00628667Chronic Posterior Laryngitis With Suspected Laryngopharyngeal RefluxCOMPLETEDPHASE42002-022003-032003-03
NCT0065460248-wk Open Label Phase IIIb to Evaluate Efficacy and SafetyCOMPLETEDPHASE32002-022004-11
NCT00379249Rosuvastatin ORBITAL GermanyCOMPLETEDPHASE32002-022004-02
NCT00396240ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL GoalsWITHDRAWNPHASE42002-02
NCT00254774Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid CyclingCOMPLETEDPHASE32002-012006-03
NCT00235937Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus ZoladexCOMPLETEDPHASE22001-122006-12
NCT00657527Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery DiseaseCOMPLETEDPHASE32001-122002-12
NCT00305422Effect of Quetiapine on Negative Symptoms and CognitionCOMPLETEDPHASE32001-112003-01
NCT00654407Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb HypercholesterolemiaCOMPLETEDPHASE32001-112004-09
NCT00251927Esomeprazole (NEXIUM) vs. SurgeryCOMPLETEDPHASE32001-102009-042009-04
NCT00641446Varicella Vaccination With PulmicortCOMPLETEDPHASE42001-102003-102003-10
NCT02670642Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERDCOMPLETEDPHASE32001-082002-112002-11
NCT00252720DIabetic Retinopathy Candesartan Trials.COMPLETEDPHASE32001-082008-042008-02
NCT00252694DIabetic Retinopathy Candesartan TrialsCOMPLETEDPHASE32001-082008-042008-02
NCT00038077Reversal of Ventricular Remodeling With Toprol-XLCOMPLETEDPHASE32001-082003-092003-09
NCT00034905A Comparison of Seroquel vs. Risperidone in SchizophreniaCOMPLETEDPHASE42001-072002-092002-09
NCT00233584Pulmicort Asthma Prevention (Post-PAC)COMPLETEDNA2001-072006-062006-05
NCT00252733Diabetic Retinopathy Candesartan TrialsCOMPLETEDPHASE32001-062008-042008-04
NCT00641264Quality of Life Validation in LaryngitisCOMPLETEDPHASE42001-052003-062003-06
NCT00635856Open Label Trial to Assess Iressa in Prostate Cancer PatientsCOMPLETEDPHASE22001-052003-02
NCT00241553Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCOMPLETEDPHASE32001-042003-022003-02
NCT00632723IRESSA™ (Gefitinib) in Breast Cancer PatientsCOMPLETEDPHASE22001-042005-10
NCT00654537STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose RangesCOMPLETEDPHASE32001-042004-10
NCT00629512Prevention of Gastric UlcersCOMPLETEDPHASE32001-032002-122002-12
NCT00241514Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCOMPLETEDPHASE32001-022003-022003-02
NCT00629928Ulcer Prevention IICOMPLETEDPHASE32001-022003-032003-03
NCT00633672A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is ContinuedCOMPLETEDPHASE32001-022003-102003-10
NCT00633412A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US OnlyCOMPLETEDPHASE32001-022003-03
NCT00241540Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCOMPLETEDPHASE32001-012002-082002-08
NCT00239278Budesonide / Formoterol in Treatment of Exacerbations of COPDCOMPLETEDPHASE22001-012005-01
NCT00637182Gynecomastia Extension StudyCOMPLETEDPHASE32001-012002-102002-06
NCT00241527Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCOMPLETEDPHASE32000-122002-092002-09
NCT00034879Iressa Expanded Access Program (EAP)COMPLETEDPHASE32000-082003-102003-10
NCT00232661PROACT - Pre-Operative Arimidex Compared To TamoxifenCOMPLETEDPHASE32000-082007-122003-01
NCT00272740SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast CancerCOMPLETEDPHASE22000-03
NCT01523054Metoprolol in Acute Myocardial Infarction. A PK/PD StudyCOMPLETEDPHASE12000-022002-042002-04
NCT00635973Open-Label Extension of Other SZ1839 (Iressa) TrialsCOMPLETEDPHASE32000-022003-10
NCT00641212Children, Perennial Allergic Rhinitis (PAR), l-t GrowthCOMPLETEDPHASE42000-012003-042003-04
NCT00654394Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic SubjectsCOMPLETEDPHASE32000-012004-08
NCT00206063Long Term Open Follow-up With H376/95 vs. WarfarinTERMINATEDPHASE21999-082006-042004-06
NCT00654303OLE Study to Evaluate Safety / Efficacy of ZD4522COMPLETEDPHASE31999-082005-02
NCT00232674Efficacy Study of the Effect of Budesonide on EmphysemaCOMPLETEDPHASE41999-072004-02
NCT00634712Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)COMPLETEDPHASE31999-062003-052003-05
NCT00634309Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)COMPLETEDPHASE31999-062003-052003-05
NCT00634400Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)COMPLETEDPHASE31999-032003-052003-05
NCT00241449A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast CancerCOMPLETEDPHASE31998-112012-012007-03
NCT00234390PreAsthmaControl (PAC)COMPLETEDPHASE41998-112004-12
NCT00227318TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention TrialCOMPLETEDPHASE31998-072005-102005-10
NCT00784862ATAC - Pharmacokinetics (PK) Sub-ProtocolCOMPLETEDPHASE31998-061999-03
NCT00784940ATAC - Bone Density Sub-ProtocolCOMPLETEDPHASE31998-062007-042005-03
NCT00784680ATAC - Quality of Life Sub-ProtocolCOMPLETEDPHASE31998-042004-04
NCT00286117ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 YearsCOMPLETEDPHASE31998-032006-05
NCT00256737Sopran - Omeprazole Treatment Versus SurgeryCOMPLETEDPHASE31998-012005-102005-10
NCT00814125ATAC - Endometrial Sub-ProtocolCOMPLETEDPHASE31997-062005-12
NCT00635713Second Line Breast Cancer TrialCOMPLETEDPHASE31997-052004-09
NCT00287534Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.COMPLETEDPHASE21996-112004-09
NCT00641914Inhaled Steroid Treatment as Regular Therapy in Early AsthmaCOMPLETEDPHASE41996-102003-022003-02
NCT00849030ATAC - Arimidex, Tamoxifen Alone or in CombinationCOMPLETEDPHASE31996-072010-042001-06
NCT00291759ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.COMPLETEDPHASE31996-012009-062009-06
NCT003005083 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast CancerCOMPLETEDPHASE31996-01
NCT00672282Casodex vs Placebo in Non-Metastatic Early Prostate CancerCOMPLETEDPHASE31995-102008-08
NCT00673205(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate CancerCOMPLETEDPHASE31995-092008-082008-08
NCT00657904Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerCOMPLETEDPHASE31995-082008-082008-07
NCT00846976Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate CancerCOMPLETEDPHASE31994-122013-062013-06
NCT01194193Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced TumoursWITHDRAWNPHASE1
NCT00888082Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With ChemotherapyWITHDRAWNPHASE32012-042012-04